CURRICULUM VITAE NORBERT GLEICHER, MD Revised
-
Upload
khangminh22 -
Category
Documents
-
view
1 -
download
0
Transcript of CURRICULUM VITAE NORBERT GLEICHER, MD Revised
Page 2
CURRICULUM VITAE Norbert Gleicher, MD (email: [email protected])
Address The Center for Human Reproduction
21 E. 69th Street, New York, NY 10021
Telephone 212-994-4400
Date of Birth August 20, 1948
Place of
Birth
Cracow, Poland
Citizenship United States
Academic Background 1954-1966 Grammar and high school, Vienna, Austria
1966-1970 Vienna University School of Medicine
1970-1973 Tel-Aviv University School of Medicine, Tel-Aviv, Israel - MD Degree
1973-1974 Rotating internship, Ihilov Municipal Hospital, Tel-Aviv, Israel
1/1975-
6/1975
Research Fellow, Department of Obstetrics & Gynecology, Mount Sinai
Medical Center, New York (GYN-Tumor Immunology)
1975-1978 Residency in Obstetrics & Gynecology, Mount Sinai Medical Center, New
York; Chairman, S.B. Gusberg, MD
1978-6/1981 Assistant Professor, Department of Obstetrics & Gynecology, Mount Sinai
School of Medicine of the City University of New York
1981-1986 Assistant Professor of Immunology and Microbiology, Rush Medical College,
Chicago, Illinois
1981-1990 Professor of Obstetrics and Gynecology, Rush Medical College, Chicago,
Illinois
1987-1990 Associate Professor of Immunology and Microbiology, Rush Medical College,
Chicago, Illinois
1991-
04/1996
Professor of Obstetrics and Gynecology and Professor of Immunology,
Microbiology, the University of Health Sciences/Chicago Medical School,
North Chicago, Illinois
04/1996-
09/1999
Clinical Professor of Obstetrics and Gynecology, University of Illinois at
Chicago, Chicago, Illinois
2000-2002 Adj. Clinical Professor of Obstetrics and Gynecology, New York University
School of Medicine, New York, NY
2003-2011 Vis. Professor of Obstetrics and Gynecology, Yale University School of
Medicine, New Haven, CT
5/2015-
6/2017
Professor (Adjunct), Laboratory Stem Cell Biology and Molecular
Embryology, Rockefeller university, New York, NY
3/2016-
Present
Professor (Adjunct), Department of Obstetrics & Gynecology, Medical
University Vienna, Vienna, Austria
6/2017-
Present
Guest Investigator, Laboratory Stem Cell Biology and Molecular Embryology,
Rockefeller university, New York, NY
Medical Licenses
E.C.F.M.G. #2024628
State of New York #131555-1
(active)
Page 3
State of Virginia #28644
State of Illinois #036-062902
(active)
State of Indiana #01042178
State of California #A38772 (active)
State of Connecticut
State of Florida
Specialty Boards Diplomat, The American Board of Obstetrics and Gynecology 1981
Voluntary recertification 1999
Certifications Fellow, American College of Obstetricians and Gynecologists (FACOG)
Fellow, American College of Surgeons
Advanced Council for Gynecologic Endoscopy, Inc., Certification for advanced operative
laparoscopy and hysteroscopy.
The American Board of Obstetrics and Gynecology, 1981; Voluntary Recertification, 1998.
Professional Appointments 1/1979-
6/1981
Assistant Professor, Department of Obstetrics and Gynecology, Mount Sinai
School of Medicine of the City University of New York,
New York, New York Director, Laboratory of Reproductive Immunology. Assistant Attending, Department of Obstetrics and Gynecology, Mount Sinai
Services at Elmhurst General Hospital, Queens, New York Member, Student Promotions Committee, Mount Sinai School of Medicine, New
York Member, Curriculum Committee, Mount Sinai School of Medicine, New York
1/1979-
1/1981
Course Director of Reproduction Course (2nd year Medical School Curriculum);
Director of Medical Education, Department of Obstetrics and Gynecology
Mount Sinai School of Medicine; Course Director, Reproduction Section,
Pathophysiology Course, CUNY. New York
2/1979-
6/1981
Director, Division of Reproductive Immunology, Department of Obstetrics and
Gynecology, Mount Sinai School of Medicine, New York
7/1980-
1/1981
Chairman, Medical Education Committee, Department of Obstetrics and
Gynecology, Mount Sinai School of Medicine, New York
7/1980-
6/1981
Chairman, Subcommittee D of the Curriculum Committee, Mount Sinai School of
Medicine, New York
1981-2002 Chairman, The Center for Human Reproduction, Illinois
6/1981-
1990
Chairman, Department of Obstetrics and Gynecology, Mount Sinai Hospital
Medical Center, Chicago, Illinois
6/1981-
1990
Member and Chairman of many committees, Mount Sinai Hospital Medical
Center, Chicago, Illinois. Full list available on request.
1990-1994 Attending, Department of Obstetrics and Gynecology, Mount Sinai Hospital
Medical Center, Chicago, Illinois
1987-
Present
President, The Foundation for Reproductive Medicine
Page 4
1990-2004 Attending, Department of Obstetrics and Gynecology, Michael Reese Hospital
Medical Center, Chicago, Illinois
1990-2004 Attending, Department of Obstetrics and Gynecology, Grant Hospital, Chicago,
Illinois
1992-1993 Attending, Department of Obstetrics and Gynecology, St. Francis Hospital of
Evanston, Evanston, Illinois
1993-2004 Consultant, Department of Obstetrics and Gynecology, St. Francis Hospital of
Evanston, Evanston, Illinois
1995-1996 Consultant, Department of Obstetrics and Gynecology, Mount Sinai Hospital
Medical Center, Chicago, Illinois
1996-
3/1997
President, CEO and Chairman of the Board, GynCor Inc.
3/1997-
9/1998
CEO and Chairman of the Board, GynCor, Inc.
1998-1999 Chief Medical Officer and Chairman of the Board, GynCor, Inc.
1999-2004 Chairman, President, and Medical Director, The Center for Human Reproduction,
IL
1999-
Present
Chairman, President and Medical Director, Medical Offices for Human
Reproduction, New York
9/1999-
Present
Attending, Department of Obstetrics and Gynecology, Lenox Hill Hospital, New
York, New York
2000-2003 Visiting Professor, XX of Ob/Gyn, NYU University, New York, NY
2004-2010 Visiting Professor, Department of Ob/Gyn, Yale University, New Haven, CT
2015-2017 Professor (Adj), Rockefeller University, New York, NY
2017-
Present
Professor (Adj), Department of Ob/Gyn, Vienna Medical School, Vienna, Austria
2018-
Present
Guest Investigator, Rockefeller University, New York, NY
Editorial Boards 1979-1982 Editorial Board, The Mount Sinai Journal of Medicine
1990 Editor, “Seminars in Reproductive Medicine,” The Mount Sinai Journal of
Medicine
l980-2001 Editor-in-Chief, American Journal of Reproductive Immunology and
Microbiology, official organ of The American Society for the Immunology of
Reproduction
1983-2007 Editor-in-Chief, Journal of In Vitro Fertilization and Embryo Transfer; renamed
Journal of Assisted Reproduction and Genetics, 1992
1984-1990 1984-1990 Contributing Editor, The Mount Sinai Journal of Medicine
2008-
Present
Member, Expert Review in Obstetrics & Gynecology
2008 –
Present
Editorial Board Member, International Journal of Obstetrics and Gynecology
2009-2014 Editorial Board Member, RBMOnline
2012-
Present
Editorial Board Member, Asian Pacific Journal of Reproduction
Page 5
2012-
Present
Faculty Member, Faculty of 1000
2014-2019 Academic Editor, PLoS ONE Editorial Board
2015-
Present
Editorial Board Member, Endocrine
2015-
Present
Editorial Board Member, Journal of Reproductive Biology and Endocrinology
2017-
Present
Editorial Board Member, Journal of Translational Medicine
2021-
Present
Editorial Board Member, Clinical and Translational Medicine
Book Editorships
1. Gleicher N (ed): Reproductive Immunology. Progress in Clinical and Biological
Research, Volume 70. Alan R. Liss, Inc., New York, New York 1982.
2. Elkayam U, Gleicher N (eds): Cardiac Problems in Pregnancy. Diagnosis and
Management of Maternal and Fetal Disease. Alan R. Liss, Inc., New York, New York,
1982.
3. Gleicher N (ed.): Principles of Medical Therapy in Pregnancy. Plenum Publishing
Corporation, New York, New York; 1985.
4. Elrad H, Friberg J, Giglia R, Gleicher N, Mayden K (eds.): Handbook of Realtime
Ultrasonography in Obstetrics and Gynecology. Plenum Publishing Corporation New
York, New York; 1985.
5. Gleicher N (ed): Reproductive Immunology. Immunology and Allergy Clinics in North
America. W.B. Saunders Company, Philadelphia, Pennsylvania, 1989.
6. Elkayam U, Gleicher N (eds): Cardiac Problems in Pregnancy Diagnosis Management of
Maternal and Fetal Disease, 2nd edition. Alan R. Liss, Inc., New York, New York, 1990.
7. Gleicher N (ed): Principles and Practice of Medical Therapy in Pregnancy, 2nd edition.
Appleton & Lange, Norwalk, Connecticut, 1992.
8. Gleicher N (ed): Tubal Catheterization Procedures, Wiley-Liss, New York, New York,
1992.
9. Gleicher N (ed): Autoimmunity in Reproduction. Immunology and Allergy Clinics in
North America. W.B. Saunders Company, Philadelphia, Pennsylvania, 1994.
10. Elkayam U, Gleicher N. (eds): Cardiac Problems in Pregnancy, 3rd edition. Wiley-Liss,
Inc.; New York, New York, 1998.
11. Gleicher, N (ed): Managed Care: Infertility and Reproductive Medicine Clinics of North
America. W.B. Saunders Company, Philadelphia, Pennsylvania, January 1998.
12. Gleicher N (ed): Principles & Practice of Medical Therapy in Pregnancy, 3rd edition.
Appleton & Lange, Stamford, Connecticut, 1998.
Guest Editorships
1. Reproductive Immunology: “Festschrift in honor of Saul B. Gusberg, M.D., D.SC”,
Mount Sinai J Med l980; 47:5.
2. Reproductive Immunology: Immunology & Allergy Clinics of North America 1990;
10:1:W.B. Saunders Company, Philadelphia, Pennsylvania, February 1990.
3. Autoimmunity in Reproduction: Immunology & Allergy Clinics of North America; 14:4;
W.B. Saunders Company, Philadelphia, Pennsylvania, November 1994.
Page 6
4. Managed Care: Infertility & Reproduction Medicine Clinics of North America; 9:1; W.B.
Saunders Company, Philadelphia, Pennsylvania, January 1998.
Memberships
American Association of Gynecologic Laparoscopists
American College of Obstetrics and Gynecologists (ACOG)
American College of Physician Executives
American College of Surgeons
American Federation for Clinical Research
American Institute of Ultrasound in Medicine
American Medical Association
American Medical Society of Vienna
American Society for the Immunology of Reproduction
American Society for Reproductive Medicine (formerly AFS)
American Society of Abdominal Surgeons
Association of Professors of Gynecology and Obstetrics (until 1990)
Central Association of Obstetricians and Gynecologists
Chicago Association of Gynecologic Endoscopists
Falloppius International Society (FIS)
Federation of American Societies for Experimental Biology
GynecoRadiology Society (now Special Interest Group – Imaging, ASRM)
Illinois Perinatal Association
International Association of Private Assisted Reproductive Technology Clinics and
Laboratories
International Society for Gynecologic Endoscopy
International Society for the Study of Hypertension in Pregnancy
Israel Medical Society
Reproductive Biology Professional Group of the American
Society for Assisted Reproductive Technology
Society for Male Reproduction and Urology of the American Society for Reproductive
Medicine
Society for Reproductive Investigation
Society for Reproductive Medicine
Society of Obstetric Medicine
The American Association of Immunologists
The Chicago Gynecological Society
The Endocrine Society
The New York Academy of Sciences
The New European Surgical Academy
Yale Obstetrical and Gynecological Society
World Association of Medical Editors (WAME)
Grants
In addition to the continuous support from the Foundation for Reproductive Medicine:
07/79-06/80 Lalor Foundation Fellowship
07/79 The Beckman Company
Page 7
07/80-06/81 Lalor Foundation Fellowship (renewal)
01/82-12/82 Development and Research Contract, Kontron Medical
Instruments
1982-1983 Family Focus Grant, State of Illinois
1983-1984 Family Focus Grant, State of Illinois (Renewal)
1983-1984 Family Planning Center Grant
1985-1987 Institutional Grant, Mount Sinai Hospital
1986-1987 Sears, Cesarean Section Community Grant
1988 Blue Cross/Blue Shield of Illinois
Cesarean Section Reduction Initiative Grant
1988 Blue Cross/Blue Shield of Illinois Consultation Services Grant
1988 Estrogen Equivalence Study, PBI, Denver, CO 80223
1988-1990 Transvaginal Balloon Tuboplasty Study, Multicenter Study with Mount
Sinai Hospital Medical Center as lead center. C.R. Bard, Inc.,
Billerica, MA 01821
1988-1994 Consultation Contract and Development Support; Bard Reproductive
Systems, Billerica, MA 01821
Honors and Awards
06/79 “The Dr. Solomon Silver Award in Clinical Medicine,” presented by “The
Richard and Hilda Rosenthal Foundation” at the Mount Sinai Medical
Center, New York, New York.
06/80 Program Director, The First S. B. Gusberg Seminar on Reproductive
Immunology, New York, June 26 and 27, l980.
06/80-
1983
Vice-President, American Society for the Immunology of Reproduction.
12/80 Co-Director, Mount Sinai Update: Medical and Surgical Complications of
Pregnancy. Postgraduate Course of the Mount Sinai School of Medicine,
New York, December 11 and 12, l980.
06/8l Program Chairman, The Second International S. B. Gusberg Symposium
01/82 Board Member, Professional Education Committee, American Cancer
Society, Chicago Unit, Chairman, Physicians’ Subcommittee.
05/82 Member, The International Coordination Committee for the Immunology of
Reproduction.
06/82 Session Chairman, Third Annual International Symposium on the
Immunology of Reproduction, Winston-Salem, North Carolina, June 23-
26, 1982.
1982 Reviewer, National Institutes of Health (Site visit team).
10/82 Invited Panelist, The Third World Congress of the International Society for
the Study of Hypertension
03/83 Co-Director, A Seminar on In Vitro Fertilization, Chicago, Illinois.
06/83 Moderator: Immunology—Infections, Fourth Annual Chicago Area Schools
of Medicine Review Course in Obstetrics and Gynecology, June 6-11,
1983.
Page 8
06/83 Moderator: Immunologic Environment of the Uterus and Mammary Gland.
Fourth International Symposium of the American Society for the
Immunology of Reproduction. Park City, Utah, June 8-11, 1983.
11/83 Program Director: Medical Complications of Pregnancy. Postgraduate
Course, Chicago, Illinois, November 11-12, 1983.
11/83 Program Director: Basic and Advanced Realtime Ultrasonography in
Obstetrics and Gynecology, Chicago, Illinois, November 30 - December
2, 1983
01/84 Session Chairman: Diagnosis and Management of Maternal and Fetal Heart
Disease. A Postgraduate Course, sponsored by the University of Southern
California, Beverly Hills, California, January 13-14, 1984.
05/84 Session Chairman, 3rd World Congress of In Vitro Fertilization and Embryo
Transfer, Helsinki, Finland, May 14-17, 1984.
11/84 Program Director: Medical Complications of Pregnancy Postgraduate Course,
Chicago, Illinois, November 9-10, 1984.
5/85 Session Chairman, The 6th International Symposium on the Immunology of
Reproduction, Varna, Bulgaria, May 31 - June 2, 1985.
06/85 Reviewer, National Institutes of Health, (site visit team), Study Section
HDMC.
08/85 Member, Special Study Section, NICHD for RFA.
09/85 Special Outside Consultant, NICHD.
10/85 Official invited discussant of the Annual PrizePaper of the Central
Association of Obstetrician and Gynecologist: Branch et al: The lupus
anticoagulant: A recently recognized and treatable cause of recurrent
abortion and fetal death. New Orleans, October 10, 1985.
11/85 Boler L., Zbella EA, Gleicher N: Quantitation of proteinuria in pregnancy.
The use of single voided urine samples. American College of Surgeons
Meeting, Chicago Chapter, November 30, 1985 (2nd prize paper).
03/86 Chairperson, Special Study Section NICHD, RFA, Mechanisms of
Immunologic Infertility.
04/86 Session Chairman, Future Aspects in Human In Vitro Fertilization Congress,
Vienna Austria, April 2-4, 1986.
04/86 Official Guest Visitor of the Bulgarian Academy of Sciences, Sofia, Bulgaria,
April 7-10, 1986.
04/86 Session Chairman, New Aspects in Clinical IVF. At the Future Aspects in
Human In Vitro Fertilization Congress, Vienna Austria, April 2-4, 1986.
09/86 Session Chairman, Free Communications. At the Fourth Annual Meeting of
the Society for the Advancement of Contraception, Chicago, IL,
September 23-26, 1986.
10/86 Visiting Professor, Tokyo University, Tokyo, Japan.
10/87 Invited Honorary Speaker, Annual Meeting of the Korean Association of
Obstetricians and Gynecologists, Seoul, South Korea, October 16 and 17,
1987
10/87 Visiting Professor, Niigata University, Japan, October 19 - 21, 1987.
10/87 Visiting Professor, Nagoya University, Japan, October 22 -25, 1987.
Page 9
10/87 Chairman, Workshop, Immunodiagnosis and Immunotherapy in
Reproduction, 6th World Congress on Human Reproduction, Tokyo,
Japan, October 25 - 30, 1987.
10/87 Invited Plenary Speaker, Symposium on Immunology of Pregnancy. Idem.
11/87 Visiting Professor, Department of Obstetrics and Gynecology, Wayne State
University, November 24, 1987.
08/88 Invited Panelist, Immunotherapy of Recurrent Spontaneous Abortion.
Immunological Obstetrics Symposium. Indianapolis, Indiana, August 5-7,
1988.
08/88 Moderator: Autoimmunity in Pregnancy. Immunological Obstetric
Symposium. Indianapolis, Indiana, August 5-7, 1988.
12/88 Course Director, Postgraduate Course on Recent Developments in Obstetrics
and Gynecology. Chicago, Illinois, December 8-10, 1988.
04/89 Invited speaker, 6th World Congress of In Vitro Fertilization and Alternate
Assisted Reproduction, Jerusalem, Israel, April 2-7, 1989.
04/89 Co-chairman, Session on Male Infertility, 6th World Congress of In Vitro
Fertilization and Alternate Assisted Reproduction, Jerusalem, Israel, April
6, 1989.
04/89 Co-chairman, International Meeting on Pregnancy Loss, Tel-Aviv, Israel,
April 9-12, 1989.
04/89 Invited speaker, International Meeting on Pregnancy Loss, Tel-Aviv, Israel,
April 9-12, 1989.
07/89 Invited Workshop Chairman: 4th International Congress of Reproductive
Immunology. Kiel, FRG, July 26-29, 1989.
10/89 Visiting Professor, Department of Obstetrics and Gynecology, Keio
University, Tokyo, Japan.
10/89 Visiting Professor, Department of Obstetrics and Gynecology, Nagoya
University, Nagoya, Japan.
11/89 Transcervical Balloon Tuboplasty: A Multicenter Study. Price paper of the
General Program of The 45th Annual Meeting of The American Fertility
Society, San Francisco, CA, November 13, 1989.
01/90 Course Director, Postgraduate Course on “The Modern Approach to Tubal
Occlusion - Transcervical Balloon Tuboplasty (T.B.T).” Chicago, Illinois,
January 26-27, 1990.
02/90 Course Director, Postgraduate Course on “The Modern Approach to Tubal
Occlusion - Transcervical Balloon Tuboplasty (T.B.T.).” Los Angeles,
California, February 23, 1990.
03/90 Session Chairman and Invited Speaker. Workshop on Retrograde Tubal
Catheterization, Centre Francais du Commerce Eterieur, Paris, France,
March 2-3, 1990.
03/90 Course Director, Postgraduate Course on “The Modern Approach to Tubal
Occlusion - Transcervical Balloon Tuboplasty (T.B.T.).” New York, New
York, March 30 -31, 1990.
06/90 Program Chairman, Tenth Anniversary Meeting of the American Society for
the Immunology of Reproduction. Chicago, Illinois, June 20-23, 1990.
06/90 Session Co-chairman, Plenary session on workshop reports. Idem.
Page 10
06/90 Session Co-chairman, Immunology of Reproduction. 7th World Congress on
Human Reproduction. Helsinki, Finland, June 2 - July 1, 1990.
06/90 Session Co-chairman, Technical advances. Idem.
08/90 International Advisory Committee of The International Conference on
Rheumatic Disease in Pregnancy, Jerusalem, Israel, May 17-22, 1992.
10/90 Moderator, Gynecology/Obstetrics Panel Discussion. “What’s New in In
Vitro Fertilization and Other Assisted Reproductive Technologies?” 1990
Clinical Congress of the American College of the American College of
Surgeons. San Francisco, October 7-12, 1990 (10/8/90).
10/90 Moderator, Surgical Forum on Gynecology and Obstetrics: Idem (10/10/90).
10/90 Panelist, Gynecology and Obstetrics Panel Discussion: Management of
Recurrent Pregnancy Loss. Idem (10/11/90).
10/90 Formal discussant of Martin Jr., JN et al: The Natural History of HELPP
Syndrome: Patterns of Disease Progression and Regression. 58th Annual
Meeting of The Central Association of Obstetricians and Gynecologists.
Louisville, Kentucky, October 11-13, 1990 (10/12/90).
10/90 Chairman Roundtable Luncheon: Transcervical Balloon Tuboplasty (T.B.T.).
46th Annual Meeting of the American Fertility Society, Washington,
D.C., October 13-18, 1990 (10/17/90).
05/91 Ehrenkreutz fur Wissenschaft und Kunst. The Knight’s Cross of the Order of
the Arts & Sciences of the Republic of Austria.
07/91 Panelist, Is There One Best Way For Sperm Processing: 4th Annual In Vitro
Fertilization and Embryo Transfer – UCLA School of Medicine, Santa
Barbara, California, July 28-31, 1991.
10/91 Chairman Roundtable: Transvaginal Tubal Catheterization Procedures. 1991
Annual Meeting of the American Fertility Society, Orlando, FL, October
20-25, 1991 (10/21/91).
10/91 Member of International Scientific Advisory Committee, 8th World Congress
on In Vitro Fertilization & Alternate Assisted Reproduction, Kyoto,
Japan, Sept.12-15, 1993. Symposium Participant: Immunobiology of
Pregnancy.
10/91 State of Illinois Senate Resolution No. 772 offering the congratulations of the
87th General Assembly on receiving The Ehrenkreutz fur Wissenschaft
und Kunst of the Republic of Austria.
11/91 Invited speaker, The Society for Minimally Invasive Therapy, Third
International Meeting, Boston, MA; November 10-12, 1991.
01/92 Invited speaker, 13th Japan Endometriosis Symposium, Tokyo, Japan;
January 24-25, 1992.
04/92 Invited speaker: Third Conference, Endocrinology and Metabolism in Human
Reproduction: The Fallopian Tube. The Royal London Hospital, London,
UK, April 1-3,1992.
05/92 Visiting Professor, Department of OB/GYN, University of Heidelberg;
Germany; May 14, 1992.
05/92 Invited lecturer “International Conference on Rheumatic Diseases in
Pregnancy”, Jerusalem, Israel, May 17 to 22, 1992.
Page 11
05/92 Invited lecturer “Update in Obstetrics and Gynecology”, University of
Missouri-Kansas City School of Medicine; Kansas City, Missouri, May
27- 29, 1992.
08/92 Session Chairman, 5th International Congress of Reproductive Immunology,
Rome, Italy, August 30 to Sept 3, 1992.
10/92 Invited Panel Moderator “Tubal Cannulation: A New Horizon,” 1992,
American College of Surgeons 78th Annual Clinical Congress; New
Orleans, Louisiana, October 11-16, 1992.
10/92 Invited lecturer, “Reducing Cesarean Section Rates”, Evergreen Hospital
Medical Center, Kirkland, Washington, October 20, 1992.
11/92 Invited lecturer, “Abnormal Autoimmunity and Endometriosis,” 14th World
Congress on Fertility and Sterility, Caracas, Venezuela, November 24,
1992.
1992-
1994
President, GynecoRadiology Society (Precursor organization to Imaging in
Reproductive Medicine Special Interest Group of ASRM)
04/93 Invited lecturer, “Immunologic Theories of Endometriosis: Role of Humoral
Immunity,” VIIIth World Congress on Human Reproduction. Joint IVth
World Conference on Fallopian Tube in Health and Disease, Bali
Indonesia, April 5, 1993.
05/93 Invited Speaker, “Surgery in the Pregnant Cardiac Patient” Women and Heart
Disease, Creighton University School of Medicine, Cardiology Division,
Continuing Medical Education Division, Creighton Cardiac Center,
Omaha, Nebraska, May 22, 1993.
06/93 Invited Panelist, In Vitro Fertilization, Artemisia News – editoriale di cultura
medica – June 1993.
09/93 Invited lecturer, “The Immune System in ART,” 8th World Congress on In
Vitro Fertilization and Alternate Assisted Reproduction, Kyoto, Japan,
September 13, 1993.
09/93 Invited lecturer, “Gynecoradiology: A New Approach to the Investigation and
Treatment of Infertility,” International Symposium of New Reproductive
Technology - Endoscopic Transcervical Approaches, Tokyo Japan,
September 16-19, 1993.
1993 Secretary/Treasurer, World Academy for Medical Education, Vienna, Austria.
04/94 Visiting Professor, Department of OB/GYN, St. Louis University, St. Louis,
MO, April 7, 1994.
05/94 Session Chairman, “New Trends in the Immunologic Aspect of
Endometriosis,” 4th World Congress on Endometriosis, Salvador, Bahia,
Brazil, May 26, 1994.
05/94 Permanent Panelist “Second Opinion,” weekly TV program on CNBC in
affiliation with AMA and JAMA, George D. Lundberg, editor.
10/94 Invited Plenary Keynote Speaker 13th Annual Scientific Meeting of the
Fertility Society of Australia, Brisbane, Australia, October 3-7, 1994.
10/94 Session Chairman, Combined Fertility Society of Australia and Australian
Gynecological Endoscopy Society, 4th Annual Scientific Meeting,
Brisbane, Australia, October 6, 1994.
11/94 Co-Chairman, Conference “New Health Care Horizons for Europe. Defining
Page 12
and Managing Change,” sponsored by the World Academy for Medical
Education, and the Federal Government of Austria, Vienna, Austria,
November 25-27, 1994.
11/94 Grand Rounds-CHR, Michael Reese Hospital and Medical Center,
“Gynecoradiology: A New Diagnostic and Therapeutic Approach to
Infertility,” Chicago, Illinois, November 30, 1994.
03/95 Chairman Session 3: Ultrasound Diagnosis of Ectopic Pregnancy, Fifth
Conference Endocrinology and Metabolism in Human Reproduction.
03/95 Ectopic Pregnancy: Advances in Diagnosis and Treatment. Royal College of
Obstetricians and Gynecologists, March 27-29, 1995, London, England
04/95 Member International Scientific Advisory Committee, 9th World Congress on
In Vitro Fertilization and Assisted Reproduction, Vienna, Austria, April 3-
7, 1995.
04/95 Chairman, Session on Preimplantation Genetic Diagnosis, 9th World
Congress on In Vitro Fertilization and Assisted Reproduction, Vienna,
Austria, April 3-7, 1995.
04/95 Keynote Speaker, “What Infertility Patients Thins about Multi-conceptions: Is
it time to Re-Evaluate Current Practice Patterns?” 9th World Congress on
In Vitro Fertilization and Assisted Reproduction, Vienna, Austria, April 3-
7, 1995.
04/95 Invited Speaker, “Ovarian Stimulation and Hyperstimulation,” Satellite
Symposium of the 9th World Congress on IVF and Assisted
Reproduction, Budapest, Hungary, April 7-9, 1995.
05/95 Invited Speaker, “Overview of Reproductive Immunology,” 197th Annual
Meeting of the Medical and Chirurgical Faculty of Maryland, College
Park, May 6, 1995.
05/95 Consultant to the Ministry of Health, Peoples Republic of China, May 8 - 13,
1995.
05/95 Speaker, “The Role of Outcome Studies in Allergy & Clinical Immunology”
197th Annual Meeting of the Medical and Chirurgical Faculty of
Maryland, College Park, May 26, 1995
06/95 Speaker, “A Dialogue With the Austrian Medical Legal Mission,” sponsored
by the Illinois Department of Public Health, James R. Thompson Center,
Chicago, Illinois, June 1, 1995.
07/95 Session Chairman, “Response to signals: Late pregnancy,” Joint meeting of
the American Society for Reproductive Immunology and The
International Society for Immunology of Reproduction, Washington,
D.C., July 19-23, 1995.
09/95 Invited Speaker, “Cost Containment & Utilization Containment in OB/GYN,”
Illinois Association of Health Maintenance Organizations,” Ritz Carlton
Hotel, Chicago, Illinois, September 21, 1995.
10/95 Invited Speaker, “Active Labor/C Section,” Grand Rounds-CHR, North Shore
University Medical School, Manhasset, Long Island, New York, October
25, 1995.
12/95 Advisory Board, The Turkish Health & Therapy Foundation.
01/96 Invited Speaker, “Corticosteroid and Immunosuppressive Therapy in
Page 13
Reproductive Autoimmune Failure Syndrome,” International Conference
on Recurrent Abortion, Rome, Italy, January 27, 1996.
01/96 Session Chairman, International Conference on Recurrent Abortion, Rome,
Italy, January 27, 1996.
03/96 Invited Speaker, “Developing Winning Strategic Alliances” Physician
Practice Management Companies Seminar, Ambassador West Hotel,
Chicago, Illinois, March 14, 1996.
03/96 Invited Speaker, “The Physician Perspective: The Pros and Cons of
Affiliating with a PPMC” Physician Practice Management Companies
Seminar, Ambassador West Hotel, Chicago, Illinois, March 15, 1996.
04/96 Faculty Position, “Tubal Cannulation,” International Society for Gynecologic
Endoscopy, Chicago, Illinois, April 17, 1996.
05/96 Invited Speaker, “Immunology of Implantation,” Organon Symposium on
Assisted Reproductive Immunology, Chicago, Illinois, May 2, 1996.
05/96 Invited Speaker, “The Changing World of Infertility in an ERA of Managed
Care,” Assisted Reproduction: State-of-the-Art Then and Now, Chicago,
Illinois, May 2-4, 1996.
09/96 Grand Rounds-CHR, University of South Florida College of Medicine,
“Clinical Relevance of Reproductive Immunology,” Tampa, Florida,
September 11, 1996.
09/96 Invited Speaker, Smith Barney Second Annual Conference on Emerging
Sectors in Healthcare, “Managed Care” Plaza Hotel, New York, NY,
September 25, 1996.
09/96 Invited Panel Moderator Sonography- International Congress of Sonography,
AAGL 25th Annual Meeting, Chicago, Illinois, September 26, 1996.
09/96 Invited Panel Chairman, “Managed Care,” International Congress of
Gynecologic Endoscopy, AAGL 25th Annual Meeting, Chicago, Illinois,
September 27, 1996.
09/96 Invited Discussant, Ultrasound and Fetoscopy, AAGL 25th Annual Meeting,
Chicago, Illinois, September 28, 1996.
09/96 Co-chair of Technical Exhibits Committee, AAGL 25th Annual Meeting,
Chicago, Illinois, September 25-29, 1996.
10/96 Invited Speaker, “Autoantibodies as an Infertility Factor,” 5th World
Congress on Endometriosis, Yokohama, Japan, October 21, 1996.
11/96 Seminar Leader, “Infertility for Managed Care,” American Society for
Reproductive Medicine 52nd Annual Meeting, Boston, Massachusetts,
November 2-6,1996.
02/97 Invited Speaker, “GynCor, Inc.: The Management Challenge in Reproductive
Medicine”, Smith Barney’s Fifth Annual Health Care Services
Conference, Plaza Hotel, New York City, February 10-14, 1997.
02/97 Co-Moderator, “Diagnosis and Therapeutic Radiologic Intervention”,
American Association of Gynecologic Laparoscopists, “Managed Care
and Reimbursement for Fertility Surgery”, First Trimester Pregnancy
Loss” Squaw Valley, California, February 20-23, 1997.
05/97 International Advisory Committee. 10th World Congress on In Vitro
Fertilization and Assisted Reproduction, Vancouver, B.C., Canada, May
Page 14
24-28, 1997.
05/97 Co-Chair, “Ovarian Hyperstimulation Syndrome”, 10th World Congress on In
Vitro Fertilization and Assisted Reproduction, Vancouver, B.C., Canada,
May 24-28, 1997.
08/97 Grand Rounds-CHR, University of Illinois at Chicago College of Medicine,
“Impact of Managed Care on Obstetrics and Gynecology,” Columbia-
Michael Reese Hospital and Medical Center, August 13, 1997.
09/97 International Advisory Committee and Faculty: Second International
Symposium on Preimplantation Genetics, Chicago, Illinois, September
18-21, 1997.
01/98 Session Co-Chair: “Oocyte Manipulation Techniques,” Treatment of
Infertility: The New Frontiers. Boca Raton, Florida, January 1998.
03/98 Scientific Committee: International Association of Private Assisted
Reproductive Technology Clinics and Laboratories.
10/98 Organizing Committee: 7th International Congress of Reproductive
Immunology, New Delhi, India, October 27-30, 1998.
10/98 Session Co-Chair: “Immunobiology of Pregnancy,” 7th International
Congress of Reproductive Immunology, New Delhi, India, October 27-30,
1998.
10/98 Session Co-Chair: “Role of Lymphomyeloid Cells, HLA-G and Antibodies in
Pregnancy,” VII International Congress of Reproductive Immunology,
New Delhi, India, October 27-30, 1998.
10/99 Organizing Committee: 3rd International Congress on Autoimmunity,
Geneva, Switzerland, February 20-24, 2002.
1999 Ground Rounds – CHR, Lenox Hill Hospital, 1999
2000 Reviewer for PIER, the Physicians Information and Education Resource, a
project of the American College of Physicians – American Society of
Internal Medicine
01/01 Chicago Magazine – Best physician (Reproductive Endocrinology/Infertility –
Year 2000)
1999 Scientific Committee: International Association of Private Assisted
Reproductive Technology Clinics and Laboratories.
07/01 Session Co-Chair: “The Reproductive Autoimmune Failure Syndrome,
(RAFS),” VIII International Congress of Reproductive Immunology,
Opatija, Croatia, July 2-6, 2001
09/01 Session Co-Chair: “Ovulation Induction and Insemination,” 2nd World
Congress on Controversies in Obstetrics Gynecology & Infertility Paris,
France, September 6-9, 2001
09/01 Invited Speaker, “Forget About Ovulation Induction Proceed Directly to
IVF!” 2nd World Congress on Controversies in Obstetrics Gynecology &
Infertility, Paris, France, September 8, 2001.
11/01 Scientific Committee, First World Congress on Men’s Health and the Board
of the International Society on Men’s Health, Vienna, October 25–27,
2002
10/04 Member of the International Board of the New European Surgical Academy,
Berlin, Germany, October 29, 2004
Page 15
11/04 Session Chair and Advisory Board Member, Asian Pacific Congress on
Controversies in Obstetrics, Gynecology, and Infertility, Bangkok,
Thailand, November 25-28, 2004
05/05 International Advisory Committee Member, 13th World Congress on In Vitro
Fertilization, Assisted Reproduction & Genetics, Istanbul, Turkey, May
26-29, 2005
05/06 Invited Keynote Speaker, The International Ovarian Conference, Yokohama,
Japan, May 13, 2006
09/06 Invited Speaker, “Selected Research Update at CHR”; Grandrounds,
Department of Ob/Gyn, Sheba Medical Center, Tel Haschomer Hospital,
Sackler School of Medicine of Tel Aviv University, September 26, 2006.
09/06 Invited Speaker, “Selected Research Update at CHR”; Grandrounds,
Department of Ob/Gyn, Ashkelon Medical Center, Ben Gurion University
School of Medicine, September 27, 2006.
10/06 Invited Roundtable Speaker, “Pitfalls of hysterosampingography”; 62nd
Annual Meeting of the Society for Reproductive Medicine, New Orleans,
October 25, 2006
03/07 Invited Speaker, “The Aging Ovary”; Grandrounds, NYU Medical Center of
NYU School of Medicine, New York
03/07 Invited Discussant, “Is PGD Indicated for Everybody?”; World Congress of
Controversies in Obstetrics and Gynecology, Barcelona, Spain, March 22-
25, 2007
03/07 Expert Panel, “Controversies in IVF”; World Congress of Controversies in
Obstetrics and Gynecology, Barcelona, Spain, March 22-25, 2007
03/07 Chairman, “Session on Ovarian Stimulation”; World Congress of
Controversies in Obstetrics and Gynecology, Barcelona, Spain, March 22-
25, 2007
03/07 Chairman, “Session on Gamete and Ovarian Cryopreservation”; World
Congress of Controversies in Obstetrics and Gynecology, Barcelona,
Spain, March 22-25, 2007
03/07 Invited Speaker, “The Aging Ovary”; Grandrounds, Department of Ob/Gyn,
Hadassah Hospital and Hebrew University School of Medicine,
Jerusalem, Israel, March 26, 2007.
03/07 Invited Speaker, “The Aging Ovary”; Grandrounds, Department of Ob/Gyn,
Assuta Hospital, Tel Aviv, Israel and Sackler School of Medicine, Tel-
Aviv University, Israel, March 27, 2007.
04/07 Invited Speaker, “The Aging Ovary”; Grandrounds, Department of Ob/Gyn.
Allgemeubes Krankenhaus and Vienna University School of Medicine,
April 5, 2007.
05/07 Invited Speaker, “Premature Ovarian Aging”; Grandrounds, Department of
Ob/Gyn and Reproductive Sciences, Yale University School of Medicine,
New Haven, CT, May 3, 2007.
05/07 Invited Speaker, “The Aging Ovary”; 1st International Symposium in
Genetics and Assisted Reproduction Techniques, King George Palace
Hotel, Athens, Greece, May 5, 2007.
05/07 Invited Speaker, “Gynecoradiology”; Grandrounds, Southern California
Page 16
Reproductive Center, Beverly Hills, California, May 25, 2007.
09/07 Invited Speaker, “Twins in ART- A desirable outcome?”; 14th World
Congress on In Vitro Fertilization and 3rd World Congress on In Vitro
Maturation, Montreal, Canada, September 15-19, 2007.
09/07 Invited Speaker, “IVF in Older Women”; 23rd Annual Congress of the
Austrian Society for Reproductive Medicine and Endocrinology,
Innsbrick, Austria, September 20-22, 2007.
11/07 Invited Speaker, The International Ovarian Conference, Hakone, Japan,
November 2-3, 2007.
11/07 Invited Speaker, International Symposium, Genetics and Immunology of
Reproduction, Buenos Aires, Argentina, November 7-8, 2007.
11/07 Member Advisory Committee (SAC), Assisted Reproductive Techniques
Outcome Registry of Argentina (ARTORA).
06/08 Chosen to deliver 2009 Annual Patrick Steptoe Memorial Lecture of the
British Fertility Society. Keynote lecture title: “Infertility Treatment
2009: as good as it gets.”
10/08 Invited Speaker, “The FMR1 Gene as a Fertility Test”; Grandrounds, Yale
University School of Medicine, New Haven, Connecticut, October 30,
2008.
11/08 Advisory Board Member, IVF-Worldwide.com.
11/08 Chairman, Session on Assessment of Ovarian Reserve, 11th World Congress
on Controversies in Obstetrics and Gynecology, Paris, France, November
27-30, 2008.
11/08 Panelist, Round Table Discussion: Clinical Aspects of ART, 11th World
Congress on Controversies in Obstetrics and Gynecology, Paris, France,
November 27-30, 2008.
11/08 Panelist, Session on Multiple Pregnancies and Embryo Transfer (ET), 11th
World Congress on Controversies in Obstetrics and Gynecology, Paris,
France, November 27-30, 2008.
01/09 Gleicher N. Infertility treatment 2009: as good as it gets? Patrick Steptoe
Memorial Lecture; Fertility 2009, Bi-Annual Combined Meetings of the
British Fertility Society, The Association of Clinical Embryologists and
Society for Reproduction and Fertility; Edinburg International Conference
Center.
01/09 Gleicher N. Should we ever make a diagnosis of unexplained infertility?
Fertility 2009, Bi-Annual Combined Meetings of the British Fertility
Society, The Association of Clinical Embryologists and Society for
Reproduction and Fertility; Edinburg International Conference Center.
01/09 Gleicher N. The FMR1 gene as a fertility test. Masterclass in Reproductive
Medicine, Specialist Meeting in Reproductive Medicine; Apex City Hotel,
Edinburg.
01/09 Gleicher N. An update on DHEA supplementation. Masterclass in
Reproductive Medicine, Specialist Meeting in Reproductive Medicine;
Apex City Hotel, Edinburg.
02/09 Gleicher N. “Can we possibly affect follicular recruitment?” New Frontiers in
Fertility. Serono Symposia International Foundation, Lisbon, Portugal,
Page 17
February 13-14, 2009.
11/09 Co-Chair, Session Polycystic Ovarian Syndrome (PCOS) in the Asia-Pacific
Region. Organized and endorsed by The Asia and Oceana Federation of
Obstetrics and Gynecology (AOFOG). The 3rd Asia Pacific Congress on
Controversies in Obstetrics, Gynecology & Infertility, Beijing, China,
November 12-15, 2009.
12/09 Invited Speaker, The International Ovarian Conference 2009, Tokyo, Japan,
December 5, 2009.
12/09 Invited Speaker, Meeting of the Japan Infertility Study Group (ISG), Tokyo,
Japan, December 6, 2009.
2/10 Chairman, Opening Session, First International Congress on Cardiac
Problems in Pregnancy, Valencia, Spain, February 25-28, 2010
2/10 Invited Faculty, First International Congress on Cardiac Problems in
Pregnancy, Valencia, Spain, February 25-28, 2010
11/10 Invited speaker: Gleicher N. Poor responders: what’s new? Tecnobios
Procreazione Symposium 2010. Bologna, Italy, Nov. 24-25, 2010.
9/11 Invited speaker: Gleicher N. Are twins an adverse outcome after infertility
treatments? Fifth Isala Fertility Symposium. Zwolle, the Netherlands, Sep.
23, 2011.
11/11 Invited speaker: Gleicher N. Genetic issues related to the oocyte: the FMR1
gene. First meeting of the Ovarian Club, Barcelona, Spain, November 3-6,
2011.
11/11 Invited speaker: Gleicher N. Rejuvenating ovarian function: DHEA improves
IVF outcomes and reduces aneuploidy. First meeting of the Ovarian Club,
Barcelona, Spain, November 3-6, 2011.
11/11 Chairperson, Session “Ovarian aging: Assessment, Implications and New
Technologies.” First meeting of the Ovarian Club, Barcelona, Spain,
November 3-6, 2011.
11/11 Chairperson, Session “What can we do to improve implantation?” 4th Asia
Pacific Congress on Controversies in Obstetrics, Gynecology and
Infertility. Bangkok, Thailand, November 24-24, 2011.
03/12 Invited speaker: Gleicher N. “The Most Important, Largely Unknown Gene in
Reproductive Medicine and Beyond: the FMR1 Gene.” Greater Toronto
Area Reproductive Medicine Rounds, Toronto, Canada, March 22, 2012.
09/12 Member, International Scientific Board, New European Surgical Academy
Palmaplanas Innovation Days, Palma de Mallorca, Spain, September 13-
15, 2012.
05/12 Chairperson, How can we diagnose and improve the endometrium in infertile
patients. The World Congress on Building Consensus in Gynecology,
Infertility and Perinatology (BCGIP), Barcelona, Spain, May 3 – 6, 2012.
05/12 Invited speaker: Gleicher N. “Chromosomes and autoimmunity: The FMR1
gene.” American Autoimmune Related Diseases Association’s Scientific
Colloquium “Sex, Gender and Autoimmunity through the Lifespan.”
Chicago, IL, USA, May 17, 2012.
05/12 Member, Advisory Board, Congress on Cardiac Problems in Pregnancy,
Berlin, Germany, May 17-20, 2012.
Page 18
05/12 Invited speaker: Gleicher N. “Improvements in infertility techniques leading
to increased incidence of pregnancies in women with congenital or
acquired heart disease.” Congress on Cardiac Problems in Pregnancy,
Berlin, Germany, May 17-20, 2012.
06/12 Invited speaker: Gleicher N. “Twins are ethically and clinically desirable
outcome of infertility treatment.” Fertility Treatment and Multiple Births:
Ethical and Policy Issues Workshop, White Plains, New York, June 20-
21, 2012.
07/12 Keynote speaker: Gleicher N. “Decreased ovarian reserve and early
menopause: Can you do something, doctor?” The 16th World Congress on
Controversies in Obstetrics, Gynecology and Infertility, Singapore, July
19-22, 2012.
07/12 Invited speaker: Gleicher N. “IVM does not offer any advantage over current
IVF practice, and the associated risks are unknown. The 16th World
Congress on Controversies in Obstetrics, Gynecology and Infertility,
Singapore, July 19-22, 2012.
07/12 Invited speaker: Gleicher N. “Developing international standards for cross
border services, whose responsibility is it?” The 16th World Congress on
Controversies in Obstetrics, Gynecology and Infertility, Singapore, July
19-22, 2012.
07/12 Invited speaker: Gleicher N. “Can we improve pregnancy rates for patients
with DOR by better stimulation? Better protocol can improve stimulation
and pregnancy rates.” The 16th World Congress on Controversies in
Obstetrics, Gynecology and Infertility, Singapore, July 19-22, 2012.
07/12 Invited speaker: Gleicher N. “EBM has limited value in daily clinical care and
cannot replace clinical judgement.” The 16th World Congress on
Controversies in Obstetrics, Gynecology and Infertility, Singapore, July
19-22, 2012.
07/12 Chairperson, “There are ever-growing indications of the need for an effective,
reliable freezing method for oocytes and embryos. The many possible
techniques require elucidation of the best approach.” The 16th World
Congress on Controversies in Obstetrics, Gynecology and Infertility,
Singapore, July 19-22, 2012.
07/12 Panelist, “Hot controversies on ART clinical issues.” The 16th World
Congress on Controversies in Obstetrics, Gynecology and Infertility,
Singapore, July 19-22, 2012.
11/12 Panelist, “What clinicians and biologists should know about each other’s
work.” The 17th World Congress on Controversies in Obstetrics,
Gynecology & Infertility (COGI), Lisbon, Portugal, November 8-11,
2012.
11/12 Chairperson, “The Fertilization Process.” Ovarian Club II, Prague, Czech
Republic, November 8-11, 2012.
10/13 Chairperson, “Basic and technical challenges or ART.” The 18th World
Congress on Controversies in Obstetrics, Gynecology & Infertility
(COGI), Vienna, Austria, October 25-27, 2013.
10/13 Chairperson, “Anti-Müllerian hormone.” The 18th World Congress on
Page 19
Controversies in Obstetrics, Gynecology & Infertility (COGI), Vienna,
Austria, October 25-27, 2013.
10/13 Chairperson, “Improving results in IVF and male factor infertility.” The 18th
World Congress on Controversies in Obstetrics, Gynecology & Infertility
(COGI), Vienna, Austria, October 25-27, 2013.
11/13 Member, Organizing Committee, Ovarian Club III – The Inverse Pyramid:
Regulating Follicle Number and Oocyte Quality, Paris, France, November
14-17, 2013.
11/13 Chairperson, “Ovarian Stimulation, Follicular Development and Effects on
Pregnancies.” Ovarian Club III – The Inverse Pyramid: Regulating
Follicle Number and Oocyte Quality, Paris, France, November 14-17,
2013.
11/14 Member, Organizing Committee, Ovarian Club IV – Blastocysts
Development and the Process of Implantation, Paris, France, November
15 – 16, 2014.
3/14 Moderator, Oncofertility Session, World Symposium on Endometriosis,
Atlanta, GA, March 27-29, 2014.
5/14 Induction by the Mumbai Obstetrical & Gynecological Society, Mumbai,
India, May 34, 2014.
5/14 Induction by the Pune Obstetrical & Gynecological Society, Pune, India, June
1, 2014.
11/14 Session Chair, “New advances in development and implantation,” Ovarian
Club Meeting IV, Paris, France, November 7-8, 2015.
11/14 Session Chair, “Adjuvants for poor-responding patients,” COGI Vietnam, Ho
Chi Min City, Vietnam, November 20-22, 2014.
11/14 Session Chair, “Preimplantation genetic diagnosis and screening – what is it
all about?” COGI Vietnam, Ho Chi Min City, Vietnam, November 20-22,
2014.
5/15 Session Chair, “Improved implantation and luteal support,” 21st COGI
Congress, Guilin, China, May 7-10, 2015.
5/15 Session Chair, “Fertility Preservation in Cancer Patients,” 21st COGI
Congress, Guilin, China, May 7-10, 2015.
5/15 Session Chair, “Social Freezing: good news or bad news for women?” 21st
COGI Congress, Guilin, China, May 7-10, 2015.
5/15 Session Chair, “Preparation for IVF” 21st COGI Congress, Guilin, China,
May 7-10, 2015.
5/15 Session Chair, “Does time lapse provide better results?” 21st COGI Congress,
Guilin, China, May 7-10, 2015.
5/15 Member, Organizing Committee for the 21st COGI Congress, Frankfurt,
Germany, May 14-16, 2015.
5/15 Session Chair, “Are we reaching the time when science meets wishful
thinking?,” 21st COGI Congress, Frankfurt, Germany, May 14-16, 2015.
7/15 ASRM Star Award, 7/17/2015
9/15 Session Co-Chair, “Is it risk free? Is ISCI safe and effective enough to treat all
ART patients?” 22nd COGI Congress, Budapest, Hungary, Sept. 17-19,
2015.
Page 20
9/15 Session Chair, “Fibroids are encountered in increasing frequency in IVF
patients as the mean age of patients rises. Do we have to treat them all?”
22nd COGI Congress, Budapest, Hungary, Sept. 17-19, 2015.
11/15 Member, Organizing Committee for Ovarian Club VI, Barcelona, Spain,
November 14-15, 2015.
11/16 Organizing committee member, Ovarian Club VIII, Paris, France, November
4-6, 2016.
11/16 Session chair, “Stimulation of the ovary and the ovulation process,” Ovarian
Club VIII, Paris, France, November 4-6, 2016.
11/16 Session Chair, “Fertility preservation for cancer patients,” 24th World
Congress on Controversies in Obstetrics, Gynecology & Infertility
(COGI). Amsterdam, the Netherlands. November 10-13, 2016.
11/16 Session Chair, “PGS: A friend or a foe of the patients?” 24th World Congress
on Controversies in Obstetrics, Gynecology & Infertility (COGI).
Amsterdam, the Netherlands. November 10-13, 2016.
11/16 Conference chair & session chair, Translational Reproductive Biology and
Clinical Reproductive Endocrinology. New York, NY, November 17-20,
2016.
4/17 Winner, Presidential Award for Best Poster, Annual 2017 Meeting of the
Endocrine Society (ENDO 2017)
11/17 Conference chair & session chair, Translational Reproductive Biology and
Clinical Reproductive Endocrinology. New York, NY, November 16-19,
2017.
10/18 Fertility & Sterility Journal Club participant, The Pros and Cons of
Preimplantation Genetic Testing for Aneuploidy (PGT-A): Clinical and
Laboratory Perspectives.
11/18 Conference chair & session chair, Translational Reproductive Biology and
Clinical Reproductive Endocrinology. New York, NY, November 15-18,
2018.
11/19 Conference chair & session chair, Translational Reproductive Biology and
Clinical Reproductive Endocrinology. New York, NY, November 21-24,
2019.
10/21 Session chair, “Treating the unfavorable prognosis patient in IVF,” 4th IVF
Worldwide Online Congress. October 1-3, 2021.
10/21 Session chair, “Why most add-ons hurt IVF outcomes,” 4th IVF Worldwide
Online Congress. October 1-3, 2021.
Consultant – Journals
Advances in Therapy
Archives of Gynecology and Obstetrics
American Journal of Managed Care
American Journal of Obstetrics and Gynecology
American Journal of Reproductive Immunology
Annals of the Rheumatic Diseases
Annals of Internal Medicine
Biology of Reproduction
Page 21
BioMed Research International
BioMedicine
British Journal of Obstetrics and Gynaecology
British Journal of Rheumatology
BMJ Case Reports
Cell & Tissue Research
Cell Research
Cellular and Molecular Neurobiology
Clinical & Diagnostic Laboratory Immunology
Clinical Endocrinology
Clinical Immunology and Immunopathology
Clinical Medicine & Research
Computers in Biology and Medicine
Current Women’s Health Reviews
Endocrine
Endocrinology
European Journal of Obstetrics and Gynecology
European Journal of Obstetrics & Gynecology and Reproductive Biology
Expert Review in Obstetrics & Gynecology
Faculty of 1000
Fertility & Sterility
Genetics in Medicine
Genetics Research
Gynecologic and Obstetric Investigation
Gynecological Endocrinology
Gynecology & Obstetrics
Hormones
Human Molecular Genetics
Human Reproduction
Human Reproduction Update
International Archives of Allergy and Immunology
International Journal of Endocrinology
International Journal of Molecular Sciences
Journal of Assisted Reproduction and Genetics
Journal of Clinical Endocrinology & Metabolism
Journal of Clinical Metabolism & Diabetes
Journal of Fertilization: In Vitro
Journal of Human Genetics
Journal of Hypertension
Journal of Immunology
Journal of IVF-Worldwide: Reproductive Medicine, Genetics and Stem Cell Biology
Journal of Medical Genetics
Journal of Molecular Endocrinology
Journal of Obstetrics and Gynaecology
Journal of Obstetrics and Gynaecology Research
Journal of Ovarian Research
Page 22
Journal of Postgraduate Medicine
Journal of Reproductive Immunology
Journal of Rheumatology
Journal of the American Medical Association
Journal of the American Medical Association Network Open
Journal of Women’s Health
Life Sciences
Lupus
Mayo Clinic Proceedings
Medical Principles and Practice
Medical Science Monitor
Mount Sinai Journal of Medicine
New England Journal of Medicine
Nutrition & Metabolism
Obstetrics & Gynecology
Obstetrics & Gynecology International
RBM Online
Reproductive Biology
Reproductive Biology and Endocrinology
Reproductive Sciences
PLoS ONE
Rheumatology Journal
Saudi Medical Journal
Scandinavian Journal of Obstetrics & Gynecology
Southern Medical Journal
Stem Cell Research
Steroid Biochemistry & Molecular Biology
The Endocrine Society
The Lancet
Translational Pediatrics
Trends in Molecular Medicine
Vascular Cell
Consultant – Professional
Blue Cross/Blue Shield of Illinois
Blue Cross/Blue Shield of California
Blue Cross/Blue Shield of Rochester, New York
Carle Clinic, Urbana-Champaign, Illinois
Health Care Compare, Downers Grove, Illinois
National Blue Cross/Blue Shield Association
Rush/Prudential Health Plan, Illinois
Presentations
1. Gleicher N: Immunology of pregnancy and cancer. The American College of Surgeons,
District Meeting; New York, September 19, 1979.
Page 23
2. Roboz J, Wu K, Chahinian P, Gleicher N, Holland J: Applications of adriamycin
analysis in human malignant effusions and amniotic fluid by high performance liquid
chromatography. International Liquid Chromatography Symposium; Boston, October
11-12, 1979.
3. Gleicher N: Immunodiagnostic techniques: Reality or promise? Gynecologic Oncology
Post-Graduate Course, The Department of Obstetrics and Gynecology, The Page and
William Black Postgraduate School of the Mount Sinai School of Medicine (CUNY) in
cooperation with the American Cancer Society, New York Division; Mount Sinai
Medical Center, New York, March 6, l980.
4. Gleicher N: Maternal heart disease in pregnancy. In Current Concepts of Fetal Maternal
Medicine, The Department of Obstetrics and Gynecology, and the Page and William
Black Postgraduate School of Medicine of the Mount Sinai School of Medicine (CUNY),
Postgraduate Course; New York, March 27, l980.
5. Beers PC, David S, Reyniak JV, Gleicher N: Antibodies to autologous gonadotropins.
Society for Gynecologic Investigation, Denver, Colorado, March l9-22, l980.
6. Gleicher N: The immunologic concept of EPH-gestosis. First S.B. Gusberg Seminar on
Reproductive Immunology; New York, New York, June 26, l980.
7. Gleicher N: Common denominators of pregnancy and malignancy. First S.B. Gusberg
Seminar on Reproductive Immunology; New York, New York, June 27, l980.
8. Siegel I, Gleicher N: Red cell immune adherence in pregnancy and malignancy. First
S.B. Gusberg Seminar on Reproductive Immunology; New York, New York, June 27,
l980.
9. Gleicher N: Introduction to intercurrent disease in pregnancy. In Mount Sinai Update:
Medical and Surgical Complications of Pregnancy, The Department of Obstetrics and
Gynecology, and the Page and William Black Postgraduate School of Medicine of the
Mount Sinai School of Medicine (CUNY), Postgraduate Course, New York, December
ll-l2, l980.
10. Gleicher N: Hypertensive disease of pregnancy. In Mount Sinai Update: Medical and
Surgical Complications of Pregnancy, The Department of Obstetrics and Gynecology,
and the Page and William Black Postgraduate School of Medicine of the Mount Sinai
School of Medicine (CUNY), Post-Graduate Course, New York, December ll-l2, l980.
11. Gleicher N: The maternal immune response in pregnancy. In Applied Clinical
Immunology in Obstetrics and Gynecology, The Annual Clinical Meeting of the
American College of Obstetricians and Gynecologists, Las Vegas, Nevada, April 28-30,
1980.
12. Gleicher N: Immune complex disease in pregnancy and toxemia. In Applied Clinical
Immunology in Obstetrics and Gynecology, The Annual Clinical Meeting of the
American College of Obstetricians and Gynecologists, Las Vegas, Nevada, April 28-30,
l98l.
13. Gleicher N: Update in reproductive immunology. In Mount Sinai Update in Obstetrics
and Gynecology, The Department of Obstetrics and Gynecology and The Page and
William Black Post-Graduate School of Medicine of the Mount Sinai School of
Medicine of the City University of New York, Post-Graduate Course, New York, June ll,
l981.
Page 24
14. Smolen J, Chused T, Leiserson W, Weintraub B, Gleicher N, Steinberg A: T cell
phenotypes in pregnant patients with autoimmune diseases. Second International S.B.
Gusberg Symposium on Reproductive Immunology, New York, June l8, l98l.
15. Gleicher N, Adelsberg B, Siegel I, Siegal F, Liu TL: Immune complex disease in
pregnancy. Second International S.B. Gusberg Symposium on Reproductive
Immunology, New York, June l8, l98l.
16. Siegel I, Liu TL, Gleicher N: Red cell immune adherence (RCIA) in the developing
rabbit. Second International S.B. Gusberg Symposium on Reproductive Immunology,
New York, June l9, l98l.
17. Adelsberg B, Liu TL, Phillips R, Cederquist L, Siegel I, Gleicher N: Immune complexes
in all stages of pregnancy. Second International S.B. Gusberg Symposium on
Reproductive Immunology, New York, June l9, l98l.
18. Gleicher N: Immunology of reproduction. Staff Meetings, Gottlieb Hospital, Chicago,
Illinois, February 15, 1982.
19. Gleicher N: Immune complexes in normal and abnormal pregnancy. In Basic and
Applied Immunology for the Obstetrician, Gynecologist, and Perinatologist, The 30th
Annual Clinical Meeting of the American College of Obstetricians and Gynecologists,
Dallas, Texas, April 24-25, 1982.
20. Gleicher N: Autoimmunity in pregnancy. In Basic and Applied Immunology for the
Obstetrician, Gynecologist, and Perinatologist,The 30th Annual Clinical Meeting of the
American College of the American College of Obstetricians and Gynecologists, Dallas,
Texas, April 24-25, 1982.
21. Toder V, Blank M, Gleicher N, Voljovich I, Machiah S, Nebel H: The suppression of
natural killer (NK) activity by pregnancy. 5th Symposium on the Immunology of
Reproduction, Varna, Bulgaria, May 25-29, 1982.
22. Gleicher N: Clinical reproductive immunology. Grand Rounds-CHR, Department of
Obstetrics and Gynecology, Prentice Women’s Hospital, Northwestern University, June
16, 1982.
23. Toder V, Nebel L, Gleicher N: Interferon activation of natural killer (NK) lymphocyte
precursors in human pregnancy. Third Annual Symposium of the American Society for
the Immunology of Reproduction, Bowman Gray School of Medicine, Winston-Salem,
North Carolina, June 24-26, 1982.
24. Siegel I, Lubicz S, Deppe G, Liu TL, Gleicher N: Serum dependent regulation of RCIA
(red cell immune adherence) by oxygen. Third Annual Symposium of the American
Society for the Immunology of Reproduction, Bowman Gray School of Medicine,
Winston-Salem, North Carolina, June 24-26, 1982.
25. Siegel I, Liu TL, Gleicher N: Enhanced red cell immune function in early development.
Third Annual Symposium of the American Society for the Immunology of Reproduction,
Bowman Gray School of Medicine, Winston-Salem, North Carolina, June 24-26, 1982.
26. Toder V, Nebel H, Elrad H, Blank M, Gleicher N: Human natural killer (NK) activity:
Regulatory effect of some pregnancy markers. Third Annual Symposium of the
American Society for the Immunology of Reproduction, Bowman Gray School of
Medicine, Winston-Salem, North Carolina, June 24-26, 1982.
27. Siegel I, Lubicz S, Deppe G, Liu TL, Gleicher N: Serum dependent regulation of RCIA
(red cell immune adherence) by oxygen. ACOG, District VI Meeting, Chicago, Illinois,
September 22-25, 1982.
Page 25
28. Gleicher N, Elrad H, Toder V: Suppressive effect of some pregnancy substances on
human natural killer activity. ACOG, District VI Meeting, Chicago, Illinois, September
22-25, 1982.
29. Gleicher N: The direct diagnosis of unruptured ectopic pregnancy by real-time
ultrasonography. Inaugural Thesis, The Chicago Gynecological Society Chicago, Illinois,
October 15, 1982.
30. Gleicher N: Immunologic factors in hypertension of pregnancy. International Society for
the Study of Hypertension in Pregnancy, Dallas, Texas, October 24-27, 1982.
31. Gleicher N, Toder V: Comparison of natural killer activity in normal pregnancy and
EPH-gestosis. International Society for the Study of Hypertension in Pregnancy, Dallas,
Texas, October 24-27, 1982.
32. Gleicher N, Siegel I: Additional evidence for an immunologic etiology of the
preeclampsia/eclampsia syndrome (EPH-gestosis). International Society for the Study of
Hypertension in Pregnancy, Dallas, Texas, October 24-27, 1982.
33. Gleicher N: Clinical reproductive immunology, Grand Rounds-CHR, The Chicago
Lying-In Hospital, University of Chicago, Chicago, Illinois, November 4, 1982.
34. Gleicher N: Establishing the first in vitro fertilization program in Illinois, presented at a
Seminar on In Vitro Fertilization, Chicago, Illinois, March 6, 1983.
35. Gleicher N: To enter or not, presented at a Seminar on In Vitro Fertilization, Chicago,
Illinois, March 6, 1983.
36. Gleicher N: Egg retrieval, presented at a Seminar on In Vitro Fertilization, Chicago,
Illinois, March 6, 1983.
37. Siegel I, Liu TL, Gleicher N: The effects of lipids upon the immune system - The
immune adherence connection, FASEB Meeting, Chicago, Illinois, April 4, 1983.
38. Gleicher N, Dmowski P, Siegel I, Liu TL, Toder V: Peripheral white cell subsets in
endometriosis, C.A.R.E. meeting, Chicago, Illinois, April 5, 1983.
39. Gleicher N: Ultrasonographic diagnosis of ectopic pregnancy. Grand Rounds-CHR,
Department of Obstetrics and Gynecology, Rush Presbyterian St. Luke’s Medical Center,
April 14, 1983.
40. Gleicher N: Immunology of reproduction. Ravenswood Hospital Medical Center,
Continuing Medical Education, Chicago, Illinois, April 1983.
41. Gleicher N: Immunology of pregnancy and lactation, presented at a postgraduate course
in Reproductive Immunology for Obstetricians and Gynecologists, University of Health
Sciences, The Chicago Medical School, Hektoen Institute of Research, Cook County
Hospital, Chicago, Illinois, April 22, 1983.
42. Gleicher N: Clinical applications of immunology during normal and abnormal
pregnancy, presented at a postgraduate course in Reproductive Immunology for
Obstetrics and Gynecologists, University of Health Sciences, Hektoen Institute of
Research, Cook County Hospital, Chicago, Illinois, April 22, 1983.
43. Gleicher N: Immunology for the clinician, Fourth Annual Obstetrics and Gynecology
Review Course, Chicago Area Schools of Medicine, Chicago, Illinois, June 9, 1983.
44. Gleicher N, Dmowski W, Siegel I, Liu TL, Toder V: Peripheral white blood cell subsets
in endometriosis, Fourth Annual International Symposium of the American Society for
the Immunology of Reproduction, Park City, Utah, June 8-11, 1983.
45. Siegel I, Liu TL, Gleicher N: Regulation of red cell immune adherence (RCIA) and
neutrophil immune adherence (NIA) by dietary lipids, Fourth Annual International
Page 26
Symposium of the American Society for the Immunology of Reproduction, Park City,
Utah, June 8-11, 1983.
46. Siegel I, Liu TL, Elrad H, Gleicher N: Defense against infection - A selective role for
unsaturated fatty acid, Fourth Annual International Symposium of the American Society
for the Immunology of Reproduction, Park City, Utah, June 8-11, 1983.
47. Siegel I, Liu TL, Wissner R, Gleicher N: Red cell immune adherence (RCIA) co-factors
in adult and cord serums, Fourth Annual International Symposium of the American
Society for the Immunology of Reproduction, Park City, Utah, June 8-11, 1983.
48. Friberg J, Gleicher N, Fullen N: Seminal bacteria and embryonic development in an in
vitro fertilization/embryo transfer program, Recent Progress in Human In Vitro
Fertilization, Congress I, Vienna, June 22-24, 1983.
49. Gleicher N, Friberg J: Alternative approaches to egg retrieval, Recent Progress in
Human In Vitro Fertilization, Congress I, Vienna, June 22-24, 1983.
50. Gleicher N: Clinical reproductive immunology. Visiting Lectureship, Department of
Obstetrics and Gynecology, Methodist Hospital, Indianapolis, Indiana, August 10, 1983.
51. Gleicher N: Official discussion of paper: The HELLP Syndrome. A unique variant of
preeclampsia/eclampsia, by Weinstein L. 51st Annual Meeting of the Central
Association of Obstetrics and Gynecologists, Colorado Springs, Colorado, October 14-
16, 1983.
52. Gleicher N: Principles of medical therapy in pregnancy, Medical Complications of
Pregnancy, A Postgraduate Course, Chicago, Illinois, November 11, 1983.
53. Gleicher N: Pulmonary hypertension and Eisenmenger’s syndrome, Idem.
54. Gleicher N: Hypertensive diseases of pregnancy, Idem.
55. Gleicher N: SLE and autoimmunity in pregnancy, Idem.
56. Gleicher N: Introduction to Real-Time Ultrasonography. In Basic and Advanced Real-
Time Ultrasonography in Obstetrics and Gynecology - A Postgraduate Course, Chicago,
Illinois, November 30 - December 2, 1983.
57. Gleicher N: Congestive heart failure and non-immunologic hydrops, Idem.
58. Gleicher N: Ectopic pregnancy, Idem.
59. Gleicher N: The ovary - normal and pathology; Follicular sonography and sonographic
egg retrieval, Idem.
60. Gleicher N: Immunology of endometriosis. Endometriosis ‘83, A Postgraduate course
sponsored by Rush Medical College, December 2 and 3, 1983.
61. Toder V, Elrad C, Durdana A, Gleicher N: Natural killer lymphocytes in newborns.
Proc. of the First Joint Meeting of the Israeli Soc for Life Sciences, 1983, A141.
62. Gleicher N: Intrauterine dysrhythmias; A diagnostic and therapeutic approach, Diagnosis
and Management of Maternal and Fetal Heart Disease. A Postgraduate Course sponsored
by the University of Southern California School of Medicine, Postgraduate Division,
Beverly Hills, California, January 13-14, 1984.
63. Gleicher N: Hypertensive pregnancy; Diagnosis, prognosis and management, Idem.
64. Gleicher N: Management of hypertension in pregnancy, Annual Scientific Sessions of
the American College of Cardiology, Dallas, Texas, March 25-29, 1984, (by invitation).
65. Gleicher N: Official discussant of inaugural thesis, Hobart, J.M: Perinatal Outcome in
Ultrasonically Determined Post Term Pregnancy, 963rd Meeting of the Chicago
Gynecological Society, January 20, 1984.
Page 27
66. Gleicher N: Hypertension diseases; Grand Rounds-CHR, Gottlieb Memorial Hospital,
Melrose Park, Illinois, January 16, 1984.
67. Gleicher N: Immunology of endometriosis, Washtenaw Obstetrical and Gynecological
Society, Michigan, January 18, 1984.
68. Gleicher N: Autoimmunity in obstetrics and gynecology, Grand Rounds-CHR, The
University of Michigan Medical Center, Ann Arbor, Michigan, January 19, 1984.
69. Gleicher N: Cesarean section rates in the USA: The short-term failure of the Consensus
Development Conference. 31st Annual Meeting of the Society for Gynecologic
Investigation, San Francisco, March 21-24, 1984.
70. Siegel I, Gleicher N: Effects of short-term dietary restriction on survival of mammary
ascites tumor bearing rats. Idem.
71. Gleicher N: Management of hypertension in pregnancy. Symposium on Pregnancy in the
Patient with Cardiac Disease. Invited Speaker to the 33rd Annual Scientific Session of
the American College of Cardiology, Dallas, Texas, March 25-29, 1984.
72. Gleicher N: The profession of obstetrics and gynecology. At a Career Seminar for
Medical Students, Chicago Medical Society Student Branch, Chicago, April 14, 1984.
73. Gleicher N: Gynecologic sonography. Departmental Teaching Day, Department of
Obstetrics and Gynecology, Loyola University Medical School, April 25, 1984.
74. Friberg J, Gleicher N: High dose human menopausal gonadotropin therapy for
successful ovulation induction for IVF program in perimenopausal women. 3rd World
Congress for IVF-ET, Finlandia Hall, Helsinki, Finland, May 14-17, 1984.
75. Gleicher N, Friberg J: The effect of aspiration needles on oocyte recovery rates and the
need for follicular irrigation. Idem.
76. Siegel I, Elrad H, Gleicher N: Toxicity of term amniotic fluid to human red cells. 5th
Annual Meeting of the American Society for the Immunology of Reproduction, Durham,
North Carolina, June 13-15, 1984.
77. Siegel I, Dudkiewicz A, Friberg J, Gleicher N: Chain reaction (CR) fatty acid toxicities
affecting human red cells and human sperm cells. Idem.
78. Gleicher N: Immunology in reproduction. Grand Rounds-CHR, Department of
Obstetrics and Gynecology, Lenox Hill Hospital and New York Medical College, New
York, NY, August 1, 1984.
79. Gleicher N: Immunology in OB/GYN. Grand Rounds-CHR, Christ Hospital, Oak Lawn,
Illinois, August 27, 1984.
80. Gleicher N: In vitro fertilization: The Current Status, Great Lakes Research Conference;
Invited Speaker, Nordic Hills Resort, Itasca, Illinois, September 23-25, 1984.
81. Gleicher N: Intrauterine diagnosis of congenital heart disease. Idem.
82. Gleicher N: Autoimmunity and pregnancy. Invited Speaker, International Symposium on
the Immunology of Reproduction, Tel Aviv, Israel, October 21-25, 1984.
83. Siegel I, Dudkiewicz A, Friberg J, Gleicher N: The effect of free fatty acids on human
sperm cells. International Symposium on the Immunology of Reproduction, Tel Aviv,
Israel, October 21-25, 1984.
84. Siegel I, Gleicher N: The selective toxicities of non-saturated fatty acids upon mammary
ascites tumor cells. Idem.
85. Gleicher N: Autoimmunity in pregnancy. Invited Keynote Speaker, 2nd Annual
Symposium on Research at Mount Sinai Hospital. November, 1984, Chicago, Illinois.
Page 28
86. Gleicher N: Immunology of endometriosis. 17th Annual Symposium on Obstetrics and
Gynecology. North Memorial Medical Center, Minneapolis, Minnesota, November 30,
1984.
87. Gleicher N: Intrauterine dysrhythmias and heart failure. Invited Speaker, Meeting
Internazionale Fisiopathologia Clinica Prenatale, Oggi, Rome, Italy, November 23-24,
1984.
88. Gleicher N: Treatment of cardiovascular and hypertensive diseases in pregnancy.
Semmelweis-Waters Obstetrical and Gynecological Conference, Atlantic City, New
Jersey, March 29, 1985.
89. Gleicher N: Role of sonography in IVF. In In Vitro Fertilization. The State of the Art.
The Chicago Gynecological Society, Chicago, Illinois, April 19, 1985.
90. Confino E, Friberg J, Dudkiewicz A, Gleicher: Intrauterine inseminations with washed
human spermatozoa in couples with circulating sperm agglutinating antibodies. 6th
Meeting of the American Society for the Immunology of Reproduction, Ann Arbor,
Michigan, June 12-15, 1985.
91. Siegel I, Dudkiewicz A, Friberg J, Suarez M, Gleicher N: The effect of 18 carbon
saturated and unsaturated fatty acids (FFA) on sperm motility. Idem.
92. Confino E., Friberg J, Dudkiewicz A, Gleicher N: Intrauterine insemination with washed
human spermatozoa. 41st Annual Meeting of the American Fertility Society, Illinois,
September 28-October 2, 1985.
93. Confino E, Frank J, Dudkiewicz A, Gleicher N, Friberg J: The effect of ejaculation
frequency on sperm quality. Idem.
94. Confino E, Demir R, Friberg J, Gleicher N: The predictive value of hCG beta subunit
levels in pregnancies achieved by in vitro fertilization and embryo transfer. Idem.
95. Confino E, Friberg J, Dudkiewicz A, Gleicher N: Intrauterine insemination with washed
human spermatozoa. Idem.
96. Gleicher N: A follow-up on maternal cesarean section rates. ACOG District VI Annual
Meeting, Milwaukee, Wisconsin, September 25-28, 1985.
97. Dudkiewicz A, Friberg J, Gleicher N, et al.: In vitro fertilization program at Mount Sinai
Hospital, Chicago, Phase II. Idem.
98. Confino E, Demir R, Friberg J, Gleicher N: The predictive value of hCG beta subunit
levels in pregnancies achieved by in vitro fertilization and embryo transfer. Idem.
99. Confino E, Friberg J, Dudkiewicz A, Gleicher N: Intrauterine insemination with washed
human spermatozoa. 41st Annual Meeting of The American Fertility Society, Chicago,
Illinois, September 27- October 2, 1985.
100. Sonographic oocyte retrieval for IVF. Video Presentation. Idem.
101. Confino E, Vermesh M, Thomas W, Gleicher N: An unilateral rabbit uterus
transplantation model. Video Presentation. Idem.
102. Confino E, Frank, Dudkiewicz A, Gleicher N, Friberg J: The effect of ejaculation
frequency on sperm quality. Idem.
103. Confino E, Demir R, Friberg J, Gleicher N: The predictive value of hCG beta subunit
levels in pregnancies achieved by in vitro fertilization and embryo transfer. Idem.
104. Confino E, Dudkiewicz, A, Friberg J, Gleicher N: Combined tuboplasty, oocyte retrieval
and embryo transfer. Fourth World Conference on In Vitro Fertilization, Melbourne,
Victoria, Australia, November 18-22, 1985.
Page 29
105. Mayden K, Confino E, Eden R, Miller C, Friberg J, Gleicher N: Decreased gestational
sac volumes in hMG induced pregnancies. Idem.
106. Confino E, Demir R, Friberg J, Gleicher N: The predictive value of hCG B subunit
levels in pregnancies achieved by in vitro fertilization and embryo transfer. Idem.
107. Gleicher N: Functional changes of the fetal heart. Diagnosis management and treatment.
In Present Trends of Ultrasounds in Clinical Problems of Gynecology and Obstetrics.
University “G.D. Annunzio”, Chieti, Italy, Dec. 12-13, 1985.
108. Gleicher N, El-Roeiy A: Autoantibodies in follicular fluids of IVF patients. Future
Aspects in Human In Vitro Fertilization Congress, Vienna, Austria, April 2-4, 1986.
109. Confino E, Demir R, Friberg J, Gleicher N: Does cyclic hCG secretion indicate embryo
loss in in vitro fertilization? Idem.
110. Gleicher N: Reproductive failure due to autoantibodies. Bulgarian Academy of Sciences,
Sofia, Bulgaria, April 8, 1986.
111. Gleicher N: Autoimmunity in pregnancy. Sofia Medical Faculty, Sofia, Bulgaria, April 9,
1986.
112. Gleicher N: Reproductive failure due to autoantibodies. Perinatal/Neonatal Grand
Rounds-CHR, Cook County Hospital, Chicago, Illinois, April 21, 1986.
113. El-Roeiy A, Gleicher N, Isenberg D, Kennedy R, Goldenberg M, Mashiach S, Shoenfeld
Y: Autoantibodies and common anti-DNA idiotype in pregnancies of mothers with
systemic lupus erythematosus. 3rd International Congress of Reproductive Immunology,
Toronto, Ontario, Canada, July 4, 1986.
114. Gleicher N, El-Roeiy A, Confino E, Friberg J: Abnormal antibodies in endometriosis: Is
endometriosis an autoimmune disease? Idem.
115. Confino E, El-Roeiy A, Demir R, Friberg J, Gleicher N: Thrombelastogram, lupus
anticoagulant and antinuclear antibodies in patients with endometriosis and repeated
abortions. Idem.
116. Gleicher N: Cesarean section - What are the issues? At: Cesarean Section Conference,
Mount Sinai Hospital Medical Center of Chicago, July 23, 1986.
117. Gleicher N: Vaginal birth after cesarean section (VBAC). Idem.
118. Vermesh M, Confino E, Boler LR, Friberg J, Gleicher N: Acute salpingitis in sterilized
women. Fourth Annual Meeting of the International Medical and Scientific Conference
on Contraception, Society for the Advancement of Contraception, Palmer House,
Chicago, IL, September 26, 1986.
119. Confino E, Demir R, Friberg J, Gleicher N: Does cyclic hCG secretion indicate embryo
loss in in vitro fertilization? An international collaborative study. 42nd Annual Meeting
of the American Fertility Society/18th Annual Meeting of the Canadian Fertility and
Andrology Society, Toronto, Ontario, Canada, September 30, 1986.
120. Confino E, Friberg J, Gleicher N: Transcervical Balloon Tuboplasty (TBT). Idem.
121. Confino E, Vermesh M, Boler L, Friberg J, Gleicher N: Acute salpingitis in sterilized
women. Fourth Annual Meeting of the Society for the Advancement of Contraception,
Chicago, Illinois, September 26, 1986.
122. Gleicher N: Reducing the incidence of cesarean section. Grand Rounds-CHR,
Department of Obstetrics and Gynecology, Gottlieb Memorial Hospital, Melrose Park,
Illinois, November 17, 1986.
Page 30
123. Gleicher N: Autoantibodies in reproduction. Grand Rounds-CHR, Department of
Obstetrics and Gynecology, Rush-Presbyterian - St. Luke’s Hospital, Chicago, Illinois,
December 4, 1986.
124. Gleicher N: Reproductive failure due to autoantibodies. Grand Rounds-CHR,
Department of Immunology/Microbiology, Rush-Presbyterian - St. Luke’s Hospital,
Chicago, Illinois, February 4, 1987.
125. Gleicher N: Cesarean section reduction initiative. Continuing Medical Education
Conference, Ravenswood Hospital Medical Center, Chicago, Illinois, February 5, 1987.
126. El-Roeiy A, Myers S, Gleicher N: Autoantibodies in normal pregnancy: Comparison to
non-pregnant patients. Seventh Annual Meeting of the Society of Perinatal Obstetricians,
Lake Buena Vista, Florida, February 5-7, 1987.
127. El-Roeiy A, Myers S, Gleicher N: A comparison of the autoantibody profile and
hypertensive and normotensive pregnancy. Idem.
128. Myers S, Gleicher N: A prospective program to reduce cesarean section rates: A
preliminary report. Idem.
129. Gleicher N: Endometriosis associated antibodies. Infertility Treatment Options, Elkhart
General Hospital, YWCA, Women’s Resource Center, Indiana RESOLVE, Inc, Elkhart,
Indiana, February 21, 1987.
130. Gleicher N, El-Roeiy A, Friberg J: Autoantibodies in patients with unexplained
infertility. Annual Meeting of the Society of Gynecological Investigation, Hyatt
Regency, Atlanta, Georgia, March 18-21, 1987.
131. Gleicher N, El-Roeiy A, Myers S, Friberg J: Autoantibodies in patients with idiopathic
recurrent pregnancy loss. Idem.
132. Gleicher N, El-Roeiy A, Confino E, Friberg J: Autoantibodies in patients with
unexplained infertility and recurrent pregnancy loss. Idem.
133. El-Roeiy A, Myers S, Gleicher N: Comparison of the autoantibody profile of
hypertensive and normotensive pregnancy. Idem.
134. Dudkiewicz A, Friberg J, Confino E, Madanes A, Gleicher N: The relationship between
zona-free hamster egg penetration and human fertilization in vitro. Fifth World Congress
on In Vitro Fertilization and Embryo Transfer, Scope Convention Center,
135. Gleicher N: Cesarean section reduction initiative. Continuing Medical Education
Program, Alexian Brothers Medical Center, Elk Grove Village, Illinois, April 21, 1987.
136. Gleicher N: Autoimmunity and the role of phospholipid antibodies in reproduction.
Seventh Annual Meeting of the American Society for the Immunology of Reproduction,
Indianapolis Hilton, Indianapolis, Indiana, June 24-26, 1987.
137. El-Roeiy A, Myers S, Gleicher N: A comparison of the autoantibody profile of
hypertensive and normotensive pregnancy. Idem.
138. Gleicher N, El-Roeiy A, Confino E, Friberg J: Autoantibodies in patients with
unexplained infertility and recurrent pregnancy loss: The reproductive autoimmune
failure syndrome (RAFS). Idem.
139. Confino E, Friberg J, Gleicher N: Cervical mucus-uterine fluid cross penetration
spermatozoa in patients with circulating sperm agglutinating antibodies. Idem.
140. Gleicher N: Autoimmunity in Reproduction. 6th Annual Symposium on Obstetrics and
Gynecology, University of Maryland School of Medicine, Ocean City, Maryland, June
4-6, 1987.
Page 31
141. Gleicher N: Autoimmunity in reproduction. Grand Rounds-CHR, Department of
Obstetrics and Gynecology, Mercy Hospital, University of Maryland, School of
Medicine, Baltimore, Maryland, June 4, 1987.
142. Gleicher N: Reversing the cesarean trend. CPM, 3rd International Convention, LeMoyne
College, Syracuse, New York, August 22, 1987.
143. Friberg J, Confino E, Dudkiewicz A, Gleicher N: Motion picture: Laparoscopic
cannulation of the fallopian tubes for GIFT. Forty - third Annual Meeting of the
American Fertility Society, Reno, Nevada, September 27 - September 30, 1987.
144. El-Roeiy A, Dmowski W, Friberg J, Binor Z, Gleicher N: Abnormal autoantibodies in
reproductive failure: Habitual abortion versus endometriosis. Forty-third Annual
Meeting of the American Fertility Society, Reno, Nevada, September 28-30, 1987.
145. Confino E, Friberg J, Gleicher N: Preliminary experience with transcervical balloon
tuboplasty (TBT). Forty - third Annual Meeting of the American Fertility Society, Reno,
Nevada, September 28-30, 1987.
146. Confino E, Gleicher N, Friberg J: Cervical mucus-uterine fluid cross penetration of
spermatozoa. Forty - third Annual Meeting of the American Fertility Society, Reno,
Nevada, September 28-30, 1987.
147. Gleicher N: Immunoregulatory mechanism in normal and abnormal pregnancies. Annual
Meeting, Korean Association of Obstetricians and Gynecologists, Seoul, South Korea,
October 16 - 17, 1987.
148. Gleicher N: Transcervical balloon tuboplasty. Department of Obstetrics and Gynecology,
Chulalongkorn Hospital, Faculty of Medicine, Chulalongkorn University, Bangkok,
Thailand, November 3, 1987.
149. Gleicher N: The reproductive autoimmune failure syndrome (RAFS). Department of
Obstetrics and Gynecology, Niigata University School of Medicine, Niigata, Japan,
October 19 - 21, 1987.
150. Gleicher N: The reproductive autoimmune failure syndrome (RAFS). Department of
Obstetrics and Gynecology, Nagoya City University Medical School, Nagoya, Japan,
October 22 - 25, 1987.
151. Gleicher N: The reliable detection of autoantibodies in patients with reproductive
autoimmune failure (RAFS). Workshop “Immunodiagnosis and immunotherapy in
reproductive medicine”, VIth World Congress on Human Reproduction, Tokyo, Japan,
October 26, 1987.
152. Gleicher N: Reproductive failure due to autoantibodies: The reproductive autoimmune
failure syndrome. 6th World Congress on Human Reproduction, Tokyo, Japan, October
28, 1987.
153. Gleicher N: Reproductive failure due to autoimmunity. Department of Obstetrics and
Gynecology, Wayne State University School of Medicine, Hutzel Hospital, Detroit,
Michigan, November 24, 1987.
154. Gleicher N: Abnormal autoimmunity and pregnancy. Department of Obstetrics and
Gynecology, Wayne State University School of Medicine, Hutzel Hospital, Detroit,
Michigan, Detroit, Michigan, November 24, 1987.
155. Gleicher N: Retrograde tubal canalization: An alternative approach to IVF and GIFT.
Obstetrics Gynecology Devices Panel of the FDA, 33rd Meeting, Hubert H. Humphrey
Building, Washington D.C., January 29, 1988.
Page 32
156. Gleicher N: The reproductive autoimmune failure syndrome. Hadassah Medical School
of the Hebrew University, Jerusalem, February 2, 1988.
157. Gleicher N, El-Roeiy A: Autoantibody profiles in normal females and males. Society for
Gynecology Investigation, 35th Annual Meeting, Hyatt Regency, Baltimore, Maryland,
March 17-20, 1988.
158. El-Roeiy A, Saling P, Menge A, Friberg J, Gleicher N: Cross reactivity of monoclonal
anti-sperm antibodies, inhibition with specific antigens and anti-idiotypes. Society for
Gynecologic Investigation, 35th Annual Meeting, Hyatt Regency, Baltimore, Maryland,
March 17-20, 1988.
159. El-Roeiy A, Dmowski WP, Gleicher N, Binor Z, Radwanska E, Tummon I: Effect of
Danazol and GnRH agonist (GnRH-a) on the immune system in endometriosis. Society
for Gynecologic Investigation, 35th Annual Meeting, Hyatt Regency, Baltimore,
Maryland, March 17-20, 1988.
160. Gleicher N: Cesarean topics. The Illinois Chamber’s Health Care Management
Committee, Illinois State Chamber of Commerce, Chicago, Illinois, March 9, 1988.
161. Gleicher N: Cardiac diseases in pregnancy. Invited speaker, Panel for American College
of Cardiology, 37th Annual Scientific Session, Atlanta, Georgia, March 29, 1988.
162. Gleicher N, Perisee D: Everything you always wanted to ask your doctor but were afraid
to ask? Women’s Health Congress, Mount Sinai Hospital, Chicago, Illinois, April 22,
1988.
163. Gleicher N, Harlow L, El-Roeiy A: The correlation between autoantibodies in women
with reproductive failure. 9th Annual International Symposium of the American Society
for the Immunology of Reproduction, Prout’s Neck, Maine, June 15-19, 1988.
164. Gleicher N, Harlow L, El-Roeiy A: The correlation between lupus anticoagulant and
autoantibodies. Idem.
165. Confino E, Harlow L, Friberg J, Gleicher N: The correlation between serum and
peritoneal fluids autoantibody levels in patients with endometriosis. Idem.
166. Gleicher N: Mammography in a private practice. Seminar on in- office mammography,
Marriot Hotel, O’Hare International Airport, Chicago, Illinois, June 28, 1988.
167. Gleicher N: Mammography in a private practice. Seminar on in-office mammography,
Embassy Suites, Brookfield, Wisconsin, September 13, 1988.
168. Gleicher N: Mount Sinai cesarean section initiative. Lutheran General Hospital, Park
Ridge, Illinois, Department of Obstetrics and Gynecology, Grand Rounds-CHR,
September 20, 1988.
169. Gleicher N, El-Roeiy A, Confino E, Friberg J: Reproductive failure due to
autoantibodies: Unexplained infertility and pregnancy wastage. 56th Annual Meeting of
The Central Association of Obstetricians and Gynecologists, The Marriot, Salt Lake City,
Utah, September 22-24, 1988.
170. Gleicher N: Cesarean section initiative. Grand Rounds-CHR, Michael Reese Hospital,
Chicago, Illinois, Department of Obstetrics and Gynecology, September 28, 1988.
171. Gleicher N: Cutting the c-section rate in half: It can be done. National Association of
Directors of Women’s Health Programs, 1st Annual Conference, Women’s Health:
Making a difference. The Westin Hotel, Chicago, Illinois, October 27-28, 1988.
172. Gleicher N: Active management of labor and vaginal birth after cesarean. 3rd Annual
Intensive One Day Obstetrics and Gynecology Review Course, Northwest Community
Hospital, Arlington Heights, Illinois, November 19, 1988.
Page 33
173. Gleicher N: Mount Sinai’s cesarean section initiative. Postgraduate course on Recent
Developments in Obstetrics and Gynecology, Hotel 21 East, Chicago, Illinois, December
8, 1988.
174. Gleicher N: Pregnancy loss due to abnormal autoimmune function. Idem.
175. Gleicher N: Infertility and endometriosis. Idem.
176. Gleicher N: Mammography in obstetrics and gynecology. Idem.
177. Gleicher N: Breast ultrasound. Idem.
178. Gleicher N: The multicenter TBT study. Idem.
179. Gleicher N: How to evaluate breast disease. Idem.
180. Gleicher N, Myers S: A successful program to lower cesarean section rates. Society of
Perintal Obstetricians, 1988.
181. Dudkiewicz A, Friberg J, Confino E, Gleicher N: Comparison of semen parameters from
sequentially produced ejaculates. 44th Annual Meeting of the American Fertility Society,
Atlanta, Georgia, October 10-13, 1988.
182. Confino E, Friberg J, Gleicher N: Conservative management of interstitial pregnancy.
44th Annual Meeting of the American Fertility Society, Atlanta, Georgia, October 10-13,
1988.
183. Myers S, Gleicher N: A successful program to lower cesarean section rates. Society of
Perinatal Obstetricians, 1988.
184. Gleicher N: Recent advances in infertility. 45th Annual Midwest Clinical Conference,
Hilton and Towers, Chicago, Illinois, February 24-26, 1989.
185. Gleicher N: Mammography in obstetrics and gynecology. CREOG/APGO Annual
Meeting, New Orleans, Louisiana, March 8-11, 1989.
186. Tur-Kaspa I, Confino E, Friberg J, Dudkiewicz A, Gleicher N: A GnRH-
agonist/hMG/hCG stimulation protocol for IVF increases pregnancy rates by widening
the implantation window. The Annual Meeting of the Society for Gynecologic
Investigation, March 1989, San Diego, California.
187. Confino E, DeCherney A, Coulam C, Friberg J, Haas G, Herbert C, Katz E, Vermesh M,
Gleicher N: Transcervical balloon tuboplasty: A multicenter study. 36th Annual Meeting
of the Society for Gynecologic Investigation, San Diego, CA, March 15-18, 1989.
188. Tur-Kaspa I, Dudkiewicz A, Friberg J, Confino E, Logan R, Gleicher N: Pooled
sequential ejaculates - a way to increase total number of motile spermatozoa from
oligozoospermic males. VI World Congress In Vitro Fertilization and Alternate Assisted
Reproduction, April 1989, Jerusalem, Israel.
189. Tur-Kaspa I, Confino E, Zilberstein M, Friberg J, Dudkiewicz A, Gleicher N: The
implantation window and early pregnancy loss. International Meeting on Pregnancy
Loss, April 1989, Tel-Aviv, Israel.
190. Gleicher N: IVF and immunological infertility. 6th World Congress of In Vitro
Fertilization and Alternate Assisted Reproduction, Jerusalem, Israel, April 2-7, 1989.
191. Tur-Kaspa I, Confino E, Friberg J, Dudkiewicz A, Novotny M, Gleicher N: GnRH-
agonist/HMG/HCG stimulation for IVF increases endometrial receptiveness for embryos.
Idem.
192. Dudkiewicz A, Novotny M, Friberg J, Gleicher N: Biochemical enhancement of sperm
penetration: Effects on subsequent development. Idem.
193. Gleicher N: Medical complications causing pregnancy loss. International Meeting on
Pregnancy Loss, Tel-Aviv, Israel, April 9-12, 1989.
Page 34
194. Tur-Kaspa I, Confino E, Zilberstein M, Friberg J, Dudkiewicz A, Gleicher N: Low
pregnancy wastage in IVF-ET pregnancies achieved with a GnRH-agonist/hMG/hCG
stimulation protocol. International Meeting on Pregnancy Loss, Tel-Aviv, Israel, April
9-12, 1989.
195. Zilberstein M, Puryear T, Gibori G, Gleicher N: Epidermal growth factor receptor (EGF-
R) gene expression in cultured human trophoblast cells. 45th Annual Meeting of The
American Fertility Society, November 11-16, 1989, San Francisco, CA.
196. Gleicher N: The physiological role of autoantibodies in reproduction. 4th International
Congress of Reproductive Immunology. Kiel, FRG, July 26-29, 1989.
197. Confino E, Tur-Kaspa I, Gleicher N: Opening pressure of normal and proximally
obstructed fallopian tubes. Presented at the 45th Annual Meeting of The American
Fertility Society, November 13-16, 1989, San Francisco, CA.
198. Zilberstein M, Puryear T, Gibori G, Gleicher N: Epidermal growth factor receptor (EGF-
R) gene expression in cultured human trophoblast cells. Presented at the 45th Annual
Meeting of The American Fertility Society, November 13-16, 1989, San Francisco, CA.
199. Confino E, Tur-Kaspa I, Friberg J, Gleicher N: Sonographic transcervical balloon
tuboplasty. Presented at the 45th Annual Meeting of The American Fertility Society,
November 13-16, 1989, San Francisco, CA.
200. Confino E, Gleicher N, DeCherney A, Corfman R, Coulam C, Robinson E, Friberg J,
Tur-Kaspa I, Haas G, Katz E, Vermesh M: Transcervical balloon tuboplasty: Description
of a technique to recanalize proximal tubal obstruction. Presented at the 45th Annual
Meeting of The American Fertility Society, November 13-16, 1989, San Francisco, CA.
(video presentation).
201. Confino E, DeCherney A, Corfman R, Coulam C, Robinson E, Friberg J, Haas G, Katz
E, Tur-Kaspa I, Vermesh M, Gleicher N: Transcervical balloon tuboplasty: A
multicenter study. Price paper of the General Program of The 45th Annual Meeting of
the American San Francisco, CA, November 13-16, 1989.
202. Gleicher N: The Mount Sinai cesarean section reduction initiative. Grand Rounds-CHR,
Albert Einstein College of Medicine, Bronx, New York, November 14, 1989.
203. Gleicher N: The Mount Sinai cesarean section reduction initiative. The S.B. Gusberg
Society of the Department of Obstetrics and Gynecology, Mount Sinai School of
Medicine, New York, NY, November 15, 1989.
204. Gleicher N: Mammography in obstetrics and gynecology. Grand Rounds-CHR, Cook
County Hospital, Chicago, IL, January 22, 1990.
205. Gleicher N: “Giving away the house”. Meeting of the OB/GYN physicians of West
Michigan, The Peninsular Club, Grand Rapids, Michigan, February 20, 1990.
206. Gleicher, N: Fetal rate and rhythm disorders. Visiting Professor Lectureship of The
Grand Rapids Area Medical Education Center, Saint Mary’s Hospital, Grand Rapids,
Michigan, February 21, 1990.
207. Gleicher N: C-section crises. Idem.
208. Gleicher N: Transcervical balloon tuboplasty: Description of technology to recanalize
proximal tubal obstruction. Workshop on Retrograde Tubal Catheterization, Centre
Francais du Commerce Exterieur, Paris, France, March 23, 1990.
209. Gleicher N: Transcervical balloon tuboplasty: A multicenter study. Idem.
210. Gleicher N: Pregnancy as an autograft. Tenth Anniversary Meeting of American Society
for the Immunology of Reproduction. Chicago, Illinois, June 20-23, 1990.
Page 35
211. Gleicher N: Autoimmunity and reproductive failure. VII World Congress on Human
Reproduction. Helsinki, Finland, June 26 - July 1, 1990.
212. Confino E, Tur-Kaspa I, DeCherney A, Corfman R, Coulam C, Robinson E, Haas G,
Katz E, Vermesh H, Gleicher N: Transcervical balloon tuboplasty: A multicenter study.
Idem.
213. Gleicher N: What is new in infertility? Grand Rounds-CHR, West Suburban Hospital,
Oak Park, Illinois. August 8, 1990.
214. Gleicher N: Immunologic causes of recurrent pregnancy loss: 1990 Congress of the
American College of Surgeons, San Francisco, October 7-12, 1990.
215. Zilberstein M, Harlow L, Gleicher N: Human sera containing antiphospholipid
autoantibodies (APA) inhibit phospholipase induced hCG secretion in human term
placenta villi explants. 46th Annual Meeting of the American Fertility Society,
Washington, D.C., October 13-18, 1990.
216. Confino E, Tur-Kaspa I, DeCherney A, Corfman R, Coulam C, Robinson E, Haas G,
Katz E, Vermesh M, Gleicher N: Follow up of the multicenter transcervical balloon
tuboplasty (TBT) study. Idem.
217. Confino E, Tur-Kaspa I, Gleicher N: Selective ultrasound- salpingography (SVS). Idem.
218. Dudkiewicz A, Confino E, Friberg J, Tur-Kaspa I, Novotny M, Wright J, Gleicher N:
What can we learn from chemical pregnancies. Idem.
219. Gleicher N, Pratt D, Novotny M, Parrilli M, Dudkiewicz A: The Benefit of estradiol
substitution in the luteal phase of IVF cycles. 7th World Congress on In Vitro
Fertilization & Assisted Procreation, Paris, France, June 30 - July 3, 1991.
220. Gleicher N, Pratt D, Parrilli M: The routine utilization of transvaginal tubal
catheterization for infertility. Idem.
221. Gleicher N: Antisperm antibodies - impact on ART. Fourth Annual In Vitro Fertilization
and Embryo Transfer Postgraduate Course, the Department of Continuing Education in
Health Sciences, UCLA Extension, and the Department of Obstetrics and Gynecology,
UCLA School of Medicine, Santa Barbara, CA July 28-31, 1991.
222. Gleicher N: Immunologic aspects of implantation. Idem.
223. Gleicher N: Update on tubal catheterization techniques, technologies and applications.
CARE Meeting, Chicago, IL September 24, 1991.
224. Gleicher N: Biomedical ethics & the court’s choices. Thirteenth Annual Conference,
National Association of Women Judges, Chicago, IL, October 13, 1991.
225. Gleicher N, Dudkiewicz A, Parrilli M, Pratt D: Do low luteal phase estradiol (E) levels
prevent implantation in IVF cycles? 47th Annual Meeting of the American Fertility
Society, Orlando, Fl, October 20 - 24, 1991.
226. Gleicher N, Parrilli M, Redding L, Pratt D: Hysterosalpingography (HSG) and selective
salpingography (SS) as therapeutic procedures. (Poster) Idem.
227. Gleicher N, Confino E, Corfman R, Coulam C, DeCherney A, Haas G, Katz E, Robinson
E, Tur-Kaspa I, Vermesh M: Transcervical balloon tuboplasty: multicenter study
conclusions and follow up. 47th Annual Meeting of the American Fertility Society,
Orlando, FL, October 22, 1991.
228. Gleicher N: What’s new in surgery. 1991 Clinical Congress of the American College of
Surgeons, Chicago, IL, October 25, 1991.
229. Gleicher N: The non-surgical approach to tubal obstruction. The Society for Minimally
Invasive Therapy Third International Meeting, Boston, MS, November 10-12, 1991.
Page 36
230. Gleicher N: Abnormal autoimmunity and endometriosis. 13th Japan Endometriosis
Symposium, Tokyo, Japan, January 24-25, 1992.
231. Gleicher N: Transcervical balloon tuboplasty seminar. Kyoto University, Kyoto, Japan,
January 27, 1992.
232. Gleicher N: Attend TBT case. Nihon University Itabashi Hospital, Tokyo, Japan,
233. Gleicher N: Assisted reproductive technologies. Nagoya City University, Nagoya, Japan,
January 29, 1992.
234. Gleicher N: Abnormal autoimmunity and endometriosis. Osaka University, Osaka, Japan,
January 30, 1992.
235. Gleicher N: Proximal tubal disease. 3rd Conference, Endocrinology and Metabolism in
Human Reproduction: The Fallopian Tube. The Royal London Hospital, London UK;
April 2, 1992.
236. Gleicher N: Autoimmunity in normal and abnormal pregnancies. International
Conference on Rheumatic Diseases in Pregnancy, Jerusalem, Israel; May 19, 1992.
237. Gleicher N: Vaginal approach to the breech infant. In Update in Obstetrics and
Gynecology - Postgraduate Course, University of Missouri - Kansas City School of
Medicine, Kansas City, Missouri, May 28, 1992.
238. Gleicher N, Pratt D, Kaberlein G, Dudkiewicz A: Danazol does not suppress sperm
antibodies in males. 12th National Meeting of the American Society for the Immunology
of Reproduction, Charleston, South Carolina; June 10-13, 1992.
239. Mathur S, Chihal H, Isaacson K, Gleicher N, Patrick R, Bleiler J: Endometrial
autoimmunity in endometriosis: Immunogenicity and specificity of the target antigens.
Idem.
240. Gleicher N, Pratt D, Kaberlein G, Honea K, Dudkiewicz A. The correlation of IL-4 and
IL-6 levels to the presence of autoantibodies in infertile females. Idem.
241. Gleicher N: Gyneco-Radiologic Diagnosis and Treatment of Tubal Disease. At
Comprehensive Operative Laparoscopy, Hysterectomy & Hysteroscopy. Operative
Endoscopy Workshop for Gynecologists, Scommenga A, Nezhat CR, course directors.
Chicago, IL, July 9-11, 1992.
242. Gleicher N: Antibody abnormalities and reproductive failure. 5th International Congress
of Reproductive Immunology, Rome Italy, August 30 to September 3, 1992.
243. Gleicher N: New developments in gynecoradiology. CARE Meeting, Chicago, IL,
September 22, 1992.
244. Gleicher N: Reducing cesarean rates. Evergreen Hospital Medical Center, Kirkland,
Washington, October 20, 1992.
245. Gleicher N, Liu H, Rosenwaks Z, Pratt D: Antibody Profiles as Predictors of IVF
Success. 48th Annual Meeting of the American Fertility Society, New Orleans, LA,
November 3, 1992.
246. Gleicher N, Parrilli M, Pratt D: A trial of guide wire cannulation of proximal tubal
occlusion. Idem.
247. Gleicher N, Redding L, Gurniak R, Parrilli M, Pratt D: The presentation of ampullary
tubal pregnancies during salpingography. Idem.
248. Gleicher N: Abnormal autoimmunity and endometriosis. 14th World Congress on
Fertility and Sterility, Caracas, Venezuela, November 24, 1992.
Page 37
249. Gleicher N: Gynecoradiology: A new approach to infertility care. Grand Rounds-CHR
Sinai-Samaritan Medical Center, Milwaukee Campus of the University of Wisconsin,
Department of OB/GYN, March 17, 1993.
250. Gleicher N: Gynecoradiology: A new approach to infertility care. Madison OB/GYN
Society, Madison, WI, March 17, 1993.
251. Gleicher N: Endometriosis: Time to reevaluate. Grand Rounds-CHR, Department of
OB/GYN, University of Wisconsin, Madison Campus, Madison, WI, March 18, 1993.
252. Gleicher N: Immunologic Theories of Endometriosis: Role of Humoral Immunity. 8th
World Congress on Human Reproduction Joint IVth World Conference on Fallopian
Tube in Health and Disease, Bali - Indonesia, April 5, 1993.
253. Gleicher N: Cesarean Section Rates. Blue Cross/Blue Shield Illinois Medical Director’s
Roundtable Chicago, IL - July 13, 1993.
254. Gleicher N: Clinical Aspect of ART. Abbott Laboratories Seminar Chicago, IL -
July 21, 1993.
255. Gleicher N: The bubble test: A new tool in the diagnosis of endometriosis.
CARE Meeting, Chicago, IL, September 28, 1993.
256. Gleicher N: The Immune System in ART. 8th World Congress on In Vitro Fertilization
and Alternate Assisted Reproduction Kyoto, Japan, September 13, 1993.
257. Gleicher N: Gynecoradiology: A new approach to the investigation and treatment of
infertility. International Symposium of New Reproductive Technology - Endoscopic
Transcervical Approaches, Tokyo Japan September 16, 1993.
258. Gleicher N: The bubble test: A new diagnostic test for endometriosis (video). The
American Fertility Society Annual Meeting, Montreal Canada, October 11, 1993.
259. Gleicher N, Pratt DE: How important is gynecoradiology for the evaluation of the
infertile couple? Second Annual Meeting of the GynecoRadiology Society, Montreal,
Canada, October 13, 1993.
260. Karande V, Pratt D, Gleicher N: The reduction of elevated perfusion pressures by
guidewire catheterization of fallopian tubes. Second Annual Meeting of the
GynecoRadiology Society, Montreal, Canada, October 13, 1993.
261. Gleicher N: Outcome analysis of C-Section rates. Grand Rounds-CHR. St. Anthony
Medical Center, Crown Point, IN, February 1, 1994.
262. Gleicher N: Overall perspective: Cesarean section in the 1990’s, Blue Cross Blue Shield
Managed Care Roundtable Agenda, March 11, 1994.
263. Gleicher N: Gynecoradiology: A new diagnostic and therapeutic approach towards
infertility. Grand Rounds-CHR, Department of OB/GYN, St Louis University, St. Louis,
MO, April 7, 1994
264. Gleicher N: “Immune dysfunction - A potential target treatment in endometriosis,” 4th
World Congress on Endometriosis, Salvador Bahia Brazil, May 25 -28, 1994.
265. Gleicher N: “Alterations of cell-mediated immunity in endometriosis.” Idem.
266. Gleicher N: “The bubble test and other diagnostic tools.” Idem.
267. Gleicher N: “Gynecoradiology: A new tool to diagnose and treat causes of infertility.”
Grand Rounds-CHR, Department of OB/GYN, St. Francis Hospital, Evanston, IL, Sept.
9, 1994.
268. Gleicher N: “How many embryos to transfer? Patient desires and approaches.” CARE
meeting, Chicago, IL, Sept. 20, 1994.
Page 38
269. Gleicher N: “Some new ideas about endometriosis,” Fertility Society of Australia
Meeting, Brisbane, Australia, Oct. 4-7, 1994.
270. Gleicher N: “Tubal perfusion pressures in women with endometriosis.” Idem.
271. Gleicher N: “Cesarean section reduction,” Grand Rounds-CHR, Department of OB/GYN,
Hinsdale Hospital, Hinsdale IL, Oct. 27, 1994.
272. Gleicher N, Karande V, Rabin D, Dudkiewicz A, Pratt D: “Abnormalities in IgG
subclasses in a female infertility population with gammaglobulinemias,” American
Fertility Society 50th Annual Meeting, San Antonio, TX, Nov. 5-10, 1994.
273. Gleicher N, Campbell D, Chan G, Karande V, Dudkiewicz A, Pratt D: “The attitude of
infertility patients towards multiple gestations.” Idem.
274. Gleicher N, Karande V, Rabin D: “Outcome assessment in infertility therapy: Patient
dropout rate after initial consultation.” Idem.
275. Gleicher N, Campbell DP, Chan GCL, Karande V, Dudkiewicz A, Pratt D: “The attitude
of infertility patients towards multiple gestations: Influence of age, parity and length of
infertility.” Idem.
276. Gleicher N, Parrilli M, Karande V, Dudkiewicz A, Pratt D: “Is prematurity due to
multiple conceptions in an implantation problem?”. Idem
277. Dudkiewicz A, Kaberlein G, Novotny M, Dudkiewicz C, Favero L, Pratt D, Karande V,
Gleicher N: “Can sperm motility elucidate media deficiencies not detected by mouse
two-cell culture?” Idem.
278. Gleicher N: Endometriosis - Immunology and other facets. XIII Annual Scientific
Meeting of the Fertility Society of Australia, Brisbane, Australia, October 5, 1994.
279. Gleicher N: Future evaluation of tubal function. Idem, October 7, 1994.
280. Gleicher N: Radiology. Fifth Conference Endocrinology and Metabolism in Human
Reproduction, Ectopic Pregnancy: Advances in Diagnosis and Treatment. Royal College
of Obstetricians and Gynecologists, London, England, March 27-29, 1995.
281. Gleicher N: What infertility patients think about multiple conceptions: Is it time to
reevaluate current practice patterns. 9th World Congress on In Vitro Fertilization and
Assisted Reproduction, Vienna, Austria, April 3-7, 1995.
282. Morris R, Gleicher N, Pratt D, Dudkiewicz A, Karande V, Levrant S, Minhas B:
Intracytoplasmic sperm injection (ICSI) for oocyte factors results in lower pregnancy
rates with in-vitro fertilization (IVF). Idem, April 3-7, 1995.
283. Gleicher N: Ovarian stimulation and overstimulation. Ovarian Stimulation and
Hyperstimulation, the Satellite Symposium of the 9th World Congress on IVF and
Assisted Reproduction, Hungary Academy of Sciences, Budapest, Hungary.
284. Gleicher N: Overview of reproductive immunology. 197th Annual Meeting of the
Medical and Chirurgical Faculty of Maryland. University of Maryland, College Park,
May 6, 1995.
285. Gleicher N: A Dialogue with the Austrian Medical Legal Mission, Sponsored by the
Illinois Department of Public Health, James R. Thompson Center, Chicago, Illinois, June
1, 1995.
286. Gleicher N: Cost containment and utilization containment in OB/GYN, Illinois
Association of Health Maintenance Organizations, Ritz Carlton Hotel, Chicago, Illinois,
September 21, 1995.
287. Gleicher N: Active labor/C Section, Grand Rounds-CHR, North Shore University
Medical School, Manhasset, Long Island, New York, October 25, 1995.
Page 39
288. Gleicher N: Corticosteroid and immunosuppressive therapy in reproductive autoimmune
failure syndrome, International Conference on Recurrent Abortion, Rome, Italy, January
27, 1996.
289. Gleicher N: Tubal cannulation, International Society for Gynecologic Endoscopy,
Stauffers Renaissance Hotel, Chicago, IL, April 17, 1996.
290. Gleicher N: “Managed care”, Smith Barney, Second Annual Conference on Emerging
Sectors in Health Care, Plaza Hotel, New York, NY, September 25, 1996.
291. Gleicher N: Sonography - International Congress of Sonography, AAGL 25th Annual
Meeting, Chicago, Illinois, September 26, 1996.
292. Gleicher N: Ultrasound and fetoscopy, AAGL 25th Annual Meeting, Chicago, Illinois,
September 28, 1996.
293. Gleicher N: Autoantibodies as an infertility factor in endometriosis, 5th World Congress
on Endometriosis, Yokohama, Japan, October 21, 1996.
294. Gleicher N, Karande V, Pratt D, Morris R, Vanderlaan B: Surgical utilization and
outcome in infertile HMO and PPO populations, American Society for Reproductive
Medicine, Fifty-Second Annual Meeting, Boston, Massachusetts, November 2-7, 1996.
295. Rao R, Karande V, Balin M, Levrant S, Pratt D, Ferguson R, Gleicher N: The
association of cytomegalovirus (CMV) with immunological abnormalities in a female
infertility population undergoing ART. American Society for Reproductive Medicine,
Idem. November 2-7, 1996.
296. Morris R, Ferguson R, Dudkiewicz A, Brown T, Minhas B, Rao R, Balin M, Levrant S,
Pratt D, Gleicher N: The risk of multiple pregnancy in assisted reproduction is inversely
related to age. American Society for Reproductive Medicine, Idem, November 2-7, 1996.
297. Morris R, Ferguson R, Ewing C, Dudkiewicz A, Gleicher N: Single Follicle Stimulating
Hormone Levels are Not Predictive of Subsequent Levels and Variation is Highly
Dependent on Age. American Society for Reproductive Medicine, Idem, November 2-7,
1996.
298. Gleicher N: “GynCor, Inc.: The management challenge in reproductive medicine”,
Smith Barney’s Fifth Annual Health Care Services Conference, Plaza Hotel, New York
City, New York, February 10-14, 1997.
299. Gleicher N: Managed care and reimbursement for fertility surgery. American
Association of Gynecologic Laparoscopists, Squaw Valley, California, February 20-23,
1997.
300. Gleicher N: First trimester pregnancy loss. American Association of Gynecologic
Laparoscopists, Squaw Valley, California, February 20-23, 1997.
301. Gleicher N: Diagnosis and therapeutic radiologic intervention. American Association of
Gynecologic Laparascopists, Squaw Valley, California, February 20-23, 1997.
302. Levrant S, Wang L, Miller C, Rinehart J, Karande V, Coulam C, Pratt D, Gleicher N:
Human leukocyte antigen DQA1 genotyping in women with endometriosis. The 17th
Annual Meeting of the American Society of Reproductive Immunology, Vancouver,
Canada, May 6, 1997.
303. Gleicher N: GynCor, Inc.: A company update. Smith Barney’s 1997 Third Annual
Conference on Emerging Sectors in Healthcare. Plaza Hotel, New York City, September
26, 1997.
Page 40
304. Gleicher N (Chair): How to adjust to a changing world in reproductive medicine. 53rd
Annual Meeting of the American Society for Reproductive Medicine, Cincinnati, Ohio,
October 20, 1997.
305. Gleicher N (Panelist): The GynCor model. Society of Reproductive Endocrinology:
Network Development Workshop. 53rd Annual Meeting of the American Society for
Reproductive Medicine, Cincinnati, Ohio, October 22, 1997.
306. Gleicher N: Balloon tuboplasty; Endometriosis pressure profilometry. (Telesurgery
workshop relayed via satellite from Chicago), International Congress on Fallopian Tubes,
Bombay, India, February 7, 1998.
307. Gleicher N: Adverse obstetrical outcome as a consequence of infertility treatment.
BlueCross BlueShield of Illinois Roundtable. Oakbrook Terrace, Illinois, February 11,
1998.
308. Gleicher N (Panelist): Reproductive health. UBS Securities Second Annual Women’s
Health Conference, The Pierre Hotel, New York, New York, February 19, 1998.
309. Gleicher N: Multifetal pregnancies: Should we reduce or continue? The Center for
Human Reproduction’s First Annual Post-Graduate Course, IVF Hot Topics, The Drake
Hotel, Chicago, Illinois, March 22-22, 1998
310. Gleicher N: The role of the immune system in the development of endometriosis. The
13th Congress of the European Association of Gynecologists and Obstetricians,
311. Gleicher N: A contrarian’s viewpoint on the antiphospho-lipid syndrome. The 30th
International Congress on Patho-physiology of Pregnancy, Jerusalem, Israel, May 13-15,
1998.
312. Gleicher N: What is driving the demand for women’s health care services? Fulcrum
Information Services National Conference on Women’s Health Care Services, The
Grand Hyatt, New York, New York, June 11-12, 1998.
313. Gleicher N: GynCor, Inc.: Practice management in reproductive medicine. Salomon
Smith Barney Second Annual Women’s Health Care Conference, The Plaza Hotel, New
York, New York, June 25, 1998.
314. Gleicher N: Immunological theories in the treatment of infertility. RESOLVE of Illinois
Educational Program, Lutheran General Hospital, Park Ridge, Illinois, August 11, 1998.
315. Gleicher N: GynCor and women’s healthcare. Salomon Smith Barney Fourth Annual
Emerging Sectors in Healthcare Services Conference, The Plaza Hotel, New York, New
York, September 25, 1998.
316. Gleicher N: Is there value to a utilization review program (URP) for injectable fertility
medications? Clinical Female Infertility and Gynecology Session, 54th Annual Meeting
of the ASRM, San Francisco, California, October 5, 1998.
317. Gleicher N: What is the real utilization of infertility services in an average patient
population with generous infertility benefits? Clinical Female Infertility and Gynecology
Session, 54th Annual Meeting of the ASRM, San Francisco, California, October 5, 1998.
318. Gleicher N: (Program Chair): Contracting for infertility. GynCor, Inc. and The Center
for Human Reproduction’s Symposium on the Economics of Infertility Care, Marriott
Hotel, San Francisco, California, October 6, 1998.
319. Gleicher N: The routine use of hMG stimulation for standard ovulation induction results
in pregnancy rates superior to results obtained from routine use of FSH products.
Reproductive Endocrinology Session, 54th Annual Meeting of the ASRM, San
Francisco, California, October 8, 1998.
Page 41
320. Gleicher N: Autoantibodies in reproduction. VII International Congress of Reproductive
Immunology. New Delhi, India, October 27-30, 1998.
321. Karande V, Chapman C, Gleicher N: Is there any value in splitting sibling oocytes
between intracytoplasmic sperm injection (ICSI) and conventional in vitro fertilization?
Assisted Reproduction Technology Session, Conjoint Annual Meeting of the
ASRM/CFAS, Toronto, Ontario, September 28, 1999.
322. Karande V, Chapman C, Gleicher N: A prospective of the value of blastocyst transfer in
low responders undergoing IVF-ET. Assisted Reproductive Technology Session,
Conjoint Annual Meeting of the ASRM/CFAS, Toronto, Ontario, September 28, 1999.
323. Gleicher N, Kaberlein G, Pratt D, Rinehart J, Morris R, Rao R, Karande V: Definition of
high-risk patients for high-order multiple pregnancies with ovarian stimulation by
gonadotropins. Clinical Female Infertility and Gynecology Session, Conjoint Annual
Meeting of the ASRM/CFAS, Toronto, Ontario, September 29, 1999.
324. Pratt D, Coulam C, Karande V, Gleicher N: What are the true cumulative pregnancy
rates of patients entering a standard treatment algorithm for infertility? Reproductive
Endocrinology Session, Conjoint Annual Meeting of the ASRM/CFAS, Toronto,
Ontario, September 29, 1999.
325. Gleicher N, Rinehart J, Pratt D, Morris R, Rao R, Balin M, Karande V: How does age
affect medication utilization in IVF? Assisted Reproductive Technology Session,
Conjoint Annual Meeting of the ASRM/CFAS, Toronto, Ontario, September 28, 1999.
326. Gleicher N, Coulam C, Pratt D, Rinehart J, Morris R, Rao R, Balin M, Karande V:
Comparison of utilization patterns in consecutive years: Is there value in a formal
utilization review program for infertility services? Clinical Female Infertility and
Gynecology Session, Conjoint Annual Meeting of the ASRM/CFAS, Toronto, Ontario,
September 29, 1999.
327. Gleicher N, Kaberlein G, Rinehart J, Morris R, Pratt D, Rao R, Balin M, Karande V,
High-order multiples, A preventable or unpreventable complication of controlled
Ovarian stimulation with gonadotropins? Reproductive Endocrinology Session, Conjoint
Annual Meeting of the ASRM/CFAS, Toronto, Ontario, September 29, 1999.
328. Chapman C, Karande V, Rinehart J, Gleicher N: Does the production of blastocysts from
supernumerary embryos predict pregnancy outcome after day 3 ET? Reproductive
Laboratory Session, Conoint Annual Meeting of the ASRM/CFAS, Toronto, Ontario,
September 29, 1999.
329. Gleicher N: What is the most cost effective algorithm for infertility treatment. Second
World Conference of APART, Budapest, Hungary, September 14-17, 2000.
330. Gleicher N, Oleske D., Tur-Kaspa I., Vidali A., Karande V.: Criteria for the Prevention
of High Order Multiple Births Following Ovulation Induction with Gonadotropins.
331. Gleicher N., Tur-Kaspa I., Chapman C., Karande V., Hazlett D., Skoog W.: Can We
332. Gleicher N. Tur-Kaspa I., Vidali A., Karande V.: The Changing Practice Pattern of
333. Gleicher N., Caruso, A: Treating Infertility in Men & Women Over 40. RESOLVE,
Reaching for Resolution Symposium Program, Chicago, IL, May 5, 2001.
334. Gleicher N: The Reproductive autoimmune Failure Syndrome, (RAFS). VIII
International Congress of Reproductive Immunology, Opatija, Croatia, July 4, 2001
335. Gleicher N: Forget About Ovulation Induction! Proceed Directly to IVF! 2nd World
Congress on Controversaires in Obstetrics Gynecology & Infertility, Paris, France,
September 6-9, 2001.
Page 42
336. Gleicher N: Reproductive Autoimmune Failure Syndrome. ASRI, Reproductive
Immunology in Chicago, June 9-12, 2001.
337. Gleicher N: “Is There Something Like Immunological Infertility and Pregnancy Loss
After All?” Grand Rounds-CHR, Russian Tea Room (restaurant), New York, NY,
September 1, 2001.
338. Gleicher N: Does Autoimmune—Reproductive Failure Have Evolutionary Implications?
3rd International Congress on Autoimmunity, Geneva, Switzerland, February 20-24,
2002
339. Gleicher N: “Can Ovarian Aging Be Affected After All?” Grand Rounds-CHR, Etoile
(restaurant), New York, NY, October 12, 2004.
340. Gleicher N: “The Aging Ovary: Modifying Some Long Standing Dogmas.” Grand
Rounds-CHR, Lenox Hill Hospital, New York, NY, October 20, 2004.
341. Gleicher N: Should We Proceed Directly to IVF? Reducing the Multiple Pregnancies
Risks. Asian Pacific Congress on Controversies in Obstetrics, Gynecology and Infertility,
Bangkok, Thailand, November 25-28, 2004.
342. Gleicher N: Should We Limit The Number of Embryos Transferred: The Review. Asian
Pacific Congress on Controversies in Obstetrics, Gynecology and Infertility, Bangkok,
Thailand, November 25-28, 2004.
343. Gleicher N: Maternal Autoimmune Disease: Can It Affect Future Generations? Asian
Pacific Congress on Controversies in Obstetrics, Gynecology and Infertility, Bangkok,
Thailand, November 25-28, 2004.
344. Gleicher N: “The Aging Ovary: Modifying Some Long Standing Dogmas”. Grand
Rounds-CHR, Yale OB/GYN, New Haven, CT, January 27, 2005.
345. Gleicher N: Use of Microdose GnRH (Lupron) Ovarian Stimulation Protocol to Improve
IVF Outcome in Young Women with Prematurely Aging Ovaries. 8th International
Symposium on GnRH Analogues in Cancer and Human Reproduction, Salzburg, Austria,
February 10-13, 2005.
346. Gleicher N: PGD for Elective Gender Selection. 12th World Congress on Human
Reproduction, Venice, Italy, May 10-13, 2005.
347. Gleicher N: “Does unexplained infertility really exist?” Grand Rounds-CHR, Amuse
(restaurant), New York, NY April 12, 2005.
348. Gleicher N, Barad D: Can We Reverse Ovarian Aging After All? 13th World Congress
on In Vitro Fertilization, Assisted Reproduction & Genetics, Istanbul, Turkey, May 26-
29, 2005.
349. Gleicher N: Dehydroepiandrosterone (DHEA) treatment improves response to ovulation
induction: 21st Meeting of The European Society of Human Reproduction and
Embryology, Copenhagen, Denmark, June 19-22, 2005.
350. Gleicher N: Can we affect the aging ovary, after all? Refuting some long-held dogmas:
Symposium on Anti-Aging in Human Reproduction, Osaka, Japan. September 20, 2005.
351. Barad D, Gleicher N: Dehydroepiandrosterone (DHEA) Pre-Treatment and Ovulation
Induction for In Vitro Fertilization among Women with a History of Decreased Ovarian
Reserve: ASRM/CFAS 2005, Montreal, Quebec. October 17, 2005.
352. Barad D, Gleicher N: Effect of Race in Ovulation Induction, Oocyte Recovery, and
Pregnancy Outcome in In-Vitro Fertilization: ASRM/CFAS 2005, Montreal, Quebec.
October 19, 2005.
Page 43
353. Gleicher N: Can We Treat the Aging Ovary After All? The International Ovarian
Conference 2006, Yokohama, Japan. May 13, 2006.
354. Weghofer A, Barad D, Gleicher N: Premature Ovarian Aging (POA) is Not
Characterized by an Increase in Aneuploidy rates. The 22nd Annual Meeting of the
ESHRE, Prague, Czech Republic June 18-20, 2006.
355. Gleicher N, Barad D: The Effect of Dehydroepiandroserone On Diminished Ovarian
Reserve. The 22nd Annual Meeting of the ESHRE, Prague, Czech Republic June 18-20,
2006 The 22nd Annual Meeting of the ESHRE, Prague, Czech Republic June 18-20,
2006.
356. Gleicher N: Selected research update at CHR. Grandrounds, Department of Ob/Gyn,
Sheba Medical Center, Tel Haschomer Hospital, Sackler School of Medicine of Tel
Aviv University, September 25, 2006.
357. Gleicher N: Selected research update at CHR: Grandrounds, Department of Ob/Gyn,
358. Weghofer A, Munne S, Brannath W, Chen S, Cohen J, Gleicher N: The quantitative and
359. Brill H, Barad D, Gleicher N: Dehydroepiandrosterone (DHEA) supplementation and
360. Barad D, Weghofer A, Gleicher N: Evidence for an empiric definition of diminished
361. Gleicher N, Weghofer A, Barad D: Adrenal function in women with premature aging
ovaries
362. Weghofer A, Barad D, Gleicher N: Are women with premature ovarian aging (POA) at
363. Weghofer A, Munne S, Chen S, Barad D, Cohen J, Gleicher N: Lack of association
between polycystic ovary syndrome and embryonic aneuploidy. A 62nd Annual Meeting
of the Society for Reproductive Medicine, New Orleans, October 21-25, 2006.
364. Gleicher N: The Aging Ovary. Grandrounds, Department of Ob/Gyn, Hadassah Hospital
and Hebrew University School of Medicine, Jerusalem, Israel, March 26, 2007.
365. Gleicher N: The Aging Ovary. Grandrounds, Department of Ob/Gyn, Assuta Hospital,
Tel Aviv, Israel and Sackler School of Medicine, Tel-Aviv University, Israel, March 27,
2007.
366. Gleicher N: The Aging Ovary, Grandrounds, NYU Medical Center of NYU School of
Medicine, New York, March 2007.
367. Gleicher N: Premature ovarian aging. Grandrounds, Department of Obstetrics,
Gynecology and Reproductive Sciences, Yale University School of Medicine, New
Haven, CT, May 3, 2007.
368. Gleicher N: The aging ovary. By invitation; 1st International Symposium in Genetics
and Assisted Reproduction Techniques, King George Palace Hotel, Athens, Greece, May
5th, 2007.
369. Gleicher N: Gynecoradiology. Grandrounds, Southern California Reproductive Center,
Beverly Hills, California, May 25, 2007.
370. Gleicher N: Twins in ART-a desirable outcome? A debate: the pro-view. 14th World
Congress on In-Vitro Fertilization & 3rd World Congress on In-Vitro Maturation;
Montreal, Canada; September 15-19, 2007.
371. Gleicher N: IVF in Older Women. 23rd Annual Congress of the Austrian Society for
Reproductive Medicine and Endocrinology, Innsbruck, Austria, September 20-22, 2007.
372. Singer T, Barad D, Gleicher N: A comparison of serum anti-Mullerian hormone and
cycle baseline follicle stimulating hormone in prediction of IVF outcomes. American
Society for Reproductive Medicine, 63rd Annual Meeting, Washington, D.C., October
13-17, 2007.
Page 44
373. Barad D, Weghofer A, Gleicher N: Age-specific cut-offs for FSH assessment of ovarian
function: improved diagnosis of premature ovarian aging (POA). American Society for
Reproductive Medicine, 63rd Annual Meeting, Washington, D.C., October 13-17, 2007.
374. Gleicher N, Weghofer A, Barad D: Increased euploid embryos after supplementation
with DHEA in women with premature ovarian aging. American Society for
Reproductive Medicine, 63rd Annual Meeting, Washington, D.C., October 13-17, 2007.
375. Gleicher N, Barad D: Does gender selection devalue women? American Society for
Reproductive Medicine, 63rd Annual Meeting, Washington, D.C., October 13-17, 2007.
376. Weghofer A, Brill H, Barad D, Gleicher N: Does autoimmunity play a causative role in
the pathophysiology of premature ovarian aging (POA)? American Society for
Reproductive Medicine, 63rd Annual Meeting, Washington, D.C., October 13-17, 2007.
377. Gleicher N, Weghofer A, Li JM, Barad D: Increased risk of premature ovarian aging
(POA) in Chinese women. American Society for Reproductive Medicine, 63rd Annual
Meeting, Washington, D.C., October 13-17, 2007.
378. Barad D, Gleicher N, Weghofer A, Chen S, Cohen J: Validation of age-specific cut-offs
for ovarian function assessment by FSH levels via a second patient population: inherent
differences in patient populations between IVF centers. American Society for
Reproductive Medicine, 63rd Annual Meeting, Washington, D.C., October 13-17, 2007.
379. Gleicher N, Barad D: The impact of DHEA supplementation on IVF pregnancy rates in
women ages 40-47 years. American Society for Reproductive Medicine, 63rd Annual
Meeting, Washington, D.C., October 13-17, 2007.
380. Barad D, Gleicher N: Implantation rate and pregnancy rates following all freeze
cryopreservation cycles compared to those following cryopreservation of excess
embryos. American Society for Reproductive Medicine, 63rd Annual Meeting,
Washington, D.C., October 13-17, 2007.
381. Gleicher N: The Effect of DHEA on IVF Outcome in Women above age 40. 74th
Annual Meeting, Program of the Central Association of Obstetricians and Gynecologists,
Chicago, IL, October 17-20, 2007.
382. Gleicher N: Age-specific ovarian function testing improves determination of ovarian
reserve. The International Ovarian Conference, Hakone, Japan, November 2-3, 2007.
383. Gleicher N: The aging ovary. International Symposium, Genetics and Immunology of
Reproduction, Buenos Aires, Argentina, November 7-8, 2007.
384. Gleicher N: Comparison of IVF outcomes between Europe and the USA. International
Symposium, Genetics and Immunology of Reproduction, Buenos Aires, Argentina,
November 7-8, 2007.
385. Gleicher N: Ovarian Aging. Grandrounds, Department of Obstetrics and Gynecology,
New York Medical College, Valhalla, New York, March 6, 2008.
386. Gleicher N: Impact of LH-containing gonadotropins on ploidy: Long agonist stimulation.
ART Clinical Update. Ferring in Fertility. Toronto, Ontario, Canada, June 19-21, 2008.
387. Gleicher N: Infertility Treatment 2009: as good as it gets. 2009 Annual Patrick Steptoe
Memorial Lecture, British Fertility Society, Edinburgh, United Kingdom, January 7,
2009.
388. Gleicher N: Should we ever make a diagnosis of unexplained infertility? Symposium on
Unexplained Fertility, British Fertility Society, Edinburgh, United Kingdom, January 8,
2009.
Page 45
389. Weghofer A, Barad DH, Oktay K, Gleicher N. Why abnormal autoimmune function and
number of triple CGG expansions on the FMR1 gene are independent risk factors of
premature ovarian senescence. 24th Annual Meeting of ESHRE, Barcelona, Spain, July
7, 2008; O-035.
390. Gleicher N. Improving oocyte selection and embryo quality. In FERRING Company
Symposium – “FORUM AUDITORIUM.” Better Together: HCG-driven LH activity
matters. 24th Annual meeting of ESHRE, Barcelona, Spain, July 7, 2008.
391. Li JM, Barad DH, Gleicher N. In contrast to prevalent opinion, twin pregnancies after
fertility treatments are medically, ethically and economically desirable outcomes. 24th
Annual Meeting of ESHRE, Barcelona, Spain, July 7, 2008.
392. Gleicher N. IVF outcomes in Europe and the USA, worth a discussion? In IBSA
Company Symposium – “FORUM AUDITORIUM.” Follicular stimulation outcomes,
Europe vs. USA: Any lessons to learn? 24th Annual meeting of ESHRE, Barcelona,
Spain, July 8, 2008.
393. Gleicher N, Weghofer A, Oktay K, Barad DH. The number of triple CGG repeats on the
FMR1 gene: A new test reflective of diminished ovarian reserve and female infertility.
394. Gleicher N. The FMR1 gene as a fertility test. Grandrounds, Yale University School of
Medicine, New Haven, Connecticut, October 30, 2008.
395. Oktay K, Sahin G, Ucar F, Barad D, Blanchette H, Gleicher N: Fertility preservation is
an emerging discipline extending beyond cancer patients: analysis of a large experience.”
64th Annual Meeting of the ASRM, San Francisco, CA, November 8-12, 2008 (O-141).
396. Oktay K, Oktem O, Barad D, Gleicher N: “Longevity of autologous ovarian transplants:
extended experience in humans.” 64th Annual Meeting of the ASRM, San Francisco,
CA, November 8-12, 2008 (O-146).
397. Gleicher N, Weghofer A, Oktay K, Barad D. “Relevance of low expansion CGG triple
repeat numbers on the FMR1 gene to functional ovarian reserve.” 64th Annual Meeting
of the ASRM, San Francisco, CA, November 8-12, 2008 (O-160).
398. Oktay K, Barad D, Gleicher N, Smotkin-Tangorra M. “Retrieval and cryopreservation of
large number of oocytes from a 15 year old with primary amenorrhea and diagnosis of
premature ovarian failure.” 64th Annual Meeting of the ASRM, San Francisco, CA,
November 8-12, 2008 (O-249).
399. Gleicher N, Weghofer A, Oktay K, Barad D: “Autoimmune function and number of
triple CGG expansions on the FMR1 gene as independent risk factors for premature
ovarian senescence.” 64th Annual Meeting of the ASRM, San Francisco, CA, November
8-12, 2008 (P-125).
400. Oktay K, Kim JY, Barad D, Gleicher N, Blanchett H: “Serum FSH monitoring improves
decision making in women undergoing controlled ovarian hyperstimulation with
letrozole and follicle stimulating hormone.” 64th Annual Meeting of the ASRM, San
Francisco, CA, November 8-12, 2008 (P-226).
401. Klein K, Stammler-Safar M, Krampl E, Gleicher N, Barad D, Weghofer A: “The impact
of fetal sex on prematurity in dichorial-diamniotic twin pregnancies after assisted
reproduction.” 64th Annual Meeting of the ASRM, San Francisco, CA, November 8-12,
2008 (P-306).
402. Barad DH, Weghofer A, Oktay K, Gleicher N: “Triple CGG expansions on the FMR1
gene and response to ovarian stimulation.” 64th Annual Meeting of the ASRM, San
Francisco, CA, November 8-12, 2008 (P-375).
Page 46
403. Gleicher N, Ryan E, Weghofer A, Oktay K, Blanco-Mejia S, Barad DH:
“Dehydroepiandrosterone (DHEA) reduces miscarriage rates in women with diminished
ovarian reserve: a multicenter study.” 64th Annual Meeting of the ASRM, San Francisco,
CA, November 8-12, 2008 (P-450).
404. Gleicher N, Weghofer A, Oktay K, Barad D: “The distribution of causative etiologies in
infertile women with a diagnosis of spontaneous premature ovarian senescence,
exclusive of end-stage premature ovarian failure (POF).” 64th Annual Meeting of the
ASRM, San Francisco, CA, November 8-12, 2008 (P-452).
405. Barad D, Oktay K, Weghofer A, Gleicher N: “Anti-Mullerian hormone (AMH), but not
follicle stimulating hormone (FSH), correlates to oocyte yield in in vitro fertilization.”
64th Annual Meeting of the ASRM, San Francisco, CA, November 8-12, 2008 (P-453).
406. Gleicher N: “Are patients entitled to maximal pregnancy rates with infertility
treatments?” 11th World Congress on Controversies in Obstetrics and Gynecology, Paris,
France, November 27-30, 2008.
407. Gleicher N. “Infertility treatment 2009: as good as it gets?” Patrick Steptoe Memorial
Lecture; Fertility 2009, Bi-Annual Combined Meetings of the British Fertility Society,
The Association of Clinical Embryologists and Society for Reproduction and Fertility;
Edinburg International Conference Centre, January 7-9, 2009.
408. Gleicher N. “Should we ever make a diagnosis of unexplained infertility?” Fertility 2009,
Bi-Annual Combined Meetings of the British Fertility Society, The Association of
Clinical Embryologists and Society for Reproduction and Fertility; Edinburg
International Conference Centre, January 7-9, 2009.
409. Gleicher N. “The FMR1 gene as a fertility test.” Masterclass in Reproductive Medicine,
Specialist Meeting in Reproductive Medicine; Apex City Hotel, Edinburg, January 9-10,
2009.
410. Gleicher N. “An update on DHEA supplementation.” Masterclass in Reproductive
Medicine, Specialist Meeting in Reproductive Medicine; Apex City Hotel, Edinburg,
January 9-10, 2009.
411. Gleicher N. “Can we possibly affect follicular recruitment?” New Frontiers in Fertility.
Serono Symposia International Foundation, Lisbon, Portugal, February 13-14, 2009.
412. Goyal A, Barad DH Weghofer A, Oktay K, Gleicher N. Predicting improvements in
ovarian reserve and pregnancy rates after supplementation of dehydroepiandrosterone
(DHEA) in diminished ovarian reserve. Annual Meeting of ESHRE, Amsterdam, The
Netherland, June 28 - July 1, 2009.
413. Barad DH, Weghofer A, Oktay K, Gleicher N. What are the effects of race/ethnicity on
triple CGG counts on the FMR1 (fragile X) gene? Annual Meeting of ESHRE,
Amsterdam, The Netherland, June 28 - July 1, 2009.
414. Oktay K, Turkcuoglu I, Barad DH, Gleicher N, Kim JY. Prospective comparison of
letrozole-FSH stimulation followed by hcG vs GnRHa for fertility preservation in
women with breast cancer. Annual Meeting of ESHRE, Amsterdam, The Netherland,
June 28 - July 1, 2009.
415. Gleicher N, Weghofer A, Oktay K, Barad DH. A potential new function of the FMR1
(fragile X) gene: Regulation of functional ovarian reserve. Annual Meeting of ESHRE,
Amsterdam, The Netherland, June 28 - July 1, 2009.
416. Gleicher N. Weghofer A, Barad DH. Triple CGG counts on the FMR1 (fragile X) gene
vary between races/ethnicities based on distribution, but not based on normal range and
Page 47
median. 65th Annual Meeting of the American Society for Reproductive Medicine,
Atlanta, Georgia, October 17-21, 2009.
417. Gleicher N, Goyal A, Weghofer A, Barad DH. Supplementation with
dehydroepiandrosterone (DHEA) improves ovarian reserve, as reflected by anti-
Müllerian hormone levels. 65th Annual Meeting of the American Society for
Reproductive Medicine, Atlanta, Georgia, October 17-21, 2009.
418. Barad DH, Weghofer A, Goyal A, Gleicher N. Age-specific anti-Müllerian hormone
(AMH) levels discriminate at each age between poorer and better oocytes yields. 65th
Annual Meeting of the American Society for Reproductive Medicine, Atlanta, Georgia,
October 17-21, 2009.
419. Barad DH, Weghofer A, Goyal A, Gleicher N. Further refinement in defining the effect
of heterozygous-abnormal CGG counts on the FMR1 (fragile X) gene: definition of
distinct subgroup of PCOS patients, based on normal/low genotype. 65th Annual
Meeting of the American Society for Reproductive Medicine, Atlanta, Georgia, October
17-21, 2009.
420. Gleicher N, Weghofer A, Barad DH. The FMR1 gene, a regulator of functional ovarian
reserve over reproductive life times. 65th Annual Meeting of the American Society for
Reproductive Medicine, Atlanta, Georgia, October 17-21, 2009.
421. Barad DH, Weghofer A, Goyal A, Gleicher N. What does discordance between follicle
stimulating hormone (FSH) and anti-Müllerian hormone (AMH) mean? 65th Annual
Meeting of the American Society for Reproductive Medicine, Atlanta, Georgia, October
17-21, 2009.
422. Barad DH, Weghofer A, Gleicher N. How predictive of basic pregnancy potential are
extremely low levels of anti-Müllerian hormone (AMH)? 65th Annual Meeting of the
American Society for Reproductive Medicine, Atlanta, Georgia, October 17-21, 2009.
423. Gleicher N. What does DHEA have to do with treating diminished ovarian reserve? The
3rd Asia Pacific Congress on Controversies in Obstetrics, Gynecology & Infertility,
Beijing, China, November 12-15, 2009.
424. Gleicher N. PGS is associated with lower success rate and should not be offered as a
screening tool. The 3rd Asia Pacific Congress on Controversies in Obstetrics,
Gynecology & Infertility, Beijing, China, November 12-15, 2009.
425. Gleicher N. Are twins really an adverse outcome in IVF? No. The 3rd Asia Pacific
Congress on Controversies in Obstetrics, Gynecology & Infertility, Beijing, China,
November 12-15, 2009.
426. Gleicher N. The FMR1 gene as a regulator of follicular recruitment and ovarian aging.
The International Ovarian Conference 2009, Tokyo, Japan, December 5, 2009.
427. Gleicher N. Methods to assess ovarian reserve more timely and more accurately.
Meeting of the Japan Infertility Study Group (ISG), Tokyo, Japan, December 6, 2009.
428. Gleicher N, Elkayam U. Peripartum cardiomyopathy is an autoimmune disease. First
International Congress on Cardiac Problems in Pregnancy, Valencia, Spain, February
25-28, 2010.
429. Weghofer A, Dietrich W, Ortner I, Barad DH, Biegelmayer C, Gleicher N. Age-specific
anti-Mullerian hormone (AMH) in a fertile cohort: not as stable as previously thought.
26th Annual Meeting of ESHRE, Rome, Italy, June 27-30, 2010.
Page 48
430. Barad D, Gupta A, Gleicher N. A slim PCOS-phenotype, characterized by heterozygous-
normal/low genotype on the FMR1 (fragile X) gene. 26th Annual Meeting of ESHRE,
Rome, Italy, June 27-30, 2010.
431. Gleicher N, Barad DH. A new concept of ovarian aging: oocytes remain perpetually
"young"; it is the ovarian environment in which folliculogenesis occurs that ages. 26th
Annual Meeting of ESHRE, Rome, Italy, June 27-30, 2010.
432. Gleicher N, Barad DH. Evidence based medicine (EBM): what’s next? Cannot replace
clinical judgment. Proceedings of the 13th World Congress on Controversies in
Obstetrics, Gynecology & Infertility (COGI), Berlin, Germany, Nov. 4-7, 2010; Ben-
Rafael Z ed, Monduzzi Editore 2010, p161-6.
433. Gleicher N, Weghofer A, Barad DH. Preimplantation genetic screening (PGS) is an
experimental tool that should be banned from routine clinical use: PGS, as currently
practiced, is associated with inferior results and should not be routinely offered. Idem;
pp171-5.
434. Gleicher N, Weghofer A, Barad DH. Has anti-Müllerian hormone (AMH) become
essential in assessing ovarian reserve? – NO. Idem; pp189-94.
435. Gleicher N, Weghofer A, Barad DH. Can diminished ovarian reserve be treated
effectively? – YES. Idem; pp195-201.
436. Lee I, Barad DH, Weghofer A, Gleicher N. New evidence as an explanation for the
negative impact of autoimmunity on reproductive success in association with IVF. 27th
Annual Meeting of the European Society of Human Reproduction and Embryology,
Stockholm, Sweden, July 3-6, 2011.
437. Gleicher N, Weghofer A, Barad DH. The impact of ovarian FMR1 genotypes and sub-
genotypes in young oocyte donors on ovarian reserve and recipient pregnancy rates. 27th
Annual Meeting of the European Society of Human Reproduction and Embryology,
Stockholm, Sweden, July 3-6, 2011.
438. Vidali A, Barad DH, Gleicher N. Successful treatment with intrauterine perfusion of
granulocyte colony stimulating factor (G-CSF) of chronically intractable this
endometrium. 27th Annual Meeting of the European Society of Human Reproduction
and Embryology, Stockholm, Sweden, July 3-6, 2011.
439. Weghofer A, Dietrich W, Barad DH, Gleicher N. Live birth chances in women with
extremely low anti-Mullerian hormone levels. 27th Annual Meeting of the European
Society of Human Reproduction and Embryology, Stockholm, Sweden, July 3-6, 2011.
440. Gleicher N. Are twins an adverse outcome after infertility treatments? Fifth Isala
Fertility Symposium, Zwolle, the Netherlands, September 23, 2011.
441. Gleicher N. Genetic issues related to the oocyte: the FMR1 gene. First meeting of the
Ovarian Club, Barcelona, Spain, November 3-6, 2011.
442. Gleicher N. Rejuvenating ovarian function: DHEA improves IVF outcomes and reduces
aneuploidy. First meeting of the Ovarian Club, Barcelona, Spain, November 3-6, 2011.
443. Gleicher N. Is measurement of anti-Mullerian hormone (AMH) essential? NO. 14th
World Congress on Controversies in Obstetrics, Gynecology and Infertility. Paris,
France, November 17-20, 2011.
444. Gleicher N. PGS remains an experimental tool! 14th World Congress on Controversies
in Obstetrics, Gynecology and Infertility. Paris, France, November 17-20, 2011.
Page 49
445. Gleicher N. Preconception counseling for ART: Who should inform the women about
the risks? 14th World Congress on Controversies in Obstetrics, Gynecology and
Infertility. Paris, France, November 17-20, 2011.
446. Gleicher N. Is what the physician does important in affecting the embryo quality? 4th
Asia Pacific Congress on Controversies in Obstetrics, Gynecology and Infertility.
Bangkok, Thailand, November 24-27, 2011.
447. Gleicher N. Should DHEA be used more widely? 4th Asia Pacific Congress on
Controversies in Obstetrics, Gynecology and Infertility. Bangkok, Thailand, November
24-27, 2011.
448. Gleicher N. Should we always strive to use mild stimulation for IVF? Results are too
low and dropout rates are too high to make it a viable option! 15th World Congress on
Controversies in Obstetrics, Gynecology and Infertility. Hainan, China, December 8-11,
2011.
449. Gleicher N. Preventing all multiple pregnancies by systematic single embryo transfer
(SET) for all? No. 15th World Congress on Controversies in Obstetrics, Gynecology and
Infertility. Hainan, China, December 8-11, 2011.
450. Gleicher N. PGS is an experimental tool that should be banned from routine clinical use!
PGS, as currently practiced, is associated with inferior results and should not be
routinely offered. 15th World Congress on Controversies in Obstetrics, Gynecology and
Infertility. Hainan, China, December 8-11, 2011.
451. Gleicher N. Can diminished ovarian reserve be treated effectively? Yes. 15th World
Congress on Controversies in Obstetrics, Gynecology and Infertility. Hainan, China,
December 8-11, 2011.
452. Gleicher N. Treating anovulatory PCOS patients: what should be the first choice?
Ovulation induction + IUI and/or IVF. 15th World Congress on Controversies in
Obstetrics, Gynecology and Infertility. Hainan, China, December 8-11, 2011.
453. Gleicher N. Preconception counseling for ART: Who should inform the women about
the risks? Patients are ready to take the many risks in their journey to parenthood, and
ART specialists are fully trained to weight the risk/benefit in most situations, hence they
should be the primary physicians to provide counseling. 15th World Congress on
Controversies in Obstetrics, Gynecology and Infertility. Hainan, China, December 8-11,
2011.
454. Gleicher N. AMH in ART. 15th World Congress on Controversies in Obstetrics,
Gynecology and Infertility. Hainan, China, December 8-11, 2011.
455. Gleicher N. Saving ovaries, rescuing eggs. Endometriosis 2012: Tapping the roots for
the next generation. New York, NY, March 14 – 15, 2012.
456. Gleicher N. The most important, largely unknown gene in reproductive medicine and
beyond: the FMR1 gene. Greater Toronto Area Reproductive Medicine Rounds. Toronto,
Canada, March 22, 2012.
457. Gleicher N. Intrauterine administration of granulocyte colony-stimulating factor (G-
CSF) to increase endometrial thickness. The World Congress on Building Consensus in
Gynecology, Infertility and Perinatology (BCGIP), Barcelona, Spain, May 3 – 6, 2012.
458. Gleicher N. Panel discussions: Treatment strategies for poor responder patients. The
World Congress on Building Consensus in Gynecology, Infertility and Perinatology
(BCGIP), Barcelona, Spain, May 3 – 6, 2012.
Page 50
459. Gleicher N. Debate: What should be the preferred route of progesterone administration?
The World Congress on Building Consensus in Gynecology, Infertility and Perinatology
(BCGIP), Barcelona, Spain, May 3 – 6, 2012.
460. Gleicher N. “Chromosomes and autoimmunity: The FMR1 gene.” American
Autoimmune Related Diseases Association’s Scientific Colloquium “Sex, Gender and
Autoimmunity through the Lifespan.” Chicago, IL, USA, May 17, 2012.
461. Gleicher N. “Improvements in infertility techniques leading to increased incidence of
pregnancies in women with congenital or acquired heart disease.” Congress on Cardiac
Problems in Pregnancy, Berlin, Germany, May 17-20, 2012.
462. Gleicher N. “Twins are ethically and clinically desirable outcome of infertility treatment.”
Fertility Treatment and Multiple Births: Ethical and Policy Issues Workshop, White
Plains, NY, June 20-21, 2012.
463. Gleicher N. “IVM does not offer any advantage over current IVF practice, and the
associated risks are unknown.” The 16th World Congress on Controversies in Obstetrics,
Gynecology and Infertility, Singapore, July 19-22, 2012.
464. Gleicher N. “Decreased ovarian reserve and early menopause: Can you do something,
doctor?” The 16th World Congress on Controversies in Obstetrics, Gynecology and
Infertility, Singapore, July 19-22, 2012.
465. Gleicher N. “Developing international standards for cross border services, who’s
responsibility is it?” The 16th World Congress on Controversies in Obstetrics,
Gynecology and Infertility, Singapore, July 19-22, 2012.
466. Gleicher N. “Can we improve pregnancy rates of patients with DOR by better
stimulation?: Better protocol can improve stimulation and pregnancy rates.” The 16th
World Congress on Controversies in Obstetrics, Gynecology and Infertility, Singapore,
July 19-22, 2012.
467. Gleicher N. “EBM has limited value in daily clinical care and cannot replace clinical
judgement.” The 16th World Congress on Controversies in Obstetrics, Gynecology and
Infertility, Singapore, July 19-22, 2012.
468. Weghofer A, Kim A, Barad DH, Gleicher N. The impact of androgens on pregnancy
potential in women with diminished ovarian reserve. Annual Meeting of the European
Society of Human reproduction and Embryology, Istanbul, Turkey, July 1-4, 2012.
469. Gleicher N. Treating infertility in patients with older ovaries. Austrian IVF Congress,
Vienna, Austria, October 19-20, 2012.
470. Gleicher N. Can the addition of androgens affect the results of treatment in poor
responders? The 17th World Congress on Controversies in Obstetrics, Gynecology &
Infertility (COGI), Lisbon, Portugal, November 8-11, 2012.
471. Gleicher N. Embryonic biopsy is associated with decreased implantation which should
be offset by the results to make it a viable option. The 17th World Congress on
Controversies in Obstetrics, Gynecology & Infertility (COGI), Lisbon, Portugal,
November 8-11, 2012.
472. Gleicher N. What clinicians and biologists should know about each other’s work. The
17th World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI),
Lisbon, Portugal, November 8-11, 2012.
473. Gleicher N. How androgens and genes affect follicle maturation and ovarian aging.
Ovarian Club II, Prague, Czech Republic, November 8-11, 2012.
Page 51
474. Gleicher N. Autoimmune diseases and premature labor. Maternal and Fetal Medicine
Symposium, Bogota, Colombia, November 29 - December 1, 2012.
475. Gleicher N. The current debate about the risk profile of twin pregnancies: Importance of
context and correct statistical analysis. Maternal and Fetal Medicine Symposium, Bogota,
Colombia, November 29 - December 1, 2012.
476. Gleicher N. Intricate interplay between autoimmunity and pregnancy. Maternal and Fetal
Medicine Symposium, Bogota, Colombia, November 29 - December 1, 2012.
477. Gleicher N. Is preeclampsia the equivalent of graft-versus-host-disease (GVHD), seen in
allogenic organ transplantation? Maternal and Fetal Medicine Symposium, Bogota,
Colombia, November 29 - December 1, 2012.
478. Gleicher N. Poor ovarian reserve and implantation failure: Potential treatments. How to
Improve IVF Success Rates Congress, Rome, Italy, December 14th, 2012.
479. Gleicher N. Controversies about single embryo transfer and gender selection. Meeting of
the Philadelphia Area Reproductive Endocrine Society and the Obstetrical Society of
Philadelphia, January 10, 2013.
480. Gleicher N. Diminished ovarian reserve in breast cancer patients with BRCA1 mutation.
International Congress on Oncological Perspectives of Fertility Preservation, Berlin,
Germany, March 21-23, 2013.
481. Gleicher N. Dehydroepiandrosterone (DHEA) and its role in female fertility. Eight-city
lecture tour of India (Chennai, Kolkota, Mumbai, Bangalore, Hyderabad, Delhi,
Lucknow, Nagpur), sponsored by Sun Pharmaceuticals. May 3-10, 2013.
482. Gleicher N. The importance of androgens in follicle maturation. Buenos Aires,
Argentina, May 28, 2013.
483. Gleicher N. Treating the “older” ovaries. Buenos Aires, Argentina, May 28, 2013.
484. Gleicher N. The most important, unknown gene in reproduction: the FMR1 gene.
Buenos Aires, Argentina, May 28, 2013.
485. Gleicher N. Role of androgens in the treatment of patients with low ovarian response.
International Conference: Meeting the Experts, Alicante, Spain, May 31, 2013.
486. Lee HJ, Weghofer A, Kushnir VA, Shohat-Tal A, Lazzaroni E, Barad DH, Gleicher N.
Is androgen production in association with immune system activation potential evidence
for the existence of a functional adrenal/ovarian autoimmune system in women? The
Annual Meeting of the ESHRE, London, UK, July 7-10, 2013.
487. Sen A, Prizant H, Light A, Biswas A, Lee HJ, Barad DH, Gleicher N, Hammes SR.
Androgen actions regulating follicular development. Annual Meeting of the Society for
the Study of Reproduction, Montreal, Quebec, Canada, July 22-26, 2013.
488. Gleicher N. Is low intensity (“mild” or “mini”) ovarian stimulation preferable? No. The
18th World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI),
Vienna, Austria, October 25-27, 2013.
489. Gleicher N. Why don’t we learn from experience? PGS is not a practical option! The
18th World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI),
Vienna, Austria, October 25-27, 2013.
490. Gleicher N. New concepts of ovarian function testing: taking advantage of hormone
interactions during early stages of follicle maturation. Ovarian Club III – The Inverse
Pyramid: Regulating Follicle Number and Oocyte Quality, Paris, France, November 14-
17, 2013.
Page 52
491. Gleicher N. The use of reproduction technologies in the setting of complex heart disease.
Third International Congress on Cardiac Problems in Pregnancy, Venice, Italy, February
20-24, 2014.
492. Gleicher N. Can we prevent congenital heart block in offspring from mothers at risk?
Third International Congress on Cardiac Problems in Pregnancy, Venice, Italy, February
20-24, 2014.
493. Gleicher N. Ovarian reserve in women with BRCA mutation. World Symposium on
Endometriosis, Atlanta, GA, March 27-29, 2014.
494. Gleicher N. An Update on CHR research: the Aging Ovary. Grand rounds, Tel-
Hashomer Hospital Department of Ob/Gyn and Sackler School of Medicine, Tel-Aviv
University, Israel, April 7, 2014.
495. Gleicher N. Intrauterine therapies. 2014 Annual Conference in Reproductive Medicine:
Implantation: Opening the Black Box. EXCEMED, Budapest, Hungary, May 23-24,
2014.
496. Gleicher N. Is DHEA an answer to low ovarian reserve? A 7-city lecture series
organized by Sun Pharmaceuticals, LTD, Mumbai, India, May 26 – June 4, 2014.
497. Barad DH, Khanna P, Kushnir VA, Gleicher N. Clinical in vitro fertilization (IVF)
outcomes based on comparative anti-Müllerian hormone (AMH) testing with a standard
and new highly sensitive assay. Poster presentation at ICE/ENDO 2014, Chicago,
Illinois, June 21-24. 2014.
498. Wu Y-G, Lee H-J, Barad DH, Kushnir VA, Lazzaroni-Tealdi E, Gleicher N. The impact
of advancing female age on gene expression of human granulosa cells. Poster
presentation at ICE/ENDO 2014, Chicago, Illinois, June 21-24. 2014.
499. Vega M, Barad DH, Kushnir VA, Lazzaroni-Tealdi E, Wu Y-G, Lee H-J, Gleicher N.
Low functional ovarian reserve (FOR) is in infertile women associated with presence of
antiphospholipid antibodies. Poster presentation at ICE/ENDO 2014, Chicago, Illinois,
June 21-24. 2014.
500. Wu Y-G, Lee H-J, Barad DH, Kushnir VA, Lazzaroni-Tealdi E, Gleicher N.
Proliferation and gene expression are affected by advancing female age in cultured
human granulosa cells. Poster presentation at ICE/ENDO 2014, Chicago, Illinois, June
21-24. 2014.
501. Kushnir VA, Sen A, Hammes SR, Barad DH, Lazzaroni-Tealdi E, Wu Y-G, Lee H-J,
Gleicher N. Proof of concept in a mouse model for beneficial effects of
dehydroepiandrosterone (DHEA) on small growing follicles. Poster presentation at
ICE/ENDO 2014, Chicago, Illinois, June 21-24. 2014.
502. Barad DH, Khanna P, Kushnir VA, Lazzaroni-Tealdi E, Wu Y-G, Lee H-J, Gleicher N.
Differences in AMH assessments between standard and new high sensitivity AMH
assays and impact on prediction of IVF outcomes. ASRM 2014, Honolulu, Hawaii,
October 18-22, 2014.
503. Wu Y-G, Lee H-J, Barad DH, Kushnir VA, Lazzaroni-Tealdi E, Gleicher N. Effects of
advancing female age on proliferation and gene expression in cultured human granulosa
cells from post-hCG retrieved follicles. ASRM 2014, Honolulu, Hawaii, October 18-22,
2014.
504. Wu Y-G, Lee HJ, Barad DH, Kushnir VA, Lazzaroni-Tealdi E, Sen A, Gleicher N. The
effects of dehydroepiandrosterone (DHEA) on cultured human granulosa cells from
Page 53
postovulatory human follicles after in vitro fertilization (IVF). ASRM 2014, Honolulu,
Hawaii, October 18-22, 2014.
505. Khanna P, Kushnir VA, Barad DH, Gleicher N. Live births rates following oocyte
donation reflect performance of IVF centers in autologous IVF cycles. ASRM 2014,
Honolulu, Hawaii, October 18-22, 2014.
506. Kushnir VA, Khanna P, Barad DH, Gleicher N. Assessment of practice in IVF clinics in
which success in autologous and donor oocyte cycles do not correlate. ASRM 2014,
Honolulu, Hawaii, October 18-22, 2014.
507. Kushnir VA, Wu Y-G, Chen I-C, Lee H-J, Barad DH, Lazzaroni-Tealdi E, Gleicher N.
Mitochondrial DNA abundance declines in human cumulus granulosa cells with age.
ASRM 2014, Honolulu, Hawaii, October 18-22, 2014.
508. Lee H-J, Wu Y-G, Lazzaroni-Tealdi E, Barad DH, Kushnir VA, Gleicher N. Aging is
associated with differential gene expression in human granulosa and cumulus cells
leading to rapid progression of meiotic and oocyte maturation competence. ASRM 2014,
Honolulu, Hawaii, October 18-22, 2014.
509. Vega M, Barad DH, Weghofer A, Kushnir VA, Gleicher N. Evidence that a degree of
mucosal inflammation is beneficial for pregnancy success in association with IVF.
ASRM 2014, Honolulu, Hawaii, October 18-22, 2014.
510. Gleicher N. Preimplantation genetic screening (PGS), still in search of a clinical
application. Middle East Fertility Society 21st Annual Meeting, Abu Dhabi, UAE,
September 25-27, 2014.
511. Gleicher N. The FMR1 gene, the most important unknown gene in human reproduction.
Middle East Fertility Society 21st Annual Meeting, Abu Dhabi, UAE, September 25-27,
2014.
512. Gleicher N. Finding the best egg with the old-fashioned molecular biology. Ovarian
Club Meeting IV, Paris, France, November 7-8, 2015.
513. Gleicher N. DHEA: Adjuvants are beneficial. COGI Vietnam, Ho Chi Min City,
Vietnam, November 20-22, 2014.
514. Gleicher N. Adjusting ovarian stimulation to patient age. COGI Vietnam, Ho Chi Min
City, Vietnam, November 20-22, 2014.
515. Gleicher N. How to improve ovarian responses to COS. The 21st World Congress on
Controversies in Obstetrics, Gynecology & Infertility (COGI), Guilin, China, May 7-10,
2015
516. Gleicher N. Can we pharmacologically affect embryo ploidy? The 21st World Congress
on Controversies in Obstetrics, Gynecology & Infertility (COGI), Guilin, China, May 7-
10, 2015
517. Gleicher N. Debate (Con): To maximize the outcome of IVF treatment every embryo
should undergo PGS. . The 21st World Congress on Controversies in Obstetrics,
Gynecology & Infertility (COGI), Guilin, China, May 7-10, 2015
518. Gleicher N. Pitfalls related to the technology. The 21st World Congress on
Controversies in Obstetrics, Gynecology & Infertility (COGI), Frankfurt, Germany, May
14-16, 2015.
519. Gleicher N. Debate (Con): Should PGS be offered to all IVF patients? The 21st World
Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI), Frankfurt,
Germany, May 14-16, 2015.
Page 54
520. Gleicher N. “Burning out” PCOS patients. The 21st World Congress on Controversies in
Obstetrics, Gynecology & Infertility (COGI), Frankfurt, Germany, May 14-16, 2015.
521. Gleicher N. G-CSF: Does it add real value to IVF success? The 21st World Congress on
Controversies in Obstetrics, Gynecology & Infertility (COGI), Frankfurt, Germany, May
14-16, 2015.
522. Barad D. H., Weghofer A, Latham G.J., Filipovic-Sadic S, Kushnir V.A., Gleicher N.
Significant skews in methylation fractions in previously described genotypes and sub-
genotypes of the FMR1 gene. ESHRE Annual Meeting, Lisbon, Portugal, June 14-17,
2015
523. Vega M, Barad, D.H., Seier K, Yu Y, Kushnir V.A., Lazzaroni-Tealdi E, Wu Y-G,
Wand Q, Weghofer A, Albertini D.F., Gleicher N. Immunologic and inflammatory
markers in prediction models of clinical pregnancy and live birth in association with in
vitro. ESHRE Annual Meeting, Lisbon, Portugal, June 14-17, 2015
524. Weghofer A, Kushnir V.A., Barad D. H., Gleicher N. The impact of thyroid stimulating
hormone (TSH) on anti-Mullerian hormone (AMH) levels in infertile women. Does TSH
affect follicular recruitment? ESHRE Annual Meeting, Lisbon, Portugal, June 14-17,
2015
525. Bisplinghoff E., Barad D. H., Weghofer A, Kushnir V.A., Gleicher N. Comparison of
FMR1 mutations distribution between Indian and other Asian patients. ESHRE Annual
Meeting, Lisbon, Portugal, June 14-17, 2015
526. Gleicher N, Vidali A, Braverman J, Kushnir V.A, Barad D.H, Albertini D. F. Further
Evidence Against Use of PGS in Poor Prognosis Patients: Reports of Normal Births
After Transfer of Embryos Reported As Aneuploid. ASRM Annual Meeting, Baltimore,
USA, Oct. 17-21, 2015.
527. Gleicher N. Debate: Does DHEA Supplementation for Poor Prognosis Patients Have
Real Benefit? Yes! COGI Congress, Budapest, Hungary, Sept. 17-19, 2015.
528. Gleicher N. Debate: To maximize the outcome of IVF treatment, should every embryo
undergo PGS? No! COGI Congress, Budapest, Hungary, Sept. 17-19, 2015.
529. Gleicher N. Secondary ovarian insufficiency: How the adrenal can control ovarian
function. Ovarian Club, Barcelona, Spain, November 2015.
530. Gleicher N. Why embryo selection is too late. Ovarian Club, Barcelona, Spain,
November 2015.
531. Gleicher N. Why embryo selection, as currently practiced, does not work. University
School of Vienna. Vienna, Austria, January 2016.
532. Gleicher N. Is PGD/PGS or time lapse benefiting IVF outcome in aging women?
Conference of Reproductive Endocrinology and ART. Guangzhou, China, March 2016.
533. Gleicher N. Is PGD/PGS or time lapse benefiting IVF outcome in aging women?
Shaoguan Maternal and Child Hospital IVF Center. Guangzhou, China, March 2016.
534. Gleicher N. Debate: Androgen supplementation in women with LFOR?: YES. The 23rd
Congress on Controversies in Obstetrics, Gynecology & Infertility. Melbourne, Australia,
March 21-23, 2016
535. Gleicher N. Debate: Are the days of transferring embryos into a compromised uterus
coming to an end?: NO The 23rd Congress on Controversies in Obstetrics, Gynecology
& Infertility. Melbourne, Australia, March 21-23, 2016
Page 55
536. Gleicher N. Debate: PGS is now proven, every embryo should undergo PGS: NO. The
23rd Congress on Controversies in Obstetrics, Gynecology & Infertility. Melbourne,
Australia, March 21-23, 2016
537. Gleicher N. How new infertility treatments negatively affected infertility treatments over
the last 10 years. The 23rd Congress on Controversies in Obstetrics, Gynecology &
Infertility. Melbourne, Australia, March 21-23, 2016
538. Gleicher N. Is there an ideal stimulation for poor ovarian reserve? The 23rd Congress on
Controversies in Obstetrics, Gynecology & Infertility. Melbourne, Australia, March 21-
23, 2016
539. Gleicher N. Is there really clinical value in embryo selection? The 23rd Congress on
Controversies in Obstetrics, Gynecology & Infertility. Melbourne, Australia, March 21-
23, 2016
540. Gleicher N. Modeling IVF results in advanced female age using AMH. The 23rd
Congress on Controversies in Obstetrics, Gynecology & Infertility. Melbourne, Australia,
March 21-23, 2016
541. Gleicher N. Why RCTs are rare in infertility and what to do about it. The 23rd Congress
on Controversies in Obstetrics, Gynecology & Infertility. Melbourne, Australia, March
21-23, 2016
542. Gleicher N. Adjuncts for Poor Responders. Ferring Advisory Board Meeting. Austin, TX,
April 21-22, 2016.
543. Gleicher N. Best Treatment Protocols for Poor Ovarian Reserve. China Academy IVF
Forum. Chengdu, China, May 13-15, 2016.
544. Gleicher N. Is there really clinical value in embryo selection? China Academy IVF
Forum. Chengdu, China, May 13-15, 2016.
545. Gleicher N. Debate: PGS is now proven, every embryo should undergo PGS: NO. China
Academy IVF Forum. Chengdu, China, May 13-15, 2016.
546. Gleicher N. Treatment of thin endometrium. China Academy IVF Forum. Chengdu,
China, May 13-15, 2016.
547. Gleicher N. Can We Affect Oocyte Aging? Ovarian Club VII. Hong Kong, China, May
21-22, 2016.
548. Gleicher N. PGS by Single Trophectoderm Biopsy Cannot Distinguish Aneuploidy from
Normal Embryos Ovarian Club VII. Hong Kong, China, May 21-22, 2016.
549. Kushnir VA, et al. Proof of concept in a mouse model for beneficial effects of
dehydroepiandrosterone (DHEA) on small growing follicles. Endocrine Society Meeting
(ENDO 2016), Boston, MA, April 1- 4, 2016.
550. Bisplinghoff E, et al. Comparison of FMR1 mutations distribution between Indian and
other Asian patients. ESHRE Meeting, Helsinki, Finland, July 3-6, 2016.
551. Wang Q, et al. Reduced mRNA levels and isoforms of the FMR1 gene in infertile
women with low CGGnn<26 repeats. ESHRE Meeting, Helsinki, Finland, July 3-6, 2016.
552. Kushnir VA, et al. World trends in assisted reproductive technology (ART) 2004-2013.
ESHRE Meeting, Helsinki, Finland, July 3-6, 2016.
553. Barad DH, et al. Association of skewed X-Chromosome inactivation with FMR1 CGG
repeat length and AMH levels as indictor of functional ovarian reserve in infertile
women. ESHRE Meeting, Helsinki, Finland, July 3-6, 2016.
Page 56
554. Gleicher N. Elective single embryo transfer: Is it the ultimate goal? Paradigmatically no.
Stand-Alone Scientific Symposium for Fertility. Barcelona, Spain, September 16-17,
2016.
555. Gleicher N. The 2015 COGEN statement on PGS was not premature as PGS is
advantageous to patients and is not potentially harmful. 2nd World Congress on
Controversies in Preconception, Prenatal Genetic Diagnosis. Barcelona, Spain,
September 22-24, 2016.
556. Wu YG et al. What is the best lead follicle size for ovulation induction in older women
≥43 years to avoid premature luteinization of follicles? 72nd Annual Meeting of the
American Society for Reproductive Medicine, Salt Lake City, UT, October 15-19, 2016.
557. Kushnir VA et al. Effects of newly introduced practices over 10 years (2004-2013) on
worldwide trends in assisted reproductive technology. 72nd Annual Meeting of the
American Society for Reproductive Medicine, Salt Lake City, UT, October 15-19, 2016.
558. Kushnir VA et al. Utilization and effects of embryo banking on art outcome reporting in
the U.S. 72nd Annual Meeting of the American Society for Reproductive Medicine, Salt
Lake City, UT, October 15-19, 2016.
559. Barad DH et al. Prevalence and effect of preimplantation genetic screening (PGS) on
oocyte donation cycles in the United States: 2005 to 2013. 72nd Annual Meeting of the
American Society for Reproductive Medicine, Salt Lake City, UT, October 15-19, 2016.
560. Kushnir VA et al. Contribution of third party reproduction to the birth cohort following
art in the U.S.A. 72nd Annual Meeting of the American Society for Reproductive
Medicine, Salt Lake City, UT, October 15-19, 2016.
561. Barad DH et al. Contribution of cryopreservation cycles to cumulative live birth
outcomes following oocyte donation with preimplantation genetic screening (PGS) in
the United States: 2005 to 2013. 72nd Annual Meeting of the American Society for
Reproductive Medicine, Salt Lake City, UT, October 15-19, 2016.
562. Shapiro AJ et al. Racial and ethnic disparities in the use of third-party art in the U.S. 72nd
Annual Meeting of the American Society for Reproductive Medicine, Salt Lake City,
UT, October 15-19, 2016.
563. Shapiro AJ et al. Effect of race and ethnicity on live birth rates in third-party art cycles
in the U.S. 72nd Annual Meeting of the American Society for Reproductive Medicine,
Salt Lake City, UT, October 15-19, 2016.
564. Kushnir VA et al. Effect of race and ethnicity on fertility rates and utilization of art in
the USA. 72nd Annual Meeting of the American Society for Reproductive Medicine, Salt
Lake City, UT, October 15-19, 2016.
565. Barad DH et al. Effect of time trends of preimplantation genetic screening (PGS)
utilization on oocyte donation cycle live birth rates in the United States: 2005 to 2013.
72nd Annual Meeting of the American Society for Reproductive Medicine, Salt Lake
City, UT, October 15-19, 2016.
566. Gleicher N et al. Preimplantation genetic screening (PGS) appears unable to correctly
determine ploidy of embryos from a single trophectoderm biopsy (TEB). 72nd Annual
Meeting of the American Society for Reproductive Medicine, Salt Lake City, UT,
October 15-19, 2016.
567. Barad DH et al. Effect of PGS on IVF outcomes following eSET in oocyte donation in
the United States: 2005 to 2013. 72nd Annual Meeting of the American Society for
Reproductive Medicine, Salt Lake City, UT, October 15-19, 2016.
Page 57
568. Gleicher N. What can these studies teach us about PGS? 24th World Congress on
Controversies in Obstetrics, Gynecology & Infertility (COGI). Amsterdam, the
Netherlands. November 10-13, 2016.
569. Overcoming the technical gaps will lead to PGS to all embryos. It’s only a matter of time.
NO. PGS causes more damage than benefit. 24th World Congress on Controversies in
Obstetrics, Gynecology & Infertility (COGI). Amsterdam, the Netherlands. November
10-13, 2016.
570. Gleicher N. Why timing of ovulation induction matters in women with low functional
ovarian reserve. Ovarian Club VIII, Paris, France, November 4-6, 2016.
571. Gleicher N. Live birth rate per oocyte in natural cycles vs. hyper-stimulated cycles.
Stimulated cycles. Ovarian Club VIII, Paris, France, November 4-6, 2016.
572. Gleicher N. Accuracy of assessing embryo ploidy of human embryos with PGS in
association with IVF. Translational Reproductive Biology and Clinical Reproductive
Endocrinology. New York, NY, November 17-20, 2016.
573. Gleicher N. Androgen supplementation, a model for therapeutic interventions into early
stages of follicle maturation in humans. Translational Reproductive Biology and Clinical
Reproductive Endocrinology. New York, NY, November 17-20, 2016.
574. Gleicher N. Are twins an adverse IVF outcome? No, the single embryo transfer myth.
Translational Reproductive Biology and Clinical Reproductive Endocrinology. New
York, NY, November 17-20, 2016.
575. Gleicher N. As practiced today, embryo selection, marginally benefits few – while
potentially harming many. Translational Reproductive Biology and Clinical
Reproductive Endocrinology. New York, NY, November 17-20, 2016.
576. Gleicher N. Is the immune system (i.e., autoimmunity and inflammation) really
irrelevant to IVF success – as suggested by some? Translational Reproductive Biology
and Clinical Reproductive Endocrinology. New York, NY, November 17-20, 2016.
577. Gleicher N. Immunological pregnancy loss. Translational Reproductive Biology and
Clinical Reproductive Endocrinology. New York, NY, November 17-20, 2016.
578. Gleicher N. Intrauterine therapies. Genesis Symposium, Udaipur, India, February 23-24,
2017.
579. Gleicher N. IVF, yesterday, today and tomorrow – through my eyes. Genesis
Symposium, Udaipur, India, February 23-24, 2017.
580. Gleicher N. What in IVF represents good, intermediate and poor prognosis at different
patient ages? Ferticon, New Delhi, India, February 25-26, 2017.
581. Gleicher N. A new PCOS phenotype: Hypo-androgenic PCOS. Ferticon, New Delhi,
India, February 25-26, 2017.
582. Gleicher N. Why PGS is futile and should be abandoned. Ferticon, New Delhi, India,
February 25-26, 2017.
583. Hayes E, et al. Regulation of anti-Müllerian hormone (AMH) expression during-
follicular development. Annual 2017 Meeting of the Endocrine Society (ENDO 2017),
Orlando, FL, April 1-4, 2017.
584. Gleicher N. Impact of environment and lifestyle factors on IVF. EXCEMED Annual
Conference in Reproductive Medicine, Milan, Italy, April 21-22, 2017.
585. Gleicher N. Thin endometrium as a cause of RIF. EXCEMED Annual Conference in
Reproductive Medicine, Milan, Italy, April 21-22, 2017.
586. Gleicher N. What to do with reported PGS results? Tel-Aviv, Israel, April 26, 2017.
Page 58
587. Gleicher N. Accuracy of assessing embryo ploidy of human embryos with PGS in
association with IVF. AAB College of Reproductive Biology Symposium, Houston, TX,
May 15-18, 2017.
588. Albertini DF, et al. Ontogeny of newly described hypo-androgenic PCOS phenotype in
infertile women from younger through older ages. ESHRE Meeting, Geneva,
Switzerland, July 2-5, 2017. ESHRE Meeting, Geneva, Switzerland, July 2-5, 2017.
589. Barad DH, et al. Prevalence and impact of elective gender selection in oocyte donor
recipient cycles in the United States 2005-2013. ESHRE Meeting, Geneva, Switzerland,
July 2-5, 2017. ESHRE Meeting, Geneva, Switzerland, July 2-5, 2017.
590. Gleicher N. Day 3 vs. Day 5 Embryo Transfer? Position: Day 3. 54th Mexican Congress
of Reproductive Medicine. Cancun, Mexico, July 16-20, 2017.
591. Gleicher N. Targeting the unfavorable infertility patients. 54th Mexican Congress of
Reproductive Medicine. Cancun, Mexico, July 16-20, 2017.
592. Gleicher N. Using or not using PGS. 54th Mexican Congress of Reproductive Medicine.
Cancun, Mexico, July 16-20, 2017.
593. Gleicher N. Cardiac risks in (older) women undergoing IVF. Heart of the Matter, Atlanta,
GA, August 18-19, 2017.
594. Gleicher N. PGS or PGS or Preimplantation Genetic Testing for Aneuploidy, as it is now
suddenly renamed: The most controversial add-on in the history of IVF. CHR Grand
Rounds, New York, NY, September 5, 2017.
595. Gleicher N. Nothing more controversial than PGS. Ovarian Club IX. Barcelona, Spain,
September 15-16, 2017.
596. Gleicher N. Androgens in the Aging Process. From Basic Science to Clinical Practice -
A Translational Approach to Reproductive Medicine. Milan, Italy, September 29-30,
2017.
597. Gleicher N. New Insights into Disorders of Reproduction: Fragile X (FMR1) and a New
Hypoandrogenic PCOS Phenotype. From Basic Science to Clinical Practice - A
Translational Approach to Reproductive Medicine. Milan, Italy, September 29-30, 2017.
598. Gleicher N. Time lapse imaging. From Basic Science to Clinical Practice - A
Translational Approach to Reproductive Medicine. Milan, Italy, September 29-30, 2017.
599. Gleicher N. Pros and cons of embryo screening. From Basic Science to Clinical Practice
- A Translational Approach to Reproductive Medicine. Milan, Italy, September 29-30,
2017.
600. Gleicher N. The abnormal embryos that aren’t. Breast, Ovary and Endometriosis. New
York, NY, October 28, 2017.
601. Gleicher N. Debate: PGS: No embryo should be tested. Controversies in Obstetrics
Gynecology and Infertility 2017. Vienna, Austria, November 30 – December 2, 2017.
602. Gleicher N. The new hypo-androgenic PCOS phenotype. Vienna University School of
Medicine Grand Rounds. Vienna, Austria, November 30, 2017.
603. Gleicher N. Evidence based treatment for POF/POI. Ovarian Club X and CoGEN in
Asia (OCC 2017). Hong Kong, December 16-17, 2017.
604. Gleicher N. Debate: PGS Needs More Proof. Ovarian Club X and CoGEN in Asia (OCC
2017). Hong Kong, December 16-17, 2017.
605. Gleicher N. Assisted fertilization in older women: Primer on techniques and discussion
of cardiac risks. 5th International Congress on Cardiac Problems in Pregnancy. Bologna,
Italy, February 22-25, 2018.
Page 59
606. Gleicher N. Nothing more controversial than PGS/PGT-A. Life Conference: Reducing
Time to Live Birth. Taipei, Taiwan, March 4, 2018.
607. Gleicher N. Strategies of implement IVF in women of advanced age. Life Conference:
Reducing Time to Live Birth. Taipei, Taiwan, March 4, 2018.
608. Gleicher N. Is the hypothesis of PGS/PGT-A supportable? Dansk Fertilitetsselskabs
Arsmode. Middelfart, Denmark, March 10-11, 2018.
609. Gleicher N. How to Treat Women of Very Advanced Age with Use of Their Own Eggs.
KARM-Conference, Moscow, Russia, April 19-22, 2018.
610. Gleicher N. PGS/PGT-A: What Is the Real Value? KARM-Conference, Moscow, Russia,
April 19-22, 2018.
611. Gleicher N. Optimizing Results in Poor-Responder Patients. International Summit on
Assisted Reproduction and Genetics, Tel Aviv, Israel, May 27-29, 2018.
612. Gleicher N et al. Further characterization of a newly described hypo-androgenic PCOS-
like phenotype based on adrenal and ovarian hormone profiles. ESHRE 2018, Barcelona,
Spain, July 1-4, 2018.
613. Gleicher N et al. ACTH-stimulation in women with low functional ovarian reserve
(LFOR) confirms adrenal origin of hypo-androgenism. ESHRE 2018, Barcelona, Spain,
July 1-4, 2018.
614. Gleicher N et al. National U.S. utilization patterns and live birth rates of various ovarian
stimulation protocols for IVF. ESHRE 2018, Barcelona, Spain, July 1-4, 2018.
615. Gleicher N. The importance of androgens for normal follicle maturation. XXII Brazilian
Congress of Assisted Reproduction, Brasilia, Brazil, August 2-4, 2018.
616. Gleicher N. Why are IVF live birth rates all over the world declining? XXII Brazilian
Congress of Assisted Reproduction, Brasilia, Brazil, August 2-4, 2018.
617. Gleicher N. PGS in the optimization of TRA results: What is the real benefit of
PGS/PGT-A? XXII Brazilian Congress of Assisted Reproduction, Brasilia, Brazil,
August 2-4, 2018.
618. Gleicher N. Achieving pregnancies with autologous oocytes beyond age 43. XXII
Brazilian Congress of Assisted Reproduction, Brasilia, Brazil, August 2-4, 2018.
619. Gleicher N. Optimal care of the older women. International Haihe Health Conference,
Tianjin, China, September 8-9, 2018.
620. Gleicher N. Ovarian stimulation for older women. International Haihe Health
Conference, Tianjin, China, September 8-9, 2018.
621. Gleicher N, et al. Effects of dehydroepiandrosterone (DHEA) supplementation on sexual
function in older pre-menopausal infertile women. ASRM, Denver, Colorado, October
6-8, 2018.
622. Gleicher N, et al. A new optical system allows gauging of human oocyte maturation
status without cumulus cell removal. ASRM, Denver, Colorado, October 6-8, 2018.
623. Gleicher N. Managing young women approaching menopause, with high FSH and low
AMH. Ovarian Club, Paris, France, November 1-3, 2018.
624. Gleicher N. Advanced maternal age: Until what age autologous and until when
homologous eggs? 26th COGI, London, UK, November 23-25, 2018.
625. Gleicher N. Social freezing: oocyte survival, pregnancy rates and obstetrical outcomes.
Not as good as suggested! 26th COGI, London, UK, November 23-25, 2018.
626. Gleicher N. Reevaluation of genetic testing in light of recent advances. Evidence is
completely lacking. 26th COGI, London, UK, November 23-25, 2018.
Page 60
627. Gleicher N. The future of IVF – Can we be better? Ovarian Club XII, Hong Kong, China,
December 15-16, 2018.
628. Gleicher N, et al. Highly individualized egg retrieval (HIER). 2019 Fertility Innovation
in Reproductive Endocrinology (FIRE) Forum, Melbourne, Australia, February 16, 2019.
629. Gleicher N, et al. Adjuvants to implantation: Hype or hope? 2019 Fertility Innovation in
Reproductive Endocrinology (FIRE) Forum, Melbourne, Australia, February 16, 2019.
630. Gleicher N, et al. Who benefits from PGS/PGT-A? 2019 Fertility Innovation in
Reproductive Endocrinology (FIRE) Forum, Melbourne, Australia, February 16, 2019.
631. Gleicher N, et al. Oocyte size and morphology are related to female age, ovarian reserve
and body weight in non-polycystic ovary syndrome patients. ESHRE 2019, Vienna,
Austria, June 23-26, 2019.
632. Gleicher N, et al. Oocyte size and morphology are predictive of embryo quality. ESHRE
2019, Vienna, Austria, June 23-26, 2019.
633. Gleicher N, et al. The ovarian sensitivity index (OSI) is in infertile patients predictive of
live birth chances after IVF. ESHRE 2019, Vienna, Austria, June 23-26, 2019.
634. Gleicher N, et al. Pilot study of novel noninvasive imaging approach for determination
of meiotic status in intact human cumulus-oocyte-complexes. ESHRE 2019, Vienna,
Austria, June 23-26, 2019.
635. Gleicher N, et al. Premature ovarian aging. Polish Society of Reproductive Medicine and
Embryology Meeting, Warsaw, Poland, September 20-23, 2019.
636. Gleicher N, et al. What is too old for IVF? Polish Society of Reproductive Medicine and
Embryology Meeting, Warsaw, Poland, September 20-23, 2019.
637. Gleicher N, et al. The future of IVF: Can we do better? ART World Congress, New
York, NY, October 10-11, 2019.
638. Gleicher N, et al. Changes in U.S. utilization of donor egg IVF cycles at different female
ages between 2005-2016. Annual Meeting of the American Society for Reproductive
Medicine, Philadelphia, PA, October 12-16, 2019.
639. Rito T, et al. Self-correction of aneuploidy in human blastocysts and self-organizing
gastruloids. Annual Meeting of the American Society for Reproductive Medicine,
Philadelphia, PA, October 12-16, 2019.
640. Barad DH, et al. Transferring selected embryos, after PGT-A diagnosed as “abnormal”
where patients were refused such transfers at their original IVF centers. Annual Meeting
of the American Society for Reproductive Medicine, Philadelphia, PA, October 12-16,
2019.
641. Gleicher N. Is implantation primarily an immunologic rather than endocrine process?
Translational Reproductive Biology and Clinical Reproductive Endocrinology, New
York, NY, November 21-24, 2019.
642. Gleicher N. Why the year 2010 will live in the history of IVF in infamy for some time to
come. Translational Reproductive Biology and Clinical Reproductive Endocrinology,
New York, NY, November 21-24, 2019.
643. Gleicher N. Changing utilization of third-party egg donation in US IVF practice.
Translational Reproductive Biology and Clinical Reproductive Endocrinology, New
York, NY, November 21-24, 2019.
644. Gleicher N. A totally surprising rebound effect in complete non-responders in search of
an explanation. Translational Reproductive Biology and Clinical Reproductive
Endocrinology, New York, NY, November 21-24, 2019.
Page 61
645. Gleicher N. Current and Future Trends in Infertility Treatment. Crozer Chester Medical
Center, Upland, PA. March 3, 2020.
646. Gleicher N. How do we explain dramatic declines in live birth after IVF? SARG Summit
2020, Virtual Conference. May 23, 2020. 647. Gleicher N. A fertility center in NYC going through COVID-19, economic depression
and riots. IVF Worldwide Congress Webinar Series. June 18, 2020. 648. Gleicher N. How Identification of COVID-19 Phenotypes has Changes out
Understanding of Anti-COVID Immunity. IVF Worldwide Congress, Webinar Series.
August 25, 2020. 649. Gleicher N. A 45-year-old married woman who does not consider egg donation an
option: the CHR approach! 2nd Online Congress on IVF-Worldwide. September 12, 2020. 650. Gleicher N, Yang M. Newly arising questions about PGT-A: Results of previously
refused transfer of “abnormal” embryos and human self-correcting data in gastruloids
and early-stage embryos. Ovarian Club 2020 Meeting, Virtual Conference. November 7,
2020.
651. Gleicher N. IVF Add-ons: Scientific, Ethical, Regulatory, and Legal Considerations.
Petrie-Flom Center, Harvard Law School. November 10, 2020.
652. Gleicher N. Not even non-invasive cell-free DNA can rescue PGT. Middle Eastern
Fertility Society, Virtual Meeting. December 4, 2020.
653. Gleicher N. The underlying embryo biology for PGT-A. Ovarian Club XVI Virtual
Congress, Hong Kong. December 12, 2020.
654. Gleicher N. Older women getting pregnant means more heart disease. The 6th
International Congress on Cardiac Problems in Pregnancy. February 4, 2021.
655. Gleicher N. Why peripartum cardiomyopathy is likely an autoimmune disease. The 6th
International Congress on Cardiac Problems in Pregnancy. February 4, 2021.
656. Gleicher N. The negative impact of “add-ons” on IVF practice. Summit Meeting in
Assisted Reproduction: The Future is Now, Brazil. September 21-22.
657. Gleicher N. The platelet rich plasma ovarian replacement: experimental data. R.evolving,
7th Edition of the International Meeting “The Pelvis as a Mother,” Regional Event of
Mediterranean Society of Reproductive Medicine, Bari, Italy. September 27-29, 2021.
658. Gleicher N. 20 years of IVF stagnation, a main reason being automatic rejection of
women above age 42-43 for autologous IVF. 4th IVF Worldwide Online Congress,
Virtual Conference. October 1-3, 2021.
659. Gleicher N. Embryo banking/freezing another unsupported fashion of the moment. 4th
IVF Worldwide Online Congress, Virtual Conference. October 1-3, 2021.
660. Gleicher, N. Debate: Stimulation: We should not use more than 150 units in most
patients. The 29th World Congress on Controversies in Obstetrics, Gynecology &
Infertility (COGI), Berlin, Germany, December 2 – 4, 2021.
661. Gleicher, N. Why the PGT-A hypothesis for biological reasons, simply, cannot work.
The 29th World Congress on Controversies in Obstetrics, Gynecology & Infertility
(COGI), Berlin, Germany, December 2 – 4, 2021.
662. Gleicher, N. The hypo-androgenic PCOS-like phenotype at advanced ages, one of the
most frequent causes of repeat IVF failure. The 29th World Congress on Controversies
in Obstetrics, Gynecology & Infertility (COGI), Berlin, Germany, December 2 – 4, 2021.
Page 62
663. Gleicher N. Panel: Add-ons: Laboratories and clinical procedures. The 29th World
Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI), Berlin,
Germany, December 2 – 4, 2021.
664. Gleicher, N. Is peripartum cardiomyopathy an autoimmune disease? The 29th World
Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI), Berlin,
Germany, December 2 – 4, 2021.
665. Gleicher N. How to manage couples with advanced reproductive age and/or very low
AMH level in ART treatment. Taiwanese Society for Reproductive Medicine CME
Symposium. Virtual Conference. January 16, 2022.
666. Gleicher N. The negative impact of “add-ons” to IVF on IVF outcomes. Upper Egypt
Assisted Reproduction Conference 2022. Cairo, Egypt. February 23-25, 2022.
667. Gleicher N. A rationale to reclassify PCOS into only two phenotypes. Upper Egypt
Assisted Reproduction Conference 2022. Cairo, Egypt. February 23-25, 2022.
668. Gleicher N. The utility of PGT-A in current IVF practice. Upper Egypt Assisted
Reproduction Conference 2022. Cairo, Egypt. February 23-25, 2022.
669. Gleicher N. Why two PCOS phenotypes make much more sense than four. 4th IVF
Worldwide Online Congress. Virtual Conference. April 8-9, 2022.
670. Gleicher N. How new research in embryo biology mandates a reevaluation of
chromosomal testing in IVF and early pregnancy. 4th IVF Worldwide Online Congress.
Virtual Conference. April 8-9, 2022.
671. Gleicher N. Debate: PGT-A improves live birth rate in IVF populations with female age
over 38 and should be used routinely for embryo selection (Against). Joint RCOG/BFS
Meeting: Management of Subfertility and Assisted Conception. April 19-22, 2022.
Publications
1. Gleicher N: The long-term prognosis of pregnant women with acquired valvular heart
disease, based on 25-30 years follow-up. M.D. thesis. December 1974, Tel-Aviv
University, School of Medicine.
2. Faiferman I, Gleicher N, Cohen C, et al.: Leukocyte migration in ovarian carcinoma:
Comparison of inhibitory activity of tumor extracts. J Natl Cancer Inst 1977; 59:1593-
1597.
3. Gleicher N, Gergely Z, Deppe G: Infected ovarian hematoma as presenting symptom of
systemic lupus erythematosus (SLE). J Reprod Med l978; 21:223-227.
4. Gleicher N, Theofilopoulos A, Beers P: Immune complexes in pregnancy. Lancet 1978;
2:1108.
5. Gleicher N, Cohen C, Kerenyi T, Gusberg S: Familial malignant melanoma of the female
genitalia: A case report and review. Obstet Gynecol Surv 1979; 34:1-15.
6. Gleicher N, Cohen C, Kerenyi T, Gusberg S: A blocking factor in amniotic fluid causing
leukocyte migration enhancement. Am J Obstet Gynecol 1979; 133:386-390.
7. Gleicher N, Theofilopoulos A: Immune complexes in pregnancy. Lancet 1979; 1:216.
8. Sandler R, Knutzen V, Milano C, Gleicher N: Uterine rupture with the use of vaginal
prostaglandin E-2 suppositories. Am J Obstet Gynecol 1979; 134:348-349.
9. Gleicher N, Deppe G, Cohen C: Common aspects of immunologic tolerance in pregnancy
and malignancy. Obstet Gynecol 1979; 54:335-342.
10. Gleicher N, Midwall J, Hochberger D, Jaffin H. Eisenmenger’s syndrome and pregnancy.
Obstet Gynecol Surv 1979; 34:721-741.
Page 63
11. Gleicher N, Knutzen V, Elkayam U, et al. Rheumatic heart disease diagnosed during
pregnancy: A 30-year follow-up. Int J Gynaecol Obstet 1979; 17:51-57.
12. Gleicher N, Deppe G. Circulating anticoagulants. Am J Obstet Gynecol 1979; 133:941.
13. Gleicher N, Beers P, Kerenyi T, et al.: The Beckman Immunochemistry System. A rapid
method for the determination of immunoglobulins (IgG) and complement (C3) in
amniotic fluid and plasma. Am J Diagnost Gynecol Obstet l979; 1:165-170.
14. Roboz J, Gleicher N, Wu K, et al. Does doxorubicin cross the placenta? Lancet l979.
15. Gleicher N, Beers P, Kerenyi T, Cohen C, Gusberg S: Leukocyte migration enhancement
as an indicator of immunologic enhancement. I. Pregnancy. Am J Obstet Gynecol 1980;
136:1-4
16. Gleicher N, Beers P, Kerenyi T, Cohen C, Gusberg S: Leukocyte migration enhancement
as an indicator of immunologic enhancement. II. Malignancy. Am J Obstet Gynecol
1980; 136:126-131.
17. Gleicher N, Beers P, Kerenyi T, Cohen C, Gusberg S: Leukocyte migration enhancement
as an indicator of immunologic enhancement. III. Common denominators of pregnancy
and malignancy. Am J Obstet Gynecol 1980; 136:5-10.
18. Gleicher N: Immunologic influence of amniotic fluid. Lancet 1980; 1:541.
19. Gleicher N, Jaffin H: Eisenmenger’s syndrome and pregnancy. N Engl J Med 1980;
302:751-752.
20. Milano C, Gleicher N: The termination of septic abortion with vaginal E2 prostaglandin
suppositories. Prostaglandins 1980; 19:455-456.
21. Gleicher N, Theofilopoulos A: Immune complexes (ICs) and pregnancy: Pregnancy as an
IC-state or IC-disease and the influence of IC-diseases upon pregnancy. Diagnost
Gynecol Obstet 1980; 2:7-31.
22. Gleicher N, Milano C, Rubenstein A, et al.: Phakomatoses in reproductive medicine.
Mount Sinai J Med 1980; 47:311-316.
23. Gleicher N, Runowicz C, Brown B: Sinusoidal fetal heart rate in association with
intrapartum amnionitis. Obstet Gynecol 1980; 56:109-112.
24. Bradley B, Gleicher N: Grand multiparity in association with unilateral renal, ovarian and
Mullerian agenesis. Mount Sinai J Med 1980; 47:418-421.
25. Gleicher N, Chin J, Brown B, et al.: Intrauterine meconium aspiration syndrome.
Diagnost Gynecol Obstet 1980; 2:151-155.
26. Kerenyi T, Gleicher N, Meller J, et al.: Transplacental cardioversion of intrauterine
supraventricular tachycardia with digitalis. Lancet 1980; 2:393-395.
27. Milano C, Gleicher N: A gynecologic presentation of mixed phakomatosis. Diagnost
Gynecol Obstet 1980; 2:117-126.
28. Gleicher N, Siegel I: The immunologic concept of EPH-gestosis. Mount Sinai J Med
1980; 47:442-453.
29. Gleicher N, Siegel I, Francus K: Common denominators of pregnancy and malignancy.
Mount Sinai J Med 1980; 47:511-520.
30. Siegel I, Gleicher N: The development of the fetal immune system. Mount Sinai J Med
1980; 47:474-480.
31. Chitkara U, Gleicher N, Kerenyi T, Gergely R, Longi R: Persistent supraventricular
tachycardia in utero. Diagnost Gynecol Obstet 1980; 2:291-298.
32. Brown B, Gleicher N: Intrauterine meconium aspiration. Obstet Gynecol 1981; 57:26-29.
Page 64
33. Siegel I, Gleicher N: Fetal and maternal red cell immune adherence (RCIA) receptors.
Am J Reprod Immunol 1981; 1:88-91.
34. Theofilopoulos A, Gleicher N, Pereira A, Dixon F: The biology of immune complexes
and their possible role in pregnancy. Am J Reprod Immunol 1981; 1:92-105.
35. Tuttleman R, Gleicher N: Central nervous system hemorrhage complicating pregnancy.
Obstet Gynecol 1981; 58:651-657.
36. Runowicz C, Phillips R, Gleicher N, Beers P: Fluorescence polarization: Comments on
urine contamination. Am J Obstet Gynecol 1981; 139:613-614.
37. Gleicher N, Meller J, Sandler R, Sullum S: Wolff-Parkinson-White syndrome in
pregnancy. Obstet Gynecol 1981; 58:748-752.
38. Siegel I, Gleicher N: Peripheral white cell alterations in pregnancy. Diagnost Gynecol
Obstet 1981; 3:123-126.
39. Siegel I, Gleicher N: Toxic shock syndrome and human platelets. Lancet 1981; i:493.
40. Siegel I, Gleicher N: Red cell immune adherence (RCIA): Its application in cancer and
autoimmune disease. Immunol Commun 1981; 10:443-449.
41. Siegel I, Gleicher N: Phagocytosis: A means for autologous macrophage-lymphocyte
interactions. JAMA 1981; 246:1127.
42. Siegel I, Liu TL, Gleicher N: The red cell immune system. Lancet 1981; 2:556-559.
43. Epstein H, Waxman A, Gleicher N, Lauersen N: Meperidine induced sinusoidal fetal
heart rate and reversal with neloxone. Obstet Gynecol 1982; 59:22s-25s.
44. Gleicher N, Adelsberg B, Liu TL, Cederquist L, Phillips R, Siegel I: Immune complexes
in pregnancy. III. Immune complexes in immune complex associated conditions. Am J
Obstet Gynecol 1982; 142:1011-1015.
45. Gleicher N, Bazile F, Elrad H: Congestive heart failure after ritodrine therapy in
conjunction with EPH gestosis. N Eng J Med 1982; 306:174.
46. Gleicher N, Olaya B, Hercule J, Elrad H, Trace P, Giglia RV: The diagnosis of multiple
gestation. Diagnost Gynecol Obstet 1982; 4:223-226.
47. Siegel I, Liu TL, Gleicher N: Developmental changes of the red cell immune system in
the rabbit. J Clin Laboratory Immunol 1982; 10:41-46.
48. Phillips R, Thornton J, Gleicher N: Physician bias in cesarean sections. JAMA 1982;
248:1082-1084.
49. Gleicher N, Siegel I, Toder V: Decreased levels of helper T cells in pregnancy. N Engl J
Med 1982; 307.
50. Gleicher N, Giglia R, Deppe G, Elrad H: The diagnosis of unruptured ectopic pregnancy
by realtime ultrasonography. Obstet Gynecol 1982; 61:425-428.
51. Epstein H, Waxman A, Gleicher N, Lauersen N: Meperidine induced sinusoidal fetal
heart rate and reversal with neloxone. Obstet Gynecol 1982; 59:22s-25s.
52. Toder V, Blank M, Gleicher N, Nebel L: Immunoregulatory mechanisms in pregnancy. II.
Further characterization of suppressor lymphocytes induced by alpha-fetoprotein in
lymphoid cell cultures. J Clin Lab Immunol 1983; 11:149-154.
53. Toder V, Blank M, Gleicher N, et al.: Natural killer activity in normal pregnancy and
EPH-gestosis. Am J Obstet Gynecol 1983; 145:7-10.
54. Elkayam U, Kawaniski D, Reid C, Chandrarantna A, Gleicher N, Rahimtoola SH:
Contrast echocardiography to reduce ionizing radiation associated with cardiac
catheterization during pregnancy. Am J Cardiol 1983; 53:213-214.
Page 65
55. Gleicher N, Siegel I: Immunology of pregnancy. Wiener Klin Wochenschrift 1983;
95:377-382.
56. Gleicher N, Friberg J, Fullan N, Giglia R, Mayden K, Keskey T, Siegel I: Egg retrieval
for in vitro fertilization by sonographically controlled vaginal culdocentesis. Lancet
1983; 2:508-509.
57. Toder V, Nebel L, Gleicher N: Studies of natural killer cells in pregnancy. I. Analysis on
the single cell level. J Clin Lab Immunol 1984; 14:123-127.
58. Toder V, Nebel L, Elrad H, Blank M, Gleicher N: Studies of natural killer cells in
pregnancy. II. The immunoregulatory effect of pregnancy substances. J Clin Lab
Immunol 1984; 14:129-133.
59. Young R, Friberg J, Gleicher N, et al: Clinical experiences with in vitro fertilization -
embryo transfer at Mount Sinai Hospital Medical Center of Chicago. J Vitro Fert Embryo
Transfer 1984; 1:93-94.
60. Gleicher N, Deppe G, Friberg J: The practice of tubal sterilization: Review of a
departmental practice pattern. Mount Sinai J Med 1984; 51:157-160.
61. Gleicher N, Dmowski W, Siegel I, Lui TL, Friberg J, Radwanska E, Toder V:
Lymphocyte subsets in endometriosis. Obstet Gynecol 1984; 4:463-466.
62. Chawla R, Deppe G, Ahart S, Gleicher N: Hemorrhage following fetal scalp blood
sampling. Am J Obstet Gynecol 1984; 149:92.
63. Deppe G, Hercule Y, Gleicher N: Sciatic nerve injury complicating surgical removal of
retroperitoneal tumor. Acta Obstet Gynecol Scand 1984; 19:120-124.
64. Elkayam U, Gleicher N: Cardiac problems in pregnancy. 1. Maternal aspects. JAMA
1984; 251:2837-2838.
65. Gleicher N, Elkayam U: Cardiac problems in pregnancy. 2. Fetal aspects. JAMA 1984;
252:78-80.
66. Siegel I, Liu T\L, Janet P, Gleicher N: The effects of parenteral fat emulsion (Intralipid)
and triglycerides on immune adherence and red cell morphology in vivo and in vitro.
JAMA 1984; 251:1574-1579.
67. Toder V, Elrad H, Durdana A, Gleicher N: Proceedings of the 9th Lymphology Congress.
Immunol Hematol Res Monograph 1984; 2:334-335
68. Gleicher N: Cesarean section rates in the United States: The short term failure of the
National Consensus Development Conference in 1980. JAMA 1984; 252:3273-3276.
69. Siegel I, Gleicher N: T-cell subsets in patients with preeclampsia. Am J Obstet Gynecol
1984; 149:583-584.
70. Gleicher N: The fetus is a graft, both biologically and legally. Fertil Steril 1984; 42:824-
825.
71. Confino E, Gleicher N, Elrad H, et al: The breech dilemma: A review. Obstet Gynecol
Surv 1985; 40:330-337.
72. Gleicher N, Vermesh M, Rotmensch S, et al: Cesarean section patterns: Influence of a
Perinatology Service. Mt Sinai J Med 1985; 52:100-105.
73. Friberg J, Gleicher N: High dose human menopausal gonadotropin therapy for successful
ovulation induction for IVF program in perimenopausal women. Proceedings of the NY
Acad Science 1985; 442:168-179.
74. Confino E, Ismajovich B, David M, Gleicher N: Fetal heart rate in maternal
hypoglycemic coma. Int J Gynaecol Obstet 1985; 23:59-60.
Page 66
75. Toder V, Durdana A, Elrad H, Gleicher N: Natural killing (NK) potential of cord blood
lymphocytes. J Clin Lab Immunol 1985; 17:29-32.
76. Deppe G, Malviya VK, Hercule J, Gleicher N: Retroperitoneal pelvic lipoma. J Natl Med
Assoc 1985; 78:574-576.
77. Elrad H, Mayden K, Erhart S, Giglia R, Gleicher N: Prenatal ultrasound diagnosis of
choledochal cyst. A case report. J Ultrasound Med 1985; 4:553-555.
78. Confino E, Friberg J, Giglia R, Gleicher N: Sonographic imaging of intrauterine
adhesions. Obstet Gynecol 1985; 66:596-598.
79. Gleicher N, Friberg J: IgM gammopathy and the lupus anticoagulant syndrome in
habitual aborters. JAMA 1985; 253:3278-3281.
80. Friberg J, Suarez M, Gleicher N, Confino E: Chlamydia on Spermatozoa. J Infect
Diseases 1985; 152:854.
81. Friberg J, Gleicher N: High-dose human menopausal gonadotropin therapy for successful
ovulation induction for in vitro fertilization in perimenopausal women. In in vitro
Fertilization and Embryo Transfer, Seppala M, Edwards RG, Eds: Annals NY Acad Sci
1985; 442:168-177.
82. Keskey T, Suarez M, Gleicher N, Friberg J, Levy HB: Chlamydia trachomatis infections
in infants. Mt Sinai J Med 1986; 53:77-79.
83. Confino E, Gleicher N, Keskey I, et al: Comparison between 14” and 16” gauge needles
for aspiration of human oocytes. Mt Sinai J Med 1986; 53:250-253.
84. Zbella E, Deppe G, Gleicher N: Outpatient versus inpatient cone biopsy of the cervix. Mt
Sinai J Med 1986; 53:80-81.
85. Confino E, Mayden K, Giglia R, Vermesh M, Gleicher N: Pitfalls in sonographic
imaging of the incompetent uterine cervix. Acta Obstet Gynecol Scand 1986; 65:593-597.
86. Vermesh M, Mayden K, Confino E, Giglia R, Gleicher N: Prenatal sonographic diagnosis
of Hirschsprung’s Disease. J Ultrasound Med 1986; 5:37-39.
87. Friberg J, Suarez M, Confino E, Deppe E, Gleicher N: Mezlocillin in the treatment of
acute salpingitis. Mt Sinai J Med 1986; 53:510-513.
88. Siegel I, Dudkiewicz A, Friberg J, Suarez M, Gleicher N: Inhibition of sperm motility
and agglutination of sperm cells by free fatty acids in whole semen. Fertil Steril 1986;
45:273-279.
89. Confino E, Friberg J, Dudkiewicz A, Gleicher N: Intrauterine inseminations with washed
human spermatozoa. Fertil Steril 1986; 46:55-60.
90. Gleicher N, Boler L, Norusis M, Del Granado A: Hypertensive diseases of pregnancy and
parity. Am J Obstet Gynecol 1986; 154:1044-1049.
91. Mayden K, Confino E, Miller C, Friberg J, Gleicher N: Decreased gestational sac
volumes in pregnancies induced by human menopausal gonadotropin. Fertil Steril 1986;
45:879-882.
92. Deppe G, Zbella E, Wall D, Smith P, Gleicher N: Significance of the class II pap smear
in a high-risk population. Colposcopy Gynecol Las Surg 1986; 2:5-8.
93. Confino E, Demir R, Friberg J, Gleicher N: The predictive valve hCG B subunit levels in
pregnancies achieved by in vitro fertilization and embryo transfer: An international
collaborative study. Fertil Steril 1986; 45:526-531.
94. Confino E, Demir R, Friberg J, Gleicher N: Does cyclic hCG secretion indicate embryo
loss in in vitro fertilization? Fertil Steril 1986; 46:897-902.
Page 67
95. Zbella E, Vermesh M, Gleicher N: Contraceptive practices of female physicians.
Contraception 1986; 33:423-436.
96. Confino E, Friberg J, Gleicher N: Transcervical balloon tuboplasty (TBT). Fertil Steril
1986; 46:963-966.
97. Confino E, Friberg J, Gleicher N: A new stirrable catheter for gamete intrafallopian tube
transfer (GIFT). Fertil Steril 1986; 46:1147-1149.
98. Gleicher N: Pregnancy and autoimmunity. Acta Haematologica Scand 1986; 76:68-77.
99. Confino E, Vermesh M, Thomas Jr. W, Gleicher N: Non-vascular transplantation of the
rabbit uterus. Int J Gynaecol Obstet 1986; 24:321-325.
100. Frank J, Confino E, Friberg J, Dudkiewicz A, Gleicher N: The effect of ejaculation
frequency on sperm quality. Arch Androl 1986; 16:203-207.
101. Confino E, Friberg J, Vermesh M, Madanes A, Suarez M, Gleicher N: Mezlocillin versus
Doxycyline in the treatment of acute salpingitis. Mt Sinai J Med 1986; 53:510-513.
102. Boler L, Zbella E, Gleicher N: Quantitation of proteinuria in pregnancy by the use of
single voided urine sample. Obstet Gynecol 1987; 70:99-100.
103. Keskey T, Suarez M, Gleicher N, Friberg J, Levy H: Chlamydia trachomatis infection in
sexually abused children. Mt Sinai J Med 1987; 54:129-134.
104. Friberg J, Confino E, Suarez M, Gleicher N: Chlamydia trachomatis attached to
spermatozoa recovered from the peritoneal cavity of patients with salpingitis. J Reprod
Med 1987; 32:120-122.
105. Vermesh M, Confino E, Boler L, Friberg J, Gleicher N: Acute salpingitis in sterilized
women. Obstet Gynecol 1987; 69:265-267.
106. Myers S, Gleicher N: Breech delivery: Why the dilemma? Am J Obstet Gynecol 1987;
156:6-10.
107. Confino E, Zbella E, Gleicher N: Abscess formation post cesarean section due to a piece
of latex glove. Int J Gynaecol Obstet 1987; 25:155-157.
108. Siegel I, Liu TL, Yaghoubzadeh E, Keskey T, Gleicher N: Cytotoxic effects of free fatty
acids upon ascites tumor cells. J Natl Cancer Institute 1987; 78:271-277.
109. Giorlandino C, Gleicher N, Nanni C, Vizzone A, Gentili P, Taramanni C: The
sonographic picture of endometrium in spontaneous and induced cycles. Fertil Steril
1987; 47:508-511.
110. Confino E, Friberg J, Silverman S, Dudkiewicz A, Goldin M, Gleicher N: Penetration of
bacteriae and spermatozoa into bovine cervical mucus. Obstet Gynecol 1987; 70:134-136.
111. El-Roeiy A, Gleicher N, Friberg J, Confino E, Dudkiewicz A: Correlation between
peripheral blood and follicular fluid autoantibodies and impact on in vitro fertilization.
Obstet Gynecol 1987; 70:163-170.
112. El-Roeiy A, Shoenfeld Y, Gleicher N, Isenberg D, Kennedy R: A common anti-DNA
idiotype and other autoantibodies in sera of offspring of mothers with systemic lupus
erythematosus. Clin Exp Immunol 1987; 68:528-534.
113. Gleicher N, El-Roeiy A, Confino E, Friberg J: Is endometriosis an autoimmune disease?
Obstet Gynecol 1987; 70:115-122.
114. Holmquist-West A, El-Roeiy A, Gleicher N: An unexplained peak of pregnancy
associated thrombocytopenia. Mt Sinai J Med 1987; 54:481-486.
115. Suarez M, Friberg J, Gleicher N: The incidence of chlamydia trachomatis in peripartial
fallopian tubes. J Reprod Med 1988; 33:199-201.
Page 68
116. Confino E, Friberg J, Vermesh M, Thomas W, Gleicher N: Effects of progesterone on
postoperative adhesion formation in hysterectomized rabbits. Int J Fert 1988; 33:139-142.
117. El-Roeiy A, Valessini G, Friberg J, Shoenfeld Y, Kennedy R, Tincani A, Balestrieri G,
Gleicher N: Autoantibodies and common idiotypes in sperm antibody positive females
and males. Am J Obstet Gynecol 1988; 158:596-603.
118. Gleicher N, El-Roeiy A: The reproductive autoimmune failure syndrome (RAFS). Am J
Obstet Gynecol 1988; 159:223-227.
119. Confino E, Friberg J, Gleicher N: Spontaneous recanalization of bilateral tubal occlusion
following a pregnancy achieved by in vitro fertilization. Fertil Steril 1988; 49:723-725.
120. Confino E, Friberg J, Gleicher N: Preliminary experience with transcervical balloon
tuboplasty (TBT). Am J Obstet Gynecol 1988; 159:370-375.
121. Friberg J, Confino E, Gleicher N: Erythema multiforme in an IVF pregnancy. J Reprod
Med 1988; 33:230-231.
122. El-Roeiy A, Gleicher N: Definition of normal autoantibody levels in an apparently
healthy population. Obstet Gynecol 1988; 72:596-602.
123. Confino E, Friberg J, Gleicher N: Improved penetration of spermatozoa into uterine
fluids of women with abnormal postcoital tests. Obstet Gynecol 1988; 72:655-658.
124. Myers S, Gleicher N: A successful program to lower cesarean section rates. N Engl J
Med 1988; 319:1511-1516.
125. El-Roeiy A, Dmowski P, Gleicher N, Radwanska E, Harlow L, Binor Z, Tummon I,
Rawlins R: Danazol but not gonadotropin-releasing hormone agonists suppresses
autoantibodies in endometriosis. Fertil Steril 1988; 50:864-871.
126. Suarez M, Friberg J, Gleicher N: The incidence of chlamydia trachomatis in peripartial
fallopian tubes. J Reprod Med 1988; 33:199-201.
127. Toder V, Madanes A, Gleicher N: Immunologic aspects of IUD action. Contraception
1988; 37:391-403.
128. Confino E, Friberg J, Vermesh M, Madanes A, Suarez M, Gleicher N: Mezlocillin versus
Doxycycline in the Treatment of Acute Salpingitis. Mt Sinai J Med 1988; 55:154-157.
129. Siegel I, Liu TL, Nepomuceno N, Gleicher N: Effects of short-term dietary restriction on
survival of mammary ascites tumor-bearing rats. Cancer Invest 1988; 6:677-680.
130. Confino E, Gleicher N, Friberg J: Thromboelastogram and circulating lupus
anticoagulant. J Reprod Med 1989; 34:289-291.
131. Gleicher N: Breast disease programs in obstetrics and gynecology: A plea for training in
mammography. Am J Obstet Gynecol 1989; 161:267-270.
132. Demir R, Gleicher N, Myers S: Atraumatic antepartum subdural hematoma causing fetal
death. Am J Obstet Gynecol 1989; 160:619-620.
133. Novas J, Myers S, Gleicher N: Obstetric outcome of patients with more than one previous
cesarean section. Am J Obstet Gynecol 1989; 160:364-367.
134. Confino E, Gleicher N: Conservative surgical management of interstitial pregnancy.
Fertil Steril 1989; 52:600-603.
135. Gleicher N, El-Roeiy A, Confino E, Friberg J: Reproductive failure because of
autoantibodies: Unexplained infertility and pregnancy wastage. Am J Obstet Gynecol
1989; 160:1376-1385.
136. Tur-Kaspa I, Confino E, Friberg J, Myers S, Dudkiewicz A, Gleicher N: Ovarian
stimulation protocol for in vitro fertilization with gonadotropin releasing hormone agonist
widens the implantation window. Fertil Steril 1990; 53:859-864.
Page 69
137. Confino E, Harlow L, Gleicher N: Peritoneal fluid and serum autoantibody levels in
patients with endometriosis. Fertil Steril 1990; 53:242-245.
138. El-Roeiy A, Myers S, Gleicher N: The prevalence of autoantibodies and lupus
anticoagulant in healthy pregnant women. Obstet Gynecol 1990; 75:390-396.
139. Gleicher N, Harlow L: Commercial IgG immunoglobulin preparations exhibit IgG and
IgA autoantibody reactivity at pharmacologic but not at physiologic concentrations. Mt
Sinai J Med 1990; 57:242-248.
140. Tur-Kaspa I, Dudkiewicz A, Confino E, Gleicher N: Pooled sequential ejaculates: A way
to increase total number of motile sperm from oligozoospermic men. Fertil Steril 1990;
54:906-909.
141. Menchaca A, Akhiyat M, Gleicher N, Gottlieb L, Bernstein J: The rectus abdominis
muscle flap in a combined abdominovaginal repair of difficult vesicovaginal fistulae. A
report of three cases. J Reprod Med 1990; 35:565-568.
142. Confino E, Tur-Kaspa I, DeCherney A, Corfman R, Coulam C, Robinson E, Haas G,
Katz E, Vermesh M, Gleicher N: Transcervical balloon tuboplasty: A multicenter study.
JAMA 1990; 264:2079-2082.
143. El-Roeiy A, Myers S, Gleicher N: The relationship between autoantibodies and
intrauterine growth retardation in hypertensive disorders of pregnancy. Am J Obstet
Gynecol 1991; 164:1253-1261.
144. Myers S, Gleicher N: The Mount Sinai cesarean section reduction program: Automated
data collection and peer review. Qual Let 1991; 3:10-17.
145. Gleicher N: Caring for the uninsured and underinsured: Expansion of health care to
uninsured and underinsured has to be cost-neutral. JAMA 1991; 265:2388-2390.
146. Gleicher N, Harlow L, El-Roeiy A: The correlation between lupus anticoagulant and
autoantibodies. Mt Sinai J Med 1992; 59:32-37.
147. Gleicher N, Parrilli M, Pratt D: Hysterosalpingography and selective salpingography in
the differential diagnosis of chemical intrauterine versus tubal pregnancy. Fertil Steril
1992; 57:553-558.
148. Gleicher N, Harlow L, Zilberstein M: The regulatory effect of antiphospholipid
antibodies (APA) on signal transduction: A possible model for autoantibody induced
reproductive failure. Am J Obstet Gynecol; 1992; 167:637-42.
149. Gleicher N: Autoantibodies in normal and abnormal pregnancy. Am J Reprod Immunol
1992; 28:269-273.
150. Gleicher N: Endometriosis: A new approach is needed. Hum Reprod 1992; 7:821-824.
151. Confino E, Tur-Kaspa I, Gleicher N: Sonographic transcervical balloon tuboplasty. Hum
Reprod 1992; 7:1271-1274.
152. Gleicher N, Thurmond A, Burry K, Coulam C: Gynecoradiology: A new approach to
diagnosis and treatment of tubal disease. Fertil Steril 1992; 58:885-887.
153. Gleicher N, Parrilli M, Redding L, Pratt D, Karande V: Standardization of
hysterosalpingography and selective salpingography: A valuable adjunct to simple
opacification studies. Fertil Steril 1992; 58:1136-41.
154. Ober C., Karrison T, Harlowe L, Elias S, Gleicher N: Autoantibodies and pregnancy
history in a healthy population. Am J Obstet Gynecol 1993; 169:143-147.
155. Pratt D, Novotny M, Kaberlein G, Dudkiewicz A, Gleicher N: Antithyroid antibodies and
the association with nonorganspecific antibodies in recurrent pregnancy loss. Am J
Obstet Gynecol 1993; 837-841.
Page 70
156. Gleicher N, Confino E, Corfman R, Coulam C, DeCherney A, Haas G, Katz E, Robinson
E, Tur-Kaspa I, Vermesh M: The multicenter transcervical tuboplasty (TBT) Study:
Conclusions and comparison to alternative technologies. Hum Reprod 1993; 8:1264-1271.
157. Gleicher N, Pratt D: Abnormal (auto)immunity and endometriosis. Int J Gynecol Obstet
1993; 40:S21-S27.
158. Pratt D, Kaberlein G, Dudkiewicz A, Karande V, Gleicher N: The association of
antithyroid antibodies in euthyroid nonpregnant women with recurrent first trimester
abortions in the next pregnancy. Fertil Steril 1993; 60:1001-1005.
159. Gleicher N, Pratt D, Dudkiewicz A: What do we really know about Autoantibody
abnormalities and reproductive failure: A critical review. Autoimmunity 1993; 16:115-
140.
160. Gleicher N, Karande V, Rabin D, Pratt D: Laparoscopic removal of twin cornual
pregnancy after In Vitro Fertilization. Fertil Steril 1994; 1161-1162.
161. Gleicher N, Pratt D, Karande V, Rabin D, Dudkiewicz A: Pregnancy after intrauterine
insemination with sperm retrieved from the rectum. Fertil Steril 1994; 61:554-555.
162. Gleicher N, Redding L, Parrilli M, Karande V, Pratt D: Wire guide cannulation alone is
no treatment of proximal tubal occlusion. Hum Reprod 1994; 9:1109-1111.
163. Gleicher N, Liu HC, Dudkiewicz A, Rosenwaks A, Kaberlein G, Pratt D, Karande V:
Autoantibody profiles and immunoglobulin levels as predictors of in vitro fertilization
success. Am J Obstet Gynecol 1994; 170:1145-1149.
164. Gleicher N: Autoantibodies and pregnancy loss: Lancet 1994; 343: 747-748.
165. Gleicher N: The role of humoral immunity in endometriosis. Acta Obstet Gynecol Scand
1994: 159:15-17.
166. Aoki K, Matsuura E, Sasa H, Yagami Y, Dudkiewicz A, Gleicher N: 2-Glycoprotein I-
dependent and -independent anticardiolipin antibodies in healthy pregnant women. Hum
Reprod 1994; 9:1849-1851.
167. Cusick W, Gleicher N: Multiple conceptions, implantation, and prematurity: Assisted
Reproduction Reviews 1995; 5:4: 246-250.
168. Aoki K, Dudkiewicz A, Matsuura E, Novotny M, Kaberlein G, Gleicher N: Clinical
significance of Glycoprotein I - dependent anticardiolipin antibodies in the reproductive
autoimmune failure syndrome: Correlation with conventional antiphospholipid antibody
detection systems. Am J Obstet & Gynecol 1995; 172:926-931.
169. Gleicher N, Karande V, Rabin D, Dudkiewicz A, Pratt D: The bubble test: A new tool to
improve the diagnosis of endometriosis. Hum Reprod 1995; 10:923-926.
170. Karande V, Pratt D, Rabin D, Gleicher N: The limited value of hysterosalpingography in
assessing tubal status and fertility potential. Fertil Steril 1995; 63:1167-1171.
171. Karande V, Pratt D, Rao R, Balin M, Gleicher N: Elevated tubal perfusion pressures
during selective salpingography are highly suggestive of tubal endometriosis. Fertil Steril
1995; 64:1070-1073.
172. Gleicher N, Campbell D. Chan C, Karande V, Rao R, Balin M. Pratt D: The desire for
multiple births in couples with infertility problems contradicts present practice patterns.
Hum Reprod 1995; 10:1079-1084.
173. Gleicher N, Pratt D, Levrant S, Rao R, Balin M, Karande V: Gynecoradiologic uterine
resection (GUR). Hum Reprod 1995; 10:1801-1803.
Page 71
174. Aoki K, Kajiiura S, Matsumoto Y, Ogasawara M, Okada S, Yagami Y, Gleicher N:
Preconceptional natural-killer cell activity as predictor of miscarriage. Lancet 1995;
345:1340-1342.
175. Gleicher N: Immune dysfunction - a potential target for treatment in endometriosis.
British J Obstet Gynaecol 1995; 102 (Supplement): 4-7.
176. Karande V, Rao R, Pratt D, Balin M, Levrant S, Morris R, Dudkiewicz A, Gleicher N: A
randomized prospective comparison between intrauterine insemination and fallopian
sperm perfusion for the treatment of infertility. Fertil Steril 1995; 64:638-640.
177. Mathur S, Butler W, Chihal J, Isaacson K, Gleicher N: Target antigen(s) in endometrial
autoimmunity of endometriosis. Autoimmunity 1995; 20:211-222.
178. Gleicher N, VanderLaan B, Pratt D, Karande V: Background pregnancy rates in an
infertile population. Hum Reprod 1996; 11:1011-1012.
179. Gleicher N, Karande V: The diagnosis of proximal tubal disease. Hum Reprod 1996;
11:1825-1828.
180. Gleicher N, VanderLaan B, Karande V, Morris R, Nadherney K, Pratt D: Patient drop-out
rates during infertility therapy are considerable and vary with coverage. Obstet Gynecol
1996; 88:289-293.
181. Karande V, Pratt D, Gleicher N: The Assessment of Tubal Functional Status by Tubal
Perfussion Pressure Measurements. Hum Reprod 1996; 2:429-433.
182. Gleicher N: Antiphospholipid antibodies and reproductive failure: What they do and what
they don’t; how to, and how not to treat. Hum Reprod 1997; 12:13-15.
183. Gleicher N, Karande V, Balin M, Levrant S, Morris R, Pratt D.: What is radiation
exposure to patients during a gynecoradiologic procedure? Fertil Steril 1997; 2:401-403.
184. Karande V, Levrant S, Hoxsey R., Rinehart J, Gleicher N.: Lysis of intrauterine
adhesions using gynecoradiologic techniques. Fertil Steril 1997; 4:658-662.
185. Karande V, Morris R, Rinehart J, Miller C, Rao R, Gleicher N: Limited success using the
“flare” protocol in poor responders in cycles with low basal follicle-stimulating hormone
levels during in vitro fertilization. Fertil Steril 1997; 67:900-903.
186. Gleicher N, Coulam C: DEBATE - Ovarian Infertility -Are we overlooking (auto)
immune ovarian infertility? Hum Reprod 1997; 12:637-639.
187. Gleicher N: Autoantibodies in infertility: current opinion. Hum Reprod 1998; 2:169-176.
188. VanderLaan B, Karande V, Krohm C, Morris R, Pratt D, Gleicher N: Cost considerations
with infertility treatment therapy: outcome and cost comparison between HMO and PPO
care based on physician and facility cost. Hum Reprod 1998; 5:1200-1205.
189. Gleicher N: Strategies to improve insurance coverage for infertility services. Fertil Steril
1998; 70:1006-1008.
190. Karande V, Korn A, Morris R, Rao R, Balin M, Rinehart J, Dohn K, Gleicher N:
Prospective randomized trial comparing the outcome and cost of in vitro fertilization with
that of a traditional treatment algorithm as first-line therapy for couples with infertility.
Fertil Steril 1999; 71: 468-475.
191. Morris S, Karande V, Dudkiewicz A, Morris J, Gleicher N: Octreotide is not useful for
chlomiphene citrate resistance in patients with polycystic ovary syndrome but may
reduce the likelihood of ovarian hyperstimulation syndrome. Fertil Steril 1999, 71:452-
456.
Page 72
192. Karande V, Morris R, Chapman C, Rinehart J, Gleicher N: Impact of the “physician
factor” on pregnancy rates in a large assisted reproductive technology program: do too
many cooks spoil the broth? Fertil Steril 1999, 71:1001-1009.
193. Gleicher N: Reproductive failure prior to the onset of clinical autoimmune disease.
Rheumatology 1999; 38:485-487.
194. Karande V, Gleicher, N: OPINION – A Rational Approach to the Management of Low
Responders in In-Vitro Fertilization. Hum Reprod 1999; 14:1744-1748.
195. Coulam C, Branch D, Clark D, Gleicher N, Kutteh W, Lockshin M, Rote N: Report of the
committee for establishing criteria for diagnosis of reproductive autoimmune system,
American Journal of Reproductive Immunology 1999; 41:121-132.
196. Gleicher N: Cost effective infertility care. Hum Reprod Update 2000; 6:190-199.
197. Gleicher, N: The Consumer and Provider: Pillars of the New Health Care System. The
Physician Executive 2000; 26:38-43.
198. Gleicher N, Brown T, Dudkiewicz A, Karande V, Rao R, Balin M, Campbell D, Pratt D:
Estradiol/progesterone substitution in the luteal phase improves pregnancy rates in
stimulated cycles—but only in younger women. Early Pregnancy 2000; 1:64-73.
199. Gleicher N, Oleske D, Tur-Kaspa I, Vidali A, Karande V: Reducing the risk of high-order
multiple pregnancy after ovarian stimulation with gonadotropins. N.Engl J Med 2000;
343:2-7.
200. Gleicher, N, Karande, V: Generic Human Menopausal Gonadotropin (hMG) in Place of
More Costly Follicle-Stimulating Hormone (FSH) for Routine Ovulation Induction. J
Assist Reprod Genetics. 2000; 17:489-495.
201. Gleicher N, Vidali A, Karande V: The immunological ‘wars of roses’: Disagreements
amongst reproductive immunologists. Hum Reprod 2002; 17:539-542.
202. Gleicher N, Karande V: Gender selection for nonmedical indications. Fertil Steril 2002;
78:460-462.
203. Gleicher N: Some thoughts on the reproductive autoimmune failure syndrome (RAFS)
and Th-1 versus Th-2 immune responses. Am J. Reprod Immunol 2002; 48(4):252-40
204. Gleicher N: Modern obstetrical and infertility care may increase the prevalence of
disease: An evolutionary concept. Fertil Steril 2003; 79:249-252.
205. Rechitsky S, Verlinsky O, Kuliev, A, Orzen, S, Lazluk, K, Beck, R, Gleicher, N,
Verlinsky, Y. Preimplantation: Genetic Diagnosis for Early-Onset Torsion Dystonia.
RBM Online 2003; 8:224-228.
206. Gleicher N, Vietzke M, Vidali A: Bye-bye urinary gonadotrophins? Hum Reprod 2003;
18:476-482.
207. Gleicher, N: Safety Issues in Assisted Reproduction technology: A rebuttal, Hum Reprod
2003: 18:1765-66.
208. Gleicher N, Tang Y: Blastomere transplantation in human embryos may be a treatment
for single gene diseases. Fertil Steril 2004; 81: 977-981.
209. Gleicher N: Is It Time to Limit IVF Transfers to One Embryo? Contemp OB/GYN 2004;
8:73-85.
210. Gleicher N: Ovarian Aging: Is There a Norm? Contemp OB/GYN 2005; 65-75.
211. Barad D, Gleicher N: Increased Oocyte Production After Treatment with
Dehydroepiandrosterone, Fertil Steril 2005; 84: 756.e1-756.e3.
212. Gleicher N, Barad D: Unexplained Infertity: Does it Really Exist? Hum Reprod 2006;
21:1951-5.
Page 73
213. Gleicher N, Barad D: An Evolutionary Concept of Polycystic Ovarian Disease: Does
Evolution Favor Reproductive Success Over Survival? RBMOnline 2006; 12: 587-589.
214. Gleicher N, Weghofer A, Barad D: A Formal Comparision of the Practice of Assisted
Reproductive Technologies Between Europe and the USA. Hum Reprod 2006; 21: 1945-
50.
215. Gleicher N, Barad D: The Relative Myth of Elective Single Embryo Transfer. Hum
Reprod 2006; 21: 1337-1344.
216. Barad D, Gleicher N: Effects of Dehydroepiandrosterone (DHEA) on oocyte and embryo
yields, embryo grade and cell number in IVF. Hum Reprod 2006; 21: 2845-9.
217. Gleicher N, Barad D: “Ovarian Age-Based” Stimulation of Young Women with
Diminished Ovarian Reserve (DOR) Results In Excellent Pregnancy Rates with IVF.
Fertil Steril 2006; 86: 1621-1625.
218. Gleicher N, Weiner R, Vietzke M: The Impact of Abnormal Autoimmune Function on
Reproduction: Maternal and Fetal Consequences. J Autoimmunity 2006; 27:161-65.
219. Weghofer A, Munne S, Brannath W, Chen S, Cohen J, Gleicher N: The quantitative and
qualitative impact of gonadotropin stimulation on human preimplantation embryos. Fertil
Steril 2006; 86 (sup.2):S58 (O-137).
220. Brill H, Barad D, Gleicher N: Dehydroepiandrosterone (DHEA) supplementation and
pregnancy outcome: Effect on pregnancy rate and speed of conception. Fertil Steril 2006;
86 (sup.2):S124-5 (O-289).
221. Barad D, Weghofer A, Gleicher N: Evidence for an empiric definition of diminished
ovarian reserve (DOR), resistance to stimulation and diagnosis of premature ovarian
aging (POA), based on age-specific baseline. Fertil Steril 2006; 86: (sup.2):S125-6 (O-
291).
222. Gleicher N, Weghofer A, Barad D: Adrenal function in women with premature aging
ovaries. Fertil Steril 2006; 86 (sup.2) (O-137). Fertil Steril 2006; 86 (sup.2): S401 (P-
722).
223. Weghofer A, Barad D, Gleicher N: Are women with premature ovarian aging (POA) at
increased risk for chromosomally abnormal embryos? The association between
embryonic aneuploidy rates and POA. Fertil Steril 2006; 86: S403-4.
224. Gleicher N, Barad D: Gender as risk factor for autoimmune diseases. J Autoimmunity
2007; 26:1-6.
225. Gleicher N: Why much of the pathophysiology of preeclampsia-eclampsia has to be
autoimmune in nature. Am J Obstet Gynecol 2007; 196: 5.e1-5.e7.
226. Weghofer A, Munne S, Chen S, Barad D, Gleicher N: Lack of association between
polycystic ovary syndrome and embryonic aneuploidy. Fertil Steril 2007; 86: S462.
227. Weghofer A, Barad D, Li J, Gleicher N: Aneuploidy rates in embryos from women with
prematurely declining ovarian function: a pilot study. Fertil Steril 2007; 88: 90-4.
228. Weghofer A, Schnepf S, Barad D, Gleicher N: The impact of luteinizing hormone in
assisted reproduction: a review. Curr Opin Obstet Gynecology 2007; 19:253-257.
229. Gleicher N: Pregnancy-related cell traffic, microchimerism and autoimmunity: the
possibility of reducing autoimmune disease prevalence. Expert Rev Obstet, Gynecol
2007; 2: 341-5.
230. Barad D, Weghofer A, Gleicher N: Age-Specific levels for basal follicle-stimulating
hormone assessment of ovarian function. Obstet Gynecol 2007; 109: 1404-1410.
Page 74
231. Gleicher N, Barad D: The choice of gender: is elective gender selection, indeed, sexist?
Hum Reprod 2007; 11: 3038-41.
232. Gleicher N, Weghofer A, Barad D: Update on the comparison of assisted reproduction
outcomes between Europe and the USA: the 2002 data. Fertil Steril 2007; 87: 1301-1305.
233. Gleicher N, Weghofer A, Barad D: Female infertility due to abnormal autoimmunity:
frequently overlooked and greatly underappreciated-part I. Expert Rev Obstet Gynecol
2007; 2: 453-64.
234. Gleicher N, Weghofer A, Barad D: Female infertility due to abnormal autoimmunity:
frequently overlooked and greatly underappreciated-part II. Expert Rev Obstet Gynecol
2007; 2: 465-75.
235. Gleicher N: Postpartum depression, an autoimmune disease? Autoimmune Rev 2007;
6:572-6.
236. Gleicher N, Barad D, Weghofer A: Functional autoantibodies, a new paradigm in
autoimmunity? Autoimmune Rev 2007; 7: 42-5.
237. Gleicher N, Weghofer A, Li J-M, Barad D: Differences in ovarian function parameters
between Chinese and Caucasian oocyte donors: do they offer an explanation for lower
IVF pregnancy rates in Chinese women? Hum Reprod 2007; 22: 2879-82.
238. Gleicher N: Twins in art a desirable outcome: the ‘pro’ position. International
Proceedings of the 14th World Congress, Montreal, Canada 2007; 277-282.
239. Weghofer A, Munne S, Brannath W, Chen S, Tomkin G, Cekleniak N, Garrisi M, Barad
D, Cohen J, Gleicher N: The impact of LH-containing gonadotropins on euploidy rates in
preimplantation embryos-I. long protocol stimulation. Hum Reprod 2008;23(3):499-503.
240. Gleicher N, Weghofer A, Barad D: Too old for IVF: are we discriminating against older
women? J Assist Reprod Genet 2007; 24: 639-44.
241. Barad D, Brill H, Gleicher N: Update on the use of dehydroepiandrosterone
supplementation and pregnancy rates among women with diminished ovarian function. J
Assist Reprod Genet 2007; 24: 629-634.
242. Gleicher N: Graft-versus-host disease and immunologic rejection: implications for
diagnosis and treatments of pregnancy complications. Expert Rev Obstet Gynecol
2008;3(1): 37-49.
243. Gleicher N: Missed immunological opportunities in pregnancy. Expert Rev. Clin.
Immunol. 2008; 4: 1-3.
244. Gleicher N, Weghofer A, Barad D: Preimplantation Genetic Screening: established and
ready for prime time? Fertil Steril 2008; 89: 780-788.
245. Gleicher N, Weghofer A, Barad D: A pilot study of premature ovarian senescence: I.
Correlation of triple CGG repeats on FMR1 gene to ovarian reserve parameters FSH and
AMH. Fertil Steril 2009; 5: 1700-06.
246. Gleicher N, Weghofer A, Barad D: A pilot study of premature ovarian senescence: II.
Different genotype and phenotype foe genetic and autoimmune etiologies. Fertil Steril
2009; 5: 1707-11.
247. Gleicher N, Barad D: Single versus twin embryo implantation: evidence, cost-
effectiveness, and patient satisfaction. Gynecol & Obstet. 2008; 13: 77-83.
248. Weghofer A, Brill H, Feichtinger R, Barad D, Gleicher N: Does autoimmunity play a role
in the pathophysiology of premature ovarian ageing? RBM Online. 2008; 16: 830-834.
Page 75
249. Singer T, Barad D, Weghofer A, Gleicher N: Correlation of anti-Müllerian hormone and
baseline follicle-stimulating hormone levels. Fertil Steril. 2009; 6: 2616-19.
doi:10.1016/j.fertnstert.2008.03.034.
250. Gleicher N, Barad D: Twin pregnancy, contrary to consensus, is a desirable outcome in
infertility. Fertil Steril. 2009; 6: 2426-31. doi:10.1016/j.fertnstert.2008.02.160.
251. Gleicher N, Oktay K, Barad D: Patients are entitled to maximal IVF pregnancy rates.
RBM Online. 2009; 5: 599-602.
252. Gleicher N, Weghofer A, Barad D: Age-specific ovarian function testing: a concept
whose time has come. Expert Rev Obstet Gynecol 2008;3:595-600.
253. Gleicher N, Barad D: Arguments against elective single-embryo transfer. Expert Rev
Obstet Gynecol. 2008; 3: 481-486.
254. Weghofer A, Munne S, BrannathW, Chen S, Barad D, Cohen J, and Gleicher N: The
impact of LH-containing gonadotropin stimulation on euploidy rates in preimplantation
embryos: antagonist cycles. Fertil Steril. 2009;92(3):937-42.
255. Gleicher N, Weghofer A, Oktay K, Barad D: Is the immunological noise of abnormal
autoimmunity an independent risk factor for premature ovarian aging? Menopause.
2009;16(4):760-4.
256. Gleicher N, Weghofer A, Oktay K, Barad D: Can the FMR1 (fragile X) gene serve as
predictor of response to ovarian stimulation? Reprod Sci. 2009; 5: 462-7.
257. Weghofer A and Gleicher N: Ovarian function: a theory of relativity. Hum Reprod. 2009;
24: 17-19.
258. Gleicher N, Weghofer A and Barad D. Age-specific ovarian function. Expert Rev Obstet
Gynecol. 2008; 3(5): 595-600.
259. Gleicher N and Elkayam Uri. Peripartum cardiomyopathy, an autoimmune manifestation
of allograft rejection? Autoimmun Rev (2008), doi: 10.1016/j.autrev.2008.12.003.
260. Gleicher N, Weghofer A, Oktay K, Barad D: Relevance of low triple CGG repeats on the
FMR1 gene to ovarian reserve: Is there a normal range? RBMOnline. 2008;19(3):385-90.
261. Barad D, Weghofer A, Gleicher N: Comparing anti-Mullerian hormone (AMH) and
follicle-stimulating hormone (FSH) as predictors of ovarian function. Fertil Steril
2009;91(supl 4):1553-5.
262. Gleicher N. Should a woman undergoing IVF be allowed to select the baby’s gender?
Controversies in Obstetrics and Gynecology. 2009, 64(8):46-48.
263. Gleicher N, Weghofer A, Oktay K, Barad DH. Correlation of triple repeats on the FMR1
(fragile X) gene to ovarian reserve: A new infertility test? Acta Obstetrica et
Gynecologica Scandinavica. 2009;88(9):1024-30.
264. Gleicher N, Weghofer A, Oktay K, Barad D. Relevance of triple CGG repeats in the
FMR1 gene to ovarian reserve. RBMOnline 2009:3:385-390.
265. Weghofer A and Gleicher N: Ovarian function: a theory of relativity. Hum Reprod
2009;24:17-9.
266. Gleicher N, Oktay K, Barad DHB: Patients are entitled to maximal IVF pregnancy rates.
Reprod Biomed Online 2009;18:599-602.
267. Gleicher N et al.: Can the FMR1 (fragile X) gene serve as predictor of response to
ovarian stimulation? Reprod Sci 2009;16:462-7.
268. Gleicher N et al.: Do etiologies of premature ovarian aging (POA) mimic those of
premature ovarian failure (POF)? Hum Reprod 2009;24:2395-400.
Page 76
269. Gleicher N et al.: Miscarriage rates after dehydroepiandrosterone (DHEA)
supplementation in women with diminished ovarian reserve: a case control study. Reprod
Biol Endocrionol 2009:7;108.
270. Weghofer A, Klein K, Stammler-Safar M, Worda C, Barad DH, Husslein P and Gleicher
N: Can prematurity risk in twin pregnancies after in vitro fertilization be predicted? A
retrospective study. Reprod Biol Endocrionol 2009;7:136.
271. Weghofer A, Klein K, Stammler-Safar M, Barad DH, Worda C, Husslein P and Gleicher
N. Severity of prematurity risk in spontaneous and in vitro fertilization twins: does
conception mode serve as a risk factor? Fertil Steril 2009:92(6):2116-2118.
272. Gleicher N. Does the immune system induce labor? Lessons from preterm deliveries in
women with autoimmune diseases. Clinical Rev Allerg Immunol 2010;39(3):194-206.
273. Gleicher N, Barad D. “Patient-friendly” IVF. Expert Rev Obstet Gynecol 2010:5(1);1-4.
274. Gleicher N, Barad D. Can the FMR1 gene predict early ovarian aging? Women’s Health
2010;6(2):165-9.
275. Barad DH, Weghofer A, Goyal A, Gleicher N. Utility of age-specific serum anti-
Mullerian hormone concentrations. RBMOnline 2011;22:284-91.
276. Gleicher N, Weghofer A, Barad DH. Ovarian reserve determinations suggest new
function of FMR1 (fragile X gene) in regulating ovarian aging. RBMOnline
2010;20(6):768-775.
277. Weghofer A, Klein K, Stammler-Safar M, Worda C, Barad DH, Husslein P, Gleicher N.
The impact of fetal gender on prematurity in dichorial twin gestations after in vitro
fertilization. Reprod Bio Endocrin 2010, 8:57.
278. Gleicher N, Barad DH. Further comments on the Suleman case. Expert Rev Obstet
Gynecol 2010;5(5):501-2.
279. Gleicher N, Barad DH. Misplaced obsession with prospectively randomized studies.
RBMOnline 2010;21(4):440-443.
280. Gleicher N, Weghofer A, Barad DH. Discordances between follicle stimulating hormone
(FSH) and anti-Mullerian hormone (AMH) in female infertility. Reprod Biol Endocrionol
2010; 8:64.
281. Gleicher N, Weghofer A, Barad DH. Can egg donor selection be improved? A pilot study.
Reprod Biol Endocrinol 2010;8:76.
282. Klein K, Worda C, Stammler-Safar M, Husslein P, Gleicher N, Weghofer A. Does fetal
sex influence the risk of preterm delivery in dichorionic twin pregnancies after
spontaneous conception? Twin Res Hum Genet. 2010 Oct;13(5):495-500. doi:
10.1375/twin.13.5.495.
283. Gleicher N, Weghofer A, Barad DH. Effects of race/ethnicity on triple CGG counts in the
FMR1 gene in infertile women and egg donors. RBMOnline 2010;20:485-491.
284. Gleicher N, Weghofer A, Barad DH. Improvement in diminished ovarian reserve after
dehydroepiandrosterone supplementation. RBMOnline 2010;21:360-365.
285. Gleicher N, Barad DH. The FMR1 gene as regulator of ovarian recruitment and ovarian
reserve. Obstetrical and Gynecological Survey 2010;65(8):523-30.
286. Gleicher N, Weghofer A, Barad DH. Dehydroepiandrosterone (DHEA) reduces embryo
aneuploidy: direct evidence from preimplantation genetic screening (PGS). Reprod Biol
Endocrinol 2010; 8:140.
Page 77
287. Gleicher N, Weghofer A, Lee IH, Barad DH. FMR1 genotype with autoimmunity-
associated polycystic ovary-like phenotype and decreased pregnancy chance. PLoS One
2010 Dec 16;5(12):e15303.
288. Gleicher N. Conflicts of interest in submission and peer review: no less important than
author/investigator conflicts. Expert Rev Obstet Gynecol 2011. In Press.
289. Gleicher N, Weghofer A, Barad DH. Do chromosomally abnormal pregnancies really
preclude autoimmune etiologies of spontaneous miscarriages? Autoimmun Rev 2011;
10(6):361-3.
290. Gleicher N, Weghofer A, Barad DH. Successful treatment of unresponsive thin
endometrium. Fertil Steril 2011;95(6):2123.e-13-7.
291. Gleicher N, Weghofer A, Barad DH. Defining ovarian reserve to better understand
ovarian aging. Reprod Biol Endocrinol 2011;9:23.
292. Gleicher N, Weghofer A, Lee IH, Barad DH. Association of FMR1 Genotypes with In
Vitro Fertilization (IVF) Outcomes Based on Ethnicity/Race. PLoS One
2011;6(4):e18781.
293. Gleicher N, Barad DH. Gestational dermatosis shortly after implantation associated with
parental class II HLA compatibility and maternal immune activation: preliminary report
of a prospective case series. Dermatology 2011. DOI: 10.1159/000327377.
294. Gleicher N, Barad DH. Dehydroepiandrosterone (DHEA) supplementation in diminished
ovarian reserve (DOR). Reprod Biol Endocrinol 2011;9:67.
295. Gleicher N, Weghofer A, Barad DH. Cutting edge assessment of the impact of
autoimmunity on female reproductive success. J Autoimmunity 2012, 38(2-3):J74-80..
296. Weghofer A, Dietrich W, Ortner I, Bieglmayer C, Barad DH and Gleicher N. Anti-
Mullerian hormone levels decline under hormonal suppression: a prospective analysis in
fertile women after delivery. Reprod Biol Endocrionol 2011; 9(1):98.
297. Gleicher N, Weghofer A, Barad DH. The role of androgens in follicle maturation and
ovulation induction: friend or foe of infertility treatment? Reprod Biol Endocrinol
2011;9(1):116.
298. Gleicher N, Kim A, Weghofer A, Barad DH. Towards a better understanding of
functional ovarian reserve: AMH (AMHo) and FSH (FSHo), hormone ratios per retrieved
oocyte. J Clin Endocrinol Metab 2012; 97(3):995-1004.
299. Gleicher N, Weghofer A, Barad DH. A case-control pilot study of low intensity in vitro
fertilization (LI-IVF) in good prognosis patients. Reprod Biomed Online 2012;
24(4):396-402.
300. Gleicher N. Eliminating multiple pregnancies: an appropriate target for government
intervention? Reprod Biomed Online 2011;23(4):403-6.
301. Gleicher N, Weghofer A, Barad DH. Low-intensity IVF: Real progress? Reprod Biomed
Online 2011;23(3):247-8.
302. Gleicher N, Weghofer A, Kim A, Barad DH. The impact in older women of ovarian
FMR1 genotypes and sub-genotypes on ovarian reserve. PLoS ONE 2012;3(7):e33638.
303. Gleicher N, Weghofer A, Kim A, Barad DH. Comparison of ovarian FMR1 genotypes
and sub-genotypes in oocyte donors and infertile women. J Assist Reprod Genet 2012;
29(6):529-532.
304. Gleicher N and Barad DH. “Hype” or “hope”: Ethical and practical considerations in
association with clinical research in women with diminished ovarian reserve. Reprod
Biomed Online 2012; 25(2):98-102.
Page 78
305. Gleicher N, Kim A, Weghofer A, Barad DH. Lessons from elective in vitro fertilization
(IVF) in, principally, non-infertile women. Reprod Biol Endocrinol 2012;10:48.
306. Weghofer A, Tea M-K, Barad DH, Kim A, Singer CF, Wagner K, Gleicher N. BRCA1/2
mutations appear embryo-lethal unless rescued by low (CGGn<26) FMR1 sub-
genotypes: Explanation for the “BRCA paradox”? PLoS ONE 2012;7(4):e44753.
307. Weghofer A, Kim A, Barad DH, Gleicher N. Follicle stimulating hormone and anti-
Mullerian hormone per oocyte in predicting in vitro fertilization pregnancy in high
responders: a cohort study. PLoS ONE 2012;7(4):e34290.
308. Weghofer A, Kim A, Barad DH, Gleicher N. The impact of androgen metabolism and
FMR1 genotypes on pregnancy potential in women with dehydroepiandrosterone
(DHEA) supplementation. Hum Reprod 2012; 27(11):3287-93.
309. Gleicher N, Kim A, Weghofer A, Barad DH. Differences in ovarian aging patterns
between races are associated with ovarian genotypes and sub-genotypes of the FMR1
gene. Reprod Biol Endocrinol 2012;10:77.
310. Gleicher N, Barad DH. A review of, and commentary on, the ongoing second clinical
introduction of preimplantation genetic screening (PGS) into routine IVF practice. J
Assist Reprod Genet 2012; 29(11):1159-66.
311. Gleicher N, Kim A, Michaeli T, Lee HJ, Shohat-Tal A, Lazzaroni E, Barad DH. A pilot
cohort study of granulocyte colony-stimulating factor in the treatment of unresponsive
thin endometrium resistant to standard therapies. Hum Reprod 2013; 28(1):172-7.
312. Gleicher N. Irrational attraction of elective single embryo transfer (eSET). Hum Reprod
2012; 28(2):294-7.
313. Gleicher N. Why are reproductive cancers more common in nulliparous women? Reprod
Biomed Online 2013; 26(5):416-9.
314. Gleicher N, Kim A, Weghofer A, Shohat-Tal A, Lazzaroni E, Lee HJ, Barad DH.
Starting and resulting testosterone levels after androgen supplementation determine at all
ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian
reserve (DOR). J Assist Reprod Genet 2013;30(1):49-62.
315. Gleicher N. Avoiding currently unavoidable conflicts of interest in medical publishing by
transparent peer review. Reprod Biomed Online 2013; 26(5):411-5.
316. Gleicher N, Kim A, Weghofer A, Kushnir VA, Shohat-Tal A, Lazzaroni E, Lee HJ,
Barad DB. Hypoandrogenism in association with diminished functional ovarian reserve.
Hum Reprod 2013; 28(4):1084-91.
317. Gleicher N, Kim A, Kushnir VA, Weghofer A, Shohat-Tal A, Lazzaroni E, Lee HJ,
Barad DH. Clinical relevance of combined FSH and AMH observations in infertile
women. J Clin Endocrinol Metabol 2013; 98(5):2136-2145.
318. Gleicher N, Barad DH. Mistaken advocacy against twin pregnancies following IVF. J
Assist Reprod Genet 2013; 30(4):575-9.
319. Barad DH, Kim A, Kubba H, Weghofer A, Gleicher N. Do hormonal contraceptions prior
to in vitro fertilization (IVF) negatively affect oocyte yields? A pilot study. Reprod Biol
Endocrinol 2013;11:28.
320. Kushnir VA, Kim A, Gleicher N, Barad DH. A pilot trial of large versus small diameter
needles for oocyte retrieval. Reprod Biol Endocrinol 2013; 11:22.
321. Gleicher N, Elkayam U. Preventing congenital neonatal heart block in offspring of
mothers with anti-SSA/Ro and SSB/La antibodies: a review of published literature and
registered clinical trials. Autoimmun Rev 2013; 12(11):1039-45.
Page 79
322. Gleicher N, Weghofer A, Kushnir VA, Shohat-Tal A, Lazzaroni E, Lee HJ, Barad DH. Is
androgen production in association with immune system activation potential evidence for
existence of a functional adrenal/ovarian autoimmune system in women? Reprod Biol
Endocrinol 2013;11:58.
323. Kushnir VA, Vidali A, Barad DH, Gleicher N. The Status of public reporting of clinical
outcomes in assisted reproductive technology. Fertil Steril 2013;100(3):736-41.
324. Gleicher N, Kim A, Barad DH, Shohat-Tal A, Lazzaroni E, Michaeli T, Lee HJ, Kushnir
VA, Weghofer A. FMR1-dependent variability of ovarian aging patterns is already
apparent in young oocyte donors. Reprod Biol Endocrinol 2013;11(1):80.
325. Gleicher N. For some ART patients, twins are the best outcome. Contemporary OB/GYN
2013; In press.
326. Gleicher N, Kushnir VA, Barad DH. Therapeutic interventions into early stages of
follicle maturation: a new treatment paradigm after over 50 years of modern infertility
therapy. Endocrinol 2013;154(10):3498-501.
327. Gleicher N, Kushnir VA, Barad DH. Preimplantation genetic screening is alive and very
well: Really? Fertil Steril 2013;100(5):e36.
328. Gleicher N, Elkayam U. Some more on preventing congenital heart block. Autoimmun
Rev 2014;13(1):73-4.
329. Gleicher N, Weghofer A, Barad DH. Do BRCA1/2 mutations and low FMR1 alleles
interact or not? Eur J Hum Genet 2014; 22(2):155-6.
330. Weghofer A, Kim A, Barad DH, Gleicher N. Age at menarche: a predictor of diminished
ovarian function? Fertil Steril 2013;100(4):1039-43.
331. Gleicher N, Kushnir VA, Barad DH. What ‘misguided campaign’ against single embryo
transfer? Hum Reprod 2014 ;29(2):380-1.
332. Sen A, Kushnir VA, Barad DH, Gleicher N. Endocrine autoimmune diseases and female
infertility. Nat Revs Endocrinol 2014; 10: 37-50.
333. Gleicher N. Maternal autoimmunity and adverse pregnancy outcomes. J Autoimmun
2014; 50:83-6.
334. Barad DH, Yu Y, Kushnir VA, Shohat-Tal A, Lazzaroni E, Lee HJ, Gleicher N. A
randomized clinical trial of endometrial perfusion with granulocyte colony-stimulating
factor in in vitro fertilization cycles: impact on endometrial thickness and clinical
pregnancy rates. Fertil Steril 2014;100(3):710-715.
335. Gleicher N, Kushnir VA, Barad DH. Preimplantation genetic screening (PGS) still in
search of a clinical application: a systematic review. Reprod Biol Endocrinol 2014; 12:22.
336. Kushnir VA, Yu Y, Barad DH, Weghofer A, Himaya E, Lee H-J, Wu Y-G, Shohat-Tal A,
Lazzaroni-Tealdi E, Gleicher N. Utilizing FMR1 gene mutations as predictors of
treatment success in human in vitro fertilization. PLoS ONE 2014; 9(7):e102274.
337. Gleicher N, McAlpine JN, Gilks CB, Kushnir VA, Lee H-J, Wu Y-G, Lazzaroni-Tealdi E,
Barad DH. Absence of BRCA/FMR1 correlations in women with ovarian cancers. PLoS
ONE 2014; 9(7):e102370.
338. Gleicher N, Kushnir VA, Weghofer A, Barad DH. The “graying” of infertility services:
an impending revolution nobody is ready for. Reprod Biol Endocrinol 2014; 12:63.
339. Gleicher N, Kushnir VA, Weghofer A, Barad DH. How the FMR1 gene became relevant
to female fertility and reproductive medicine. Frontiers Genet 2014; 5:284.
340. Kushnir VA, Gleicher N. Prediciton models for assisted reproductive technology. Nat
Rev Urol 2014; 11(9):492-3.
Page 80
341. Barad DH, Kushnir VA, Lee H-J, Lazzaroni-Tealdi E, Gleicher N. Effects of inter-cycle
interval on oocyte production in humans in the presence of the weak androgen DHEA
and follicle stimulating hormone: a case-control study. Reprod Biol Endocrinol 2014;
12:68.
342. Kushnir VA, Barad DH, Gleicher N. Ovarian reserve screening before contraception?
Reprod Biomed Online 2014; 29(5):527-9.
343. Prizant H, Gleicher N, Sen A. Androgen actions in the ovary: balance is key. J
Endocrinol 2014; 222:3:R141-151.
344. Kushnir VA, Khanna P, Barad DH, Gleicher N. Establishment of comparative
performance criteria for IVF centers: correlation of live birth rates in autologous and
donor oocyte IVF cycles. Reprod Biol Endocrinol 2014; 12:122.
345. Gleicher N, Barad DH, Kushnir VA, Sen A, Weghofer A. Poor responders and androgen
adjuvant treatment: Still haven't found what I'm looking for. Reprod Biomed Online
2014; 29(5):650-2.
346. Gleicher N, Kushnir VA, Barad D. Fertility treatments and multiple births in the United
States. NEJM 370(11):1069.
347. Sen A, Prizant H, Light A, Biswas A, Hayes E, Lee HJ, Barad D, Gleicher N, Hammes
SR. Androgens regulate ovarian follicular development by increasing follicle stimulating
hormone receptor and microRNA-125b expression. Proc Natl Acad Sci U S A 2014;
111(8):3008-13.
348. Gleicher N, Kushnir VA, Barad DH. Is it time for a paradigm shift in understanding
embryo selection? Reprod Biol Endocrinol 2015; 13:3.
349. Weghofer A, Himaya E, Kushnir VA, Barad DH, Lazzaroni-Tealdi E, Yu Y, Wu Y-G,
Gleicher N. Some aspects of interactivity between endocrine and immune systems
required for successful reproduction. Reprod Biol Endocrinol 2015; 13:29.
350. Gleicher N, Kushnir VA, Barad DH. Prospectively assessing risk for premature ovarian
senescence in young females: a new paradigm. Reprod Biol Endocrinol 2015; 13:34.
351. Weghofer A, Himaya E, Kushnir VA, Barad DH, Gleicher N. The impact of thyroid
function and thyroid autoimmunity on embryo quality in women with low functional
ovarian reserve: a case control study. Reprod Biol Endocrinol 2015. 13:43
352. Gleicher N. McCulloh DH, Kushnir VA, Ganguly N, Barad DH, Goldman KN, Kushnir
MM, Albertini DF, Grifo JA. Is there an androgen level threshold for aneuploidy risk in
infertile women? Reprod Biol Endocrinol 2015;6:13:38.
353. Shohat-Tal A, Sen A, Barad DH, Kushnir V, Gleicher N. Genetics of androgen
metabolism in women with infertility and hypoandrogenism. Nat Rev Endocrinol 2015;.
354. Barad DH, Kushnir VA, Albertini D, Gleicher N. CDC analysis of ICSI/autism:
association is not causation. Hum Reprod. 2015 Jul;30(7):1745-6. doi:
10.1093/humrep/dev104
355. Gleicher N, Kushnir VA, Barad DH. Why prospectively randomized clinical trials have
been rare in reproductive medicine and will remain so? Reprod Sci 2016;23(1):6-10.
356. Wu YG, Barad DH, Kushnir VA, Lazzaroni E, Wang Q, Albertini DF, Gleicher N.
Aging-related premature luteinization of granulosa cells is avoided by early oocyte
retrieval. J Endocrinol 2015;226(3)):167-80.
357. Kushnir VA, Barad DH, Albertini DF, Sarmon SK, Gleicher N. Outcomes of fresh and
cryopreserved oocyte donation. JAMA 2015;314(6)623-4.
Page 81
358. Gleicher N, Yu Y, Himaya E, Barad DH, Weghofer A, Wu YG, Albertini DF, Want VQ,
Kushnir VA. Early decline in functional ovarian reserve in young women with low
(CGGn<26) FMR1 gene alleles. Trans Res 2015;166(5):502-7.
359. Shohat-Tal A, Sen A, Barad DH, Kushnir VA, Gleicher N. More on the conversion of
DHEA to testosterone. Nat Rev Endocrinol 2015;11(9):521.
360. Kushnir VA, Halevy N, Barad DH, Albertini DF, Gleicher N. Relative importance of
AMH and androgens changes with aging among non-obese women with polycystic ovary
syndrome. J Ovarian Res 2015;8(1):45.
361. Lee HJ, Barad DH, Kushnir VA, Shohat-Tal A, Lazzaroni-Tealdi E, Wu YG, Gleicher N.
Rescue in vitro maturation (IVM) of immature oocytes in stimulated cycles in women
with low functional ovarian reserve (LFOR). Endocrine 2015;9 (1-7).
362. Gleicher N, Vega, Darmon SK, Weghofer A, Barad DH, Wu YG, Wang Q, Zhang L,
Albertini D, Kushnir VA. Live-birth rates in very poor prognosis patients who are
defined as poor responders under the Bologna criteria with nonelective single embryo,
two-embryo, and three or more embryos transferred. Fertil Steril 2015;104(6):1435-41.
363. Albertini, N Gleicher A detour in the quest for oogonial stem cells: methods matter. Nat
Med 2015;21(10):1126-7.
364. Lazzaroni-Tealdi E, Barad DH, Albertini DF, Yu Y, Kushnir VA, Russell H, Wu YG,
Gleicher N. Oocyte scoring enhances embryo-scoring in predicting pregnancy chances
with IVF where it counts most. PLoS ONE 2015;10(12:e014362.
365. Weghofer A, Barad DH, Darmon S, Kushnir VA, Gleicher N. What affects functional
ovarian reserve, thyroid function or thyroid autoimmunity? Reprod Biol Endocrinol
2016;14(1):26.
366. Kushnir VA, Barad DH, Albertini DF, Darmon SK, Gleicher N. Effect of Embryo
Banking on U.S. National Assisted Reproductive Technology Live Birth Rates. PLoS
One 2016;11(5):e0154620.
367. Gleicher N, Kushnir V, Albertini D, Barad DH. Improvements in IVF in women of
advanced age. J Endocrinol 2016;pii: JOE-16-0105. [Epub ahead of print]
368. Gleicher N, Kushnir VA, Barad DH. Risks of spontaneously and IVF-conceived
singleton and twin pregnancies differ, requiring reassessment of statistical premises
favoring elective single embryo transfer (eSET). Reprod Biol Endocrinol 2016;14(1):25.
369. Gleicher N, Kushnir VA, Weghofer A, Barad DH. The importance of adrenal
hypoandrogenism in infertile women with low functional ovarian reserve: a case study of
associated adrenal insufficiency. Reprod Biol Endocrinol 2016;0.599305555555556
370. Kushnir VA, Darmon SK, Albertini DF, Barad DH, Gleicher N. Effectiveness of in vitro
fertilization with preimplantation genetic screening: a reanalysis of United States assisted
reproductive technology data 2011-2012. Fertil Steril 2016;pii: S0015-0282(16)00140-0.
doi: 10.1016/j.fertnstert.2016.02.026. [Epub ahead of print]
371. Kushnir VA, Solouki S, Sarig-Meth T, Vega MG, Albertini DF, Darmon SK, Deligdisch
L, Barad DH, Gleicher N. Systemic Inflammation and Autoimmunity in Women with
Chronic Endometritis. Am J Reprod Immunol 2016;doi: 10.1111/aji.12508. [Epub ahead
of print]
372. Gleicher N. Randomised controlled trials on dehydroepiandrosterone supplementation in
female infertility still not conclusive. BJOG 2016;doi: 10.1111/1471-0528.13945. [Epub
ahead of print]
Page 82
373. Gleicher N, Kushnir VA, Barad DH. The impact of patient preselection on reported IVF
outcomes. J Assist Reprod Genet 2016;33(4):455-9.
374. Gleicher N, Seier K, Kushnir VA, Weghofer A, Wu YG, Wang Q, Albertini DF, Barad
DH. Associations between peripheral androgens and cortisol in infertile women. J Steroid
Biochem Mol Biol 2016;158:82-9.
375. Gleicher N, Kushnir VA, Barad DH. Randomized controlled trial of minimal stimulation
versus conventional in vitro fertilization. Am J Obstet Gynecol 2016;214(3):412-3.
376. Gleicher et al. How FSH and AMH reflect probabilities of oocyte numbers in poor
prognosis patients with small oocyte yields. Endocrine 2016;54(2):476-483.
377. Kushnir VA and Gleicher N. Fresh versus cryopreserved oocyte donation. Curr Opin
Endocrinol Diabetes Obes 2016;23(6):451-457.
378. Orvieto R and Gleicher N. Should preimplantation genetic screening (PGS) be
implemented to routine IVF practice? J Assist Reprod Genet 2016;33(11):1445-1448.
379. Gleicher N et al. Accuracy of preimplantation genetic screening (PGS) is compromised
by degree of mosaicism of human embryos. Reprod Biol Endocrinol 2016;14(1):514.
380. Gleicher N et al. In reference to 'Strategies to manage refractory endometrium: state of
the art 2016'. Reprod Biomed Online 2016;33(5):604.
381. Wu YG et al. Different effectiveness of closed embryo culture system with time-lapse
imaging (EmbryoScope(TM)) in comparison to standard manual embryology in good and
poor prognosis patients: a prospectively randomized pilot study. Reprod Biol Endocrinol
2016;14(1):49.
382. Vega M et al. Anti-mullerian hormone levels decline with the presence of
antiphospholipid antibodies. Am J Reprod Immunol 2016;76(4):333-337.
383. Barad DH et al. The importance of redundancy of functional ovarian reserve when
investigating potential genetic effects on ovarian function. J Assist Reprod Genet
2016;33(9):1157-1160.
384. Vega MG et al. IVF outcomes in average- and poor-prognosis infertile women according
to the number of embryos transferred. Reprod Biomed Online 2016;33(3):370-375.
385. Gleicher N et al. Definition by FSH, AMH and embryo numbers of good-, intermediate-
and poor-prognosis patients suggests previously unknown IVF outcome-determining
factor associated with AMH. J Transl Med 2016;14(1):172.
386. Sermon K et al. The why, the how and the when of PGS 2.0: current practices and expert
opinions of fertility specialists, molecular biologists, and embryologists. Mol Hum
Reprod 2016;22(8):845-857.
387. Hayes E et al. Intra-cellular mechanism of Anti-Müllerian hormone (AMH) in regulation
of follicular development. Mol Cell Endocrinol 2016;433:56-65.
388. Gleicher N et al. Response to comment on: Gleicher N et al., 2016. Reprod biol
endocrinol Sep 5;14(1):54. Reprod Biol Endocrinol 2017;15(1):23.
389. Gleicher N and Orvieto R. Is the hypothesis of preimplantation genetic screening (PGS)
still supportable? A review. J Ovarian Res 2017;10(1):21.
390. Gleicher N et al. Elective single-embryo transfer (eSET) reduces pregnancy rates and
should only be used in exceptional circumstances: FOR: The statistically flawed model of
eSET. BJOG 2017;124(5):755. 391. Kushnir VA et al. Age-Specific IVF Outcomes in Infertile Women With Baseline FSH Levels
≥20 mIU/mL. Reprod Sci 2017; epub ahead of print.
392. Gleicher N. Redirecting reproductive immunology research toward pregnancy as a period
of temporary immune tolerance. J Assist Reprod Genet 2017;124(5):755.
Page 83
393. Kushnir VA et al. Systematic review of worldwide trends in assisted reproductive
technology 2004-2013. Reprod Biol Endocrinol 2017;15(1):6.
394. Gleicher N et al. New PCOS-like phenotype in older infertile women of likely
autoimmune adrenal etiology with high AMH but low androgens. J Steroid Biochem Mol
Biol 2017;167:144-152.
395. Barad DH et al. Focus on recurrent miscarriage phenotypes. Fertil Steril 2017;107(1):64-
65.
396. Kushnir VA et al. Utilization of third-party in vitro fertilization in the United States. Am
J Obstet Gynecol 2017;216(3):266.e1-266.e10.
397. Kushnir VA et al. CDC-reported assisted reproductive technology live-birth rates may
mislead the public. Reprod Biomed Online 2017;35(2):161-164.
398. Adashi EY, Gleicher N. Is a Blanket Elective Single Embryo Transfer Policy Defensible?
Rambam Maimonides Med J 2017;8(2).
399. Barad DH et al. Association of skewed X-chromosome inactivation with FMR1 CGG
repeat length and anti-Mullerian hormone levels: a cohort study. Reprod Biol Endocrinol
2017;15(1):34.
400. Gleicher N et al. A single trophectoderm biopsy at blastocyst stage is mathematically
unable to determine embryo ploidy accurately enough for clinical use. Reprod Biol
Endocrinol 2017;15(1):33.
401. Gleicher N, Orvieto R. Is the hypothesis of preimplantation genetic screening (PGS) still
supportable? A review. J Ovarian Res 2017;10(1):21.
402. Barad DH, Darmon SK, Kushnir VA, Albertini DF, Gleicher N. Impact of
preimplantation genetic screening on donor oocyte-recipient cycles in the United States.
Am J Obstet Gynecol 2017; 217(5):576.
403. Orvieto R, Vanni VS, Gleicher N. The myths surrounding mild stimulation in vitro
fertilization (IVF). Reprod Biol Endocrinol 2017;15(1):48.
404. Kushnir VA, Seifer DB, Barad DH, Sen A, Gleicher N. Potential therapeutic applications
of human anti-Müllerian hormone (AMH) analogues in reproductive medicine. J Assist
Reprod Genet 2017; 34(9):1105-1113.
405. Shapiro AJ, Darmon SK, Barad DH, Albertini DF, Gleicher N, Kushnir VA. Effect of
race and ethnicity on utilization and outcomes of assisted reproductive technology in the
USA. Reprod Biol Endocrinol 2017;15(1):44.
406. Gonda KJ, Domar AD, Gleicher N, Marrs RP. Insights from clinical experience in
treating IVF poor responders. Reprod Biomed Online 2017;36(1):12-19.
407. Inhorn MC, Birenbaum-Carmeli D, Westphal LM, Doyle J, Gleicher N, Meirow D,
Raanani H, Dirnfeld M, Patrizio P. Medical egg freezing: the importance of patient-
centered approach to fertility preservation. J Assist Reprod Genet 2017;35(1):49-59.
408. Gleicher N, Kushnir VA, Barad DH. How PGS/PGT-A laboratories succeeded in losing
all credibility. Reprod Biomed Online 2018;37(2):242-245.
409. Inhorn MC, Birenbaum-Carmeli D, Westphal LM, Doyle J, Gleicher N, Meirow D,
Dirnfeld M, Seidman D, Kahane A, Patrizio P. Ten pathways to elective egg freezing: a
binational analysis. J Assist Reprod Genet 2018;35(11):2003-2011.
410. Roy S, Gandra D, Seger C, Biswas A, Kushnir VA, Gleicher N, Kumar TR, Sen A.
Oocyte-derived factors (GDF9 and BMP15) and FSH regulate AMH expression via
modulation of H3k27AC in granulosa cells. Endocrinology 2018;159(9):3433-3445.
Page 84
411. Inhorn MC, Birenbaum-Carmeli D, Birger J, Westphal LM, Doyle J, Gleicher N, Meirow
D, Dirnfeld M, Seidman D, Kahane A, Patrizio P. Elective egg freezing and its
underlying socio-demography: a binational analysis with global implications. Reprod
Biol Endocrinol 2018;16(1):70.
412. Inhorn MC, Birenbaum-Carmeli D, Westphal LM, Doyle J, Gleicher N, Meirow D,
Raanani H, Dirnfeld M, Patrizio P. Medical egg freezing: How cost and lack of insurance
cover impact women and their families. Reprod Biomed Soc Online 2018;5:82-92.
413. Gleicher N, Kushnir VA, Darmon SK, Albertini DF, Barad DH. Older women using their
own eggs? Issue framed with two oldest reported IVF pregnancies and a live birth.
Reprod Biomed Online 2018;37(2):172-177.
414. Gleicher N. Expected advances in human fertility treatments and their likely translational
consequences. J Transl Med 2018;16(1):149.
415. Gleicher N, Kushnir VA, Barad DH. Impact of androgen supplementation on the
follicular endocrine milieu in women with hypoandrogenism. Reprod Biomed Online
2018;36(6):719-720.
416. Wu YG, Barad DH, Kushnir VA, Wang Q, Zhang L, Darmon SK, Albertini DF, Gleicher
N. With low ovarian reserve, Highly Individualized Egg Retrieval (HIER) improves IVF
results by avoiding premature luteinization. J Ovarian Res 2018;11(1):23.
417. Meldrum DR, Adashi EY, Garzo VG, Gleicher N, Parinaud J, Pinborg A, Van Voorhis B.
Prevention of in vitro fertilization twins should focus on maximizing single embryo
transfer versus twins are an acceptable complication of in vitro fertilization. Fertil Steril
2018;109(2):223-229.
418. Gleicher N, Caplan AL. An alternative proposal to the destruction of abandoned human
embryos. Nat Biotechnol 2018;36(2):139-141.
419. Kushnir VA, Darmon SK, Barad DH, Gleicher N. Degree of mosaicism in trophectoderm
does not predict pregnancy potential: a corrected analysis of pregnancy outcomes
following transfer of mosaic embryos. Reprod Biol Endocrinol 2018;16(1):6.
420. Gleicher N, Kushnir VA, Darmon SK, Wang Q, Zhang L, Albertini DF, Barad DH.
Suspected ontogeny of a recently described hypo-androgenic PCOS-like phenotype with
advancing age. Endocrine 2018;59(3):661-676.
421. Kushnir VA, Darmon SK, Barad DH, Gleicher N. New national outcome data on fresh
versus cryopreserved donor oocytes. J Ovarian Res 2018;11(1):2.p
422. Kushnir VA, Darmon SK, Barad DH, Gleicher N. Observational retrospective study of
US national utilisation patterns and live birth rates for various ovarian stimulation
protocols for in vitro fertilisation. BMJ Open 2018;8(11):e023124.
423. Kushnir VA, Darmon SK, Barad DH, Weghofer A, Gleicher N. Effects of
dehydroepiandrosterone (DHEA) supplementation on sexual function in premenopausal
infertile women. Endocrine 2018; Epub ahead of print.
424. Shapiro AJ, Darmon SK, Barad DH, Gleicher N, Kushnir VA. Vitamin D levels are not
associated with ovarian reserve in a group of infertile women with a high prevalance of
diminished ovarian reserve. Fertil Steril 2018;110(4):761-766.e1.
425. Rosenwaks Z, Handyside AH, Fiorentino F, Gleicher N, Paulson RJ, Schattman GL,
Scott RT Jr, Summers MC, Treff NR, Xu K. The pros and cons of preimplantation
genetic testing for aneuploidy: clinical and laboratory perspectives. Fertil Steril 2018; 110(3):353-361.
Page 85
426. Gleicher N, Kushnir VA, Barad DH. Unexplained infertility. Lancet 2018; 392(10157):1516-1517.
427. Patrizio P, Shoham G, Shoham Z, Leong M, Barad DH, Gleicher N. Worldwide live
births following the transfer of chromosomally "Abnormal" embryos after PGT/A: results
of a worldwide web-based survey. J Assist Reprod Genet 2019;36(8):1599-1607.
428. Inhorn MC, Birenbaum-Carmeli D, Westphal LM, Doyle J, Gleicher N, Meirow D,
Dirnfeld M, Seidman D, Kahane A, Patrizio P. Patient-centered elective egg freezing: a
binational qualitative study of best practices for women's quality of care. J Assist Reprod
Genet 2019;36(6):1081-90.
429. Gleicher N, Barad DH. Assessing in-vitro fertilization at age 40 years. Lancet
2019;393(10177):1181-3.
430. Capalbo A, Chokoshvili D, Dugoff L, Franasiak J, Gleicher N, Pennings G, Simon C.
Should the reproductive risk of a couple aiming to conceive be tested in the contemporary
clinical context? Fertil Steril 2019;111(2):229-38.
431. Wang Q, Barad DH, Darmon SK, Kushnir VA, Wu YG, Lazzaroni-Tealdi E, Zhang L,
Albertini DF, Gleicher N. Reduced RNA expression of the FMR1 gene in women with
low (CGGn<26) repeats. PLoS ONE 2018;13(12): e0209309.
432. Gleicher N, Barad DH. Not even noninvasive cell-free DNA can rescue preimplantation
genetic testing. Proc Natl Acad Sci USA 2019; Epub ahead of print.
433. Gleicher N, Kushnir VA, Barad DH. Worldwide decline of IVF birth rates and its
probable causes. Hum Reprod Open 2019; 2019(3):hoz017.
434. Kushnir VA, Darmon SK, Barad DH, Weghofer A, Gleicher N. Effects of
dehydroepiandrosterone (DHEA) supplementation on sexual function in premenopausal
infertile women. Endocrine. 2019;63(3):632-638. doi:10.1007/s12020-018-1781-3
435. Orvieto R, Kirshenbaum M, Gleicher N. Is Embryo Cryopreservation Causing
Macrosomia-and What Else?. Front Endocrinol (Lausanne). 2020;11:19. Published 2020
Jan 28.
436. Orvieto R, Gleicher N. Preimplantation genetic testing for aneuploidy (PGT-A)-finally
revealed. J Assist Reprod Genet. 2020;37(3):669-672. doi:10.1007/s10815-020-01705-w
437. Weghofer A, Barad DH, Darmon SK, Kushnir VA, Albertini DF, Gleicher N. Euploid
miscarriage is associated with elevated serum C-reactive protein levels in infertile
women: a pilot study. Arch Gynecol Obstet. 2020;301(3):831-836. doi:10.1007/s00404-
020-05461-1
438. Mochizuki L, Gleicher N. The PGS/PGT-A controversy in IVF addressed as a formal
conflict resolution analysis. J Assist Reprod Genet. 2020;37(3):677-687.
doi:10.1007/s10815-020-01688-8
439. Blumenfeld Z, Gleicher N, Adashi EY. Transiently increased risk of breast cancer after
childbirth: implications for fertility treatments and surrogacy. Hum Reprod.
2020;35(6):1253-1255. doi:10.1093/humrep/deaa102
440. Gleicher N, Barad DH, Adashi EY. Why is use of donor eggs not viewed as treatment
failure? A call for improvements in treatments with autologous oocytes. J Assist Reprod
Genet. 2020;37(7):1583-1588. doi:10.1007/s10815-020-01847-x
441. Gleicher N, Darmon S, Molinari E, Zhang L, Hu J, Albertini DF, Barad DH. A form of
secondary ovarian insufficiency (SOI) due to adrenal hypoandrogenism as new infertility
diagnosis. Endocrine. 2020 Oct 2. doi: 10.1007/s12020-020-02512-0. Epub ahead of
print. PMID: 33009651.
Page 86
442. Gleicher N. The COVID-19 pandemic through eyes of a NYC fertility center: a unique
learning experience with often unexpected results. Reprod Biol Endocrinol. 2020 Nov
4;18(1):105. doi: 10.1186/s12958-020-00663-3. PMID: 33148264; PMCID:
PMC7609825.
443. Gleicher N, Weghofer A, Darmon SK, Barad DH. Rate of rebound in follicle growth after
cessation of ovarian stimulation in initial non-responders: a prospective cohort study. J
Ovarian Res. 2021 Jan 9;14(1):11. doi: 10.1186/s13048-021-00765-5. PMID: 33422140;
PMCID: PMC7797149.
444. Gleicher N, Patrizio P, Brivanlou A. Preimplantation Genetic Testing for Aneuploidy - a
Castle Built on Sand. Trends Mol Med. 2021; 27(9):731-742.
445. Gleicher N et al. Commentary on two recently published formal guidelines on
management of “mosaic” embryos after preimplantation genetic testing for aneuploidy
(PGT-A). Rep Biol Endo 2021; 19(1):23.
446. Jianjun H et al. Predictive value of cytoplasmic granulation patterns during in vitro
fertilization in metaphase II oocytes: Part I, poor-prognosis patients. Fertil Steril 2021;
116(2):431-443.
447. Gleicher N et al. Time associations between U.S. birth rates and add-Ons to IVF practice
between 2005–2016. Rep Biol Endo 2021; 19(1):110.
448. Brivalou AH, Rivron N, Gleicher N. How will our understanding of human development
evolve over the next 10 years. Nat Commun 2021; 12(1):4614.
449. Brivanlou AH, Gleicher N. The evolution of our understanding of human development
over the last 10 years. Nat Commun 2021; 12:4615.
450. Jianjun Hu et al. Predictive value of cytoplasmic granulation patterns during in vitro
fertilization in metaphase II oocytes: part II, donor oocyte cycles. Fertil Steril 2021;
116(5):1330-1340
451. Gleicher N and Orvieto R. Transferring more than 1 embryo simultaneously is justifiable
in most patients. Reproductive BioMedicine Online 2021; 44(1):1-4.
452. Gleicher N, Darmon SK, Molinari E, Patrizio P, Barad DH. Importance of IGF-I levels in
IVF: potential relevance for growth hormone (GH) supplementation. J Assist Reprod
Genet 2022; 39:409-416.
453. Gleicher N, Patrizio P, Orvieto R. How Not to Introduce Laboratory Tests to Clinical
Practice: Preimplantation Genetic Testing for Aneuploidy. Clin Chem 2022; 68(4):501-
503.
454. Gleicher N, Albertini DF, Patrizio P, Orvieto R, Adashi EY. The uncertain science of
preimplantation and prenatal genetic testing. Nat Med 2022; 28:442-444.
455. Von Schondorf-Gleicher A, Mochizuki L, Orvieto R, Patrizio P, Caplan AS, Gleicher N.
Revisiting selected ethical aspects of current clinical in vitro fertilization (IVF) practice. J
Assist Reprod Genet 2022; Online ahead of print.
Abstracts
1. Beers, P, David S, Reyniak J, Gleicher N: Antibodies to autologous gonadotrophins.
Proceedings of the Society for Gynecologic Investigations, 27th Annual Meeting; Denver,
Colorado, March l9-22, l980.
2. Siegel I, Gleicher N: Red cell immune adherence (RCIA) in the rabbit: An animal model
for the study of red cell immunocyte function. Clin Res l98l; 29:530A.
Page 87
3. Smolen J, Chuset T, Leierson W, Weintraub B, Gleicher N, Steinberg A: T-cell
phenotypes in normal pregnancy and in pregnant patients with autoimmune diseases.
Am J Reprod Immunol l98l; l:273.
4. Gleicher N, Adelsberg B, Siegel I, Siegel F, Liu TL: Immune complex disease in
pregnancy. Idem l98l; l:273.
5. Siegel I, Liu TL, Gleicher N: Red cell immune adherence (RCIA) in the developing
rabbit. Idem l98l; l:275.
6. Adelsberg B, Liu TL, Phillips R, Cederquist L, Siegel I, Gleicher N: Immune complexes
in all stages of pregnancy. Idem l98l; l:278.
7. Toder V, Nebel L, Gleicher N: Interferon activation of natural killer (NK) lymphocyte
precursors in human pregnancy. Idem 1982; 2:169.
8. Siegel I, Lubicz, S, Deppe G, Liu TL, Gleicher N: Serum dependent regulation of RCIA
(red cell immune adherence) by oxygen. Idem 1982; 2:184.
9. Siegel I, Liu TL, Gleicher N: Enhanced red cell immune function in early development.
Idem 1982; 2:184.
10. Toder V, Nebel H, Elrad H, Blank M, Gleicher N: Human natural killer (NK) activity:
Regulatory effect of some pregnancy markers. Idem 1982; 2:169.
11. Gleicher N, Siegel I: Additional evidence for an immunologic etiology of the pre-
eclampsia/eclampsia syndrome (EPH gestosis). Clin Exp Hypertension 1982; B1:215.
12. Gleicher N, Toder V: Comparison of natural killer activity in normal pregnancy EPH-
gestosis. Idem 1982; B1:218.
13. Gleicher N: Immunologic factors in hypertension of pregnancy. Idem 1982; B1:348.
14. Deppe G, Lubicz S, Siegel I, Liu TL, Gleicher N: The effect of corticosteroids on the red
cell immune adherence (RCIA) in rabbit. Proceedings, ASCO C-151, 1982; 38.
15. Siegel I, Liu TL, Gleicher N: The effects of lipids upon the immune system. The
immune adherence connection. Fed Proc 1983; 43:1186.
16. Gleicher N, Dmowski P, Siegel I, Liu TL, Toder V: Peripheral white blood cells subsets
in endometriosis. Am J Reprod Immunol 1983; 3:192-193.
17. Siegel I, Liu TL, Gleicher N: Regulation of red cell immune adherence (RCIA) and
neutrophil immune adherence (NIA) by dietary lipids. Idem 1983; 3:197.
18. Siegel I, Liu TL, Elrad H, Gleicher N: Defense against infection - A selective role for
unsaturated fatty acid. Idem 1983; 3:197.
19. Siegel I, Liu TL, Wissner R, Gleicher N: Red cell immune adherence (RCIA) co-factors
in adult and cord serums. Idem 1983; 3:197.
20. Friberg J, Gleicher N: High dose menopausal gonadotropin therapy for successful
ovulation induction for IVF program in perimenopausal females. J Vitro Fert Embryo
Transfer 1984; 1:109.
21. Gleicher N, Friberg J: The effect of aspiration needles on oocyte recovery rates and the
need for follicular irrigation. Idem 1984; 1:110.
22. Gleicher N: Cesarean section rates in the USA: The short term failure of the Consensus
Development Conference. Proceedings of the 31st Annual Meeting of the Society for
Gynecologic Investigations, San Francisco, March 21-24, 1984, p.40.
23. Siegel I, Dudkiewicz A, Friberg J, Gleicher N: Chain reaction (CR) fatty acid toxicities
affecting human red cells and human sperm cells. Am J Reprod Immunol 1984; 5:96.
24. Siegel I, Elrad H, Gleicher N: Toxicity of term amniotic fluid to human red cells. Idem
1984; 5:98.
Page 88
25. Gleicher N: Autoimmunity and pregnancy. Idem 1984; 6:55.
26. Siegel I, Dudkiewicz A, Friberg J, Gleicher N: The effect of free fatty acids on human
sperm cells. Idem 1984; 6:59.
27. Siegel I, Gleicher N: The selective toxicities of non-saturated fatty acids upon mammary
ascites tumor cells. Idem 1984; 6:74.
28. Confino E, Friberg J, Dudkiewicz A, Gleicher N: Intrauterine inseminations with washed
human spermatozoa in couples with circulating sperm agglutinating antibodies. Am J
Reprod Immunol Microbiol 1985; 7:138-139.
29. Siegel I, Dudkiewicz A, Friberg J, Suarez M, Gleicher N: The effect of unsaturated free
fatty acids (FFA) on sperm motility. Idem 1985; 7:139.
30. Confino E, Demir R, Friberg J, Gleicher N: Does cyclic hCG secretion indicate embryo
loss in in vitro fertilization? J Vitro Fert Embryo Transfer 1986; 3:74.
31. Gleicher N, El-Roeiy: Autoantibodies in follicular fluids of IVF patients. Idem 1986;
3:71.
32. El-Roeiy A, Gleicher N, Isenberg D, Kennedy R, Goldenberg M, Mashiach S, Shoenfeld
Y: Autoantibodies and common anti-DNA idiotype in pregnancies of mothers with
systemic lupus erythematous. J Reprod Immunol 1986; Supplement:99.
33. Gleicher N, El-Roeiy A, Confino E, Friberg J: Abnormal antibodies in endometriosis: Is
endometriosis an autoimmune disease? Idem 1986; Supplement:99.
34. Confino E, El-Roeiy A, Demir R, Friberg J, Gleicher N: Thromboelastogram, lupus
anticoagulant and anti-nuclear antibodies in patients with endometriosis and repeated
abortions. Idem 1986; Supplement:99.
35. Confino E, Demir R, Friberg J, Gleicher N: Does cyclic hCG secretion indicate embryo
loss in in vitro fertilization? An international collaborative study. Fertil Steril 1986;
Supplement:68.
36. Gleicher N, El-Roeiy A, Friberg J, Confino E, Dudkiewicz A: Reproductive failure due
to abnormal autoantibodies. II:Wastage. 12th World Congress on Fertility and Sterility
Handbook, 1986, p 732.
37. Confino E, Friberg J, Gleicher N: A newly developed stirrable gift catheter (Friberg
Catheter). 12th World Congress on Fertility and Sterility Handbook, 1986, p 754.
38. Confino E, Friberg J, Gleicher N: Transcervical balloon tuboplasty (TBT): A new
method to recanalize obstructed fallopian tubes. 12th World Congress on Fertility and
Sterility Handbook, 1986, p 732.
39. Confino E, Friberg J, Gleicher N: Transcervical balloon tuboplasty (TBT). Fertil Steril
1986; Supplement:45.
40. Confino E, Vermesh M, Boler L, Friberg J, Gleicher N: Acute salpingitis in sterilized
women. Adv Contraception 1986; 2:282.
41. Gleicher N, El-Roeiy A, Friberg J, Confino E, Dudkiewicz A: Reproductive failure due
to abnormal autoantibodies. II: Wastage. 12th World Congress on Fertility and Sterility
Handbook, 1986, p 732.
42. Confino E, Friberg J, Gleicher N: A newly developed stirrable gift catheter (Friberg
Catheter). 12th World Congress on Fertility and Sterility Handbook, 1986, p 754.
43. Myers S, Gleicher N: A prospective program to reduce cesarean section rates: A
preliminary report. Society of Perinatal Obstetricians, 1986, p 300.
Page 89
44. El-Roeiy A, Myers S, Gleicher N: Autoantibodies in normal pregnancy: Comparison to
non-pregnant patients. Proceedings of the Seventh Annual Meeting of the Society of
Perinatal Obstetricians, 1987, p 301.
45. Dudkiewicz A, Friberg J, Confino E, Madanes A, Gleicher N: The relationship between
46. El-Roeiy A, Myers S, Gleicher N: A comparison of the autoantibody profile of
hypertensive and normotensive pregnancy. Am J Reprod Immunol Microbiol 1987; 14:1.
47. Gleicher N, El-Roeiy A, Confino E, Friberg J: Autoantibodies in patients with
unexplained infertility and recurrent pregnancy loss: The reproductive autoimmune
failure syndrome (RAFS). Idem 1987; 14:2.
48. Confino E, Friberg J, Gleicher N: Cervical mucus-uterine fluid cross penetration of
spermatozoa in patients with circulating sperm agglutinating antibodies. Idem 1987; 14:4.
49. El-Roeiy A, Friberg J, Valessini G, Shoenfeld Y, Kennedy R, Gleicher N: The presence
of autoantibodies and common idiotypes in sera and seminal plasma of patients with anti-
sperm antibodies. Idem 1987; 14:4.
50. El-Roeiy A, Dmowski W, Friberg J, Binor Z, Gleicher N: Habitual abortion versus
endometriosis. Fertil Steril 1987; supplement:54.
51. Confino E, Friberg J, Gleicher N: Preliminary experience with transcervical balloon
tuboplasty (TBT). Idem 1987; supplement:66.
52. Confino E, Gleicher N, Friberg J: Cervical mucus-uterine fluid cross penetration of
spermatozoa. Idem 1987; supplement:68.
53. El-Roeiy A, Myers S, Gleicher N: A comparison of the autoantibody profile of
hypertensive and normotensive pregnancy. Am J Reprod Immunol Microbiol 1987; 14:1.
54. Gleicher N, El-Roeiy A, Confino E, Friberg J: Autoantibodies in patients with
unexplained infertility and recurrent pregnancy loss: The reproductive autoimmune
failure syndrome (RAFS). Idem 14:2, 1987.
55. Gleicher N, Harlow L, El-Roeiy A: The correlation between autoantibodies in women
with reproductive failure. Idem 1988; 16:3.
56. Gleicher N, Harlow L, El-Roeiy A: The correlation between lupus anticoagulant and
autoantibodies. Idem 1988; 16(3) :32-37.
57. Dudkiewicz A, Friberg J, Confino E, Gleicher N: Comparison of semen parameters from
sequentially produced ejaculates. Fertil Steril 1988; supplement: S109.
58. Confino E, Harlow L, Friberg J, Gleicher N: The correlation between serum and
peritoneal fluids autoantibody levels in patients with endometriosis. Am J Reprod
Immunol Microbiol 1988; 16:3.
59. Confino E, Friberg J, Gleicher N: Conservative management of interstitial pregnancy.
1988 Fertil Steril supplement: S109.
60. Dudkiewicz A, Friberg J, Confino E, Gleicher N: Comparison of semen parameters from
sequentially produced ejaculates. Annual Meeting of the American Fertility Society
1988; Program supplement:175.
61. Confino E, Friberg J, Gleicher N: Conservative management of interstitial pregnancy.
Idem 1988; Program supplement:197.
62. Myers S, Gleicher N: A successful program to lower cesarean section rates. Proceeding
of The Society of Perinatal Obstetricians 1988; Program supplement:125.
63. Gleicher N, El-Roeiy A: Autoantibody profiles in normal female and males. Proceeding
of The Annual Meeting of The Society for Gynecologic Investigation, Salt Lake City,
Utah, September 22-21, 1988.
Page 90
64. Gleicher N, El-Roeiy A, Confino E, Friberg J: Reproductive failure due to
autoantibodies: Unexplained infertility and pregnancy wastage. 56th Annual Meeting of
CAOG, Salt Lake City, Utah, September 22, 1988.
65. Tur-Kaspa I, Confino E, Friberg J, Dudkiewicz A, Novotny M, Gleicher N: A GnRH-
agonist/hMG/hCG stimulation protocol for IVF increases pregnancy rates by widening
the implantation window. Proceedings of The Annual Meeting of The Society for
Gynecologic Investigation, March 15-18, 1989, San Diego, CA; 404:303.
66. Confino E, DeCherney A, Corfman R, Coulam C, Robinson E, Friberg J, Haas G, Katz E,
Tur-Kaspa I, Vermesh M, Gleicher N: Transcervical balloon tuboplasty: A multicenter
study. Idem O-004:S2.
67. Confino E, Gleicher N: Peritoneal fluid autoantibodies in endometriosis. Idem 499:31.
68. Tur-Kaspa I, Confino E, Friberg J, Dudkiewicz A, Novotny M, Gleicher N: GnRH-
agonist/ HMG/ HCG stimulation for IVF increased endometrial receptiveness for
69. Tur-Kaspa I, Dudkiewicz A, Friberg J, Confino E, Logan R, Gleicher N: Pooled
sequential ejaculates - a way to increase number of motile spermatoza from
oligozoospermic males. Idem P-011:S66.
70. Dudkiewicz A, Novotny M, Friberg J, Gleicher N: Biochemical enhancement of sperm
penetration: Effects on subsequent development. Idem p 54.
71. Tur-Kaspa I, Confino E, Zilberstein M, Friberg J, Dudkiewicz A, Gleicher N: The
implantation window and early pregnancy loss. Proceedings of the International Meeting
on Pregnancy Loss Tel- Aviv, Israel, April 1989; p 21.
72. Tur-Kaspa I, Confino E, Zilberstein M, Friberg J, Dudkiewicz A, Gleicher N: Low
pregnancy wastage in IVF-ET pregnancies achieved with a GnRH-Agonist/hMG/hCG
stimlation protcol. Idem p 21.
73. Toder, V, Kochavi E, Altaratz H, Shepshelovic J, Gleicher N: Steroid hormones regulate
functioning of growth factors at materno-fetal interface. Idem.
74. Zilberstein M, Solan N, Choh J, Gleicher N, Das C: Antibodies to epidermal growth
factor receptor (EGF) inhibits basal and EFG stimulated hCG production in human term
placental cells. Proceedings of The Endocrine Society Meeting Prout’s Neck, Maine,
June 1989; 1037:282.
75. Gleicher N, Harlow L, Dudkiewicz A: A mouse model for the reproductive autoimmune
failure syndrome (RAFS) 1. Immunization with phospholipid antigens. 8th Annual
Symposium of The American Society for the Immunology of Reproduction Portland,
Maine, June 14-18, 1989; p 80.
76. Gleicher N, Harlow L, Dudkiewicz A: A mouse model for the reproductive autoimmune
failure syndrome (RAFS) 2. Effects on fertility. Idem p 81.
77. Gleicher N, Harlow L, Dudkiewicz A: A mouse model for the reproductive autoimmune
failure syndrome (RAFS) 3. The response to pregnancy. Idem p 81.
78. Zilberstein M, Solan N, Das C, LeRoith D, Gleicher N, Catt K: Regulation of insulin-
like growth factor (IGF) gene expression in cultured cytotrophoblasts. Proceedings of
The Society for The Study of Reproduction (SSR) Meeting San Francisco, CA, August
1989; 74:72.
79. Myers S, Gleicher N: The Mount Sinai Cesarean Section Reduction Program: An update
and recommendations. Proceedings of The 117th Annual Meeting for The American
Public Health Association Chicago, IL, October 22-26, 1989.
Page 91
80. Zilberstein M, Puryear T, Gibori G, Gleicher N: Epidermal growth factor receptor (EGF-
R) gene expression in cultured human trophoblast cells. Proceedings of The 45th Annual
Meeting of The American Fertility Society San Francisco, CA, November 11-16, 1989;
O-027:S11.
81. Tur-Kaspa I, Confino E, Logan R, Myers S, Dudkiewicz A, Friberg J, Gleicher N: The
effect of sequential ejaculation on total motile sperm count in normozoospermic and
oligozoospermic males.Idem p S66.
82. Confino E, DeCherney A, Corfman R, Coulam C, Robinson E, Friberg J, Haas G, Katz E,
Tur-Kaspa I, Vermesh M, Gleicher N: Transcervical Balloon Tuboplasty - A multicenter
study. Price paper of the General Program. Idem O-004:S2.
83. Confino E, Tur-Kaspa I, Gleicher N: Opening pressure of normal and proximally
obstructed fallopian tubes. Idem O-016:S7.
84. Confino E, Tur-Kaspa I, Friberg J, Gleicher N: Sonographic Transcervical Balloon
Tuboplasty. Idem O-129:S54.
85. Confino E, DeCherney A, Corfman R, Coulam C, Robinson E, Friberg J, Haas G, Katz E,
Tur-Kaspa I, Vermesh M, Gleicher N: Transcervical Balloon Tuboplasty: Description of
a technique to recanalize proximal tubal obstruction. A video presentation. Idem FP-
03:S161.
86. Zilberstein M, Harlow L, Gleicher N: Human Sera containing anti-phospholipid
autoantibodies (APA) inhibit phospholipase induced hCG secretion in human term
placenta villi explants. Proceedings of the 46th Annual Meeting of the American Fertility
Society Washington, D.C., October 13-18, 1990; 0-047:S20.
87. Confino E, Tur-Kaspa I, DeCherney A, Corfman R, Coulam C, Robinson E, Haas G,
Katz E, Vermesh M, Gleicher N: Follow-up of the Multicenter Transcervical Balloon
Tuboplasty (TBT) Study. Idem 0-091:S39.
88. Confino E, Tur-Kaspa I, Gleicher N: Selective ultrasound salpingography (SVS). Idem
P-105:S109.
89. Dudkiewicz A, Confino E, Friberg J, Tur-Kaspa I, Novotny M, Wright J, Gleicher N:
What can we learn from chemical pregnancies. Idem P-218:S156.
90. Gleicher N: Advances in reproductive immunology. Keio J Med 1990; 39-119.
91. Gleicher N, Confino E, Corfman R, Coulam C, DeCherney A, Haas G, Katz E, Robinson
E, Tur-Kaspa I, Vermesh M: Transcervical balloon tuboplasty: Multicenter Conclusions
and follow up. Proceedings of the 47th Annual Meeting of the American Fertility Society
Orlando, Florida, October 21-24, 1991 0-103:545.
92. Gleicher N, Parrilli M, Redding L, Pratt D: Hysterosalpingography (HSG) and Selective
Salpingography (SS) as therapeutic procedures. Idem P-066;S142.
93. Gleicher N, Dudkiewicz A, Parrilli M, Pratt D: Do low luteal phase estradiol (E) levels
prevent implantation in IVF cycles? Idem. p 204, S170.
94. Gleicher N, Pratt D, Kaberlein G, Dudkiewicz A: Danazol does not suppress sperm
antibodies in males. Twelfth National Meeting of the American Society for the
Immunology of Reproduction, Charleston, South Carolina; June 10-13, 1992, Am J
Reprod Immunol 27:51.
95. Mathur S, Chihal H, Isaacson K, Gleicher N, Patrick R, Bleiler J: Endometrial
autoimmunity in endometriosis: Immunogenicity and specificity of the target antigens.
Idem p 132.
Page 92
96. Gleicher N, Pratt D, Kaberlein G, Honea K, Dudkiewicz A: The Correlation of IL-4 and
IL-6 levels to the presence of autoantibodies in infertile females. Idem p 137.
97. Gleicher N, Liu HC, Rosenwaks Z, Pratt D: Antibody profiles as predictor of IVF
success. 48th Annual Meeting of the American Fertility Society New Orleans, Louisiana;
November 2-5, 1992, 0-087, S39.
98. Gleicher N, Parrilli M, Pratt D: A trial guide of wire cannulation as treatment of
proximal tubal occlusion. Idem. P-179, S101.
99. Gleicher N, Redding L, Gurniak R, Parrilli M, Pratt D: The presentation of ampullary
tubal pregnancies during salpingography. Idem. P-189, S103.
100. Gleicher N: Immunologic theories of endometriosis: Role of humoral immunity. VIII
World Congress on Human Reproduction Joint IV World Conference on Fallopian Tube
in Health and Disease. April 4-9, 1993. SY04-6.
101. Gleicher N: Immune dysfunction - A potential target for treatment in endometriosis. 4th
World Congress on Endometriosis, Salvador, Bahia, Brazil, May 26, 1994. Program.
102. Karande V, Pratt D, Rabin D, Gleicher N: Elevated Tubal Perfusion Pressures (TP)
During Selective Salpingography (SS) Are Highly Suggestive of Tubal Endometriosis.
50th Annual Meeting of the American Fertility Society, November 5-10, 1994.
103. Dudkiewicz A, Kaberlein G, Favero L, Novotny M, Pratt D, Karande V, Levrant S,
Morris R, Minhas B, Gleicher N: Do increasing sperm concentrations effect abnormal
fertilization rates within current IVF stimulation regimens? (Abstract OC84) IXth World
Congress on In Vitro Fertilization and Assisted Reproduction, Vienna, Austria, April 3-7,
1995. J Assist Reprod Genet; Supplement 1995; 12:47S.
104. Karande V, Pratt D, Dudkiewicz A, Gleicher N: Estradiol/progesterone substitution in
the luteal phase improves pregnancy rates in stimulated cycles Fertil Steril Program
Supplement (Abstract OC208). 1995 Idem; 12:78S.
105. Morris R, Gleicher N, Pratt D, Dudkiewicz A, Karande V, Levrant S, Minhas B: Egg
factor: Is intracytoplasmic sperm injection (ICSI) efficacious therapy? Fertil Steril
Program Supplement (Abstract OC225). 1995 Idem; 12:83S.
106. Gleicher N: What infertility patients think about multiple conceptions: Is it time to
reevaluate current practice patterns? Fertil Steril Program Supplement (Abstract PS73)
1995 Idem; 12:P12S.
107. Dudkiewicz A, Kaberlein G, Zhu Y, Dudkiewicz A, Novotny M, Gleicher N: A novel
method of centralized semen analysis from a satellite office high-resolution video
recording Fertil Steril Program Supplement (Abstract OC374) 1995 Idem; 12:P120S.
108. Morris R, Gleicher N, Pratt D, Dudkiewicz A, Karande V, Levrant S, Minhas B:
Intracytoplasmic Sperm Injection (ICSI) Is Only Beneficial When Fertilization Failure Is
Due To Sperm Defects: American Society for Reproductive Medicine, Seattle WA,
October 7-12, 1995 (Abstract 0-160) Fertil Steril Program Supplement S79.
109. Morris R, Dudkiewicz A, Gleicher N: The Presence of Autoantibodies (ABS) Does Not
Predict Elevations in Follicle Stimulating Hormone (FSH) Fertil Steril Program
Supplement (Abstract P219) 1995 Idem; S193.
110. Cusick W, Buttino L, Vintzileos A, Gleicher N: Fetal down syndrome detection: A cost
analysis of alternative screening programs Fertil Steril Program Supplement (Abstract 90)
Am J Obstet Gynecol 1996;174(1)part 2:338.
111. Karande V, Rinehart J, Pratt D, Gleicher N: Is the inadvertent administration of
leuprolide acetate in early human pregnancy truly associated with normal outcomes? The
Page 93
Pacific Coast Fertility Society, April 17-21, 1996 (Abstract P-34) Fertil Steril Program
Supplement. a27.
112. Gleicher N, Karande V, Pratt D, Morris R, VanderLaan B: Surgical Utilization and
113. Rao R, Karande V, Balin M, Levrant S, Morris R, Pratt D, Ferguson R, Gleicher N: The
114. Morris R, Ferguson R, Dudkiewicz A, Brown T, Minhas B, Rao R, Balin M, Levrant
115. Morris R, Ferguson R, Weing C, Dudkiewicz A, Gleicher N: Single Follicle Simulating
116. Levrant S, Ferguson R, Karande V, Pratt D, Morris R, Rao R, Balin M, Dudkiewicz A,
Gleicher N: Cycle Parameters Predictive of Multiple Pregnancy Risk in Women
Undergoing COII with Gonadotropins. Idem
117. Levrant S, Ferguson R, Rinehart J, Karande V, Pratt D, Rao R, Balin M, Gleicher N:
Multivariate Logistic Analysis of Factors Predictive of Clinical Pregnancy in Women
Undergoing Gonadotropin Ovulation Induction. Idem.
118. Gleicher N, Vanderlaan B: Victim of Ones Own Success: Selective Patient Enrollment in
a Capitated Managed Care Infertility Program as a Consequence of High Patient
Satisfaction. Idem.
119. Morris R, Ewing C, Carey R, Dudkiewicz A, Gleicher N: Prevalence and Importance of
Occult Ovarian Failure in Oocyte Donors. Idem.
120. Rao R, Karande V, Balin M, Levrnt S, Morris R, Pratt D, Ferguson R, Gleicher N: The
Association of Cytomegalovirus (CMV) with Immunological Abnormalities in a Female
Infertility Population Undergoing ART. Idem.
121. Karande V, Rinehart J, Morris R, Miller C, Gleicher N: Improved Pregnancy Rates in
Poor Responder Patients with Cessation of Gonadotropin Releasing Hormone Agonist
(GnRH-a) Down-Regulation Prior to Stimulation with High Dosage of Gonadotropins, J
Assist Reprod Genetics, 1997; 14: 62S.
122. Wang L, Cui H, Roussev R, Dudkiewicz A, Gleicher N: “Mosaicism” Artifact in
Fluorescent In-Situ Hybridization in Human Leukocyte Nuclei with X/Y Chromosome
and 21-DNA Probes, J Assist Reprod Genetics, 1997; 14: 87S.
123. Cui H, Matthews C, Rudzki Z, Wang L, Dudkiewicz A, Gleicher N: Diagnosis of Sickle
Cell Anemia Following Amplification of the Whole B-Globin Gene for Preimplantation
Diagnosis, J Assist Reprod and Genetics, 1997; 14: 89S.
124. Karande V, Rinehart J, Morris J, Gleicher N: Does the Clomiphene Challenge Test
(CCT) have any Value in Screening Poor Responder Patients Undergoing IVF-ET? J
Assist Reprod Genetics, 1997; 14: 211S.
125. Levrant S, Wang L, Miller C, Rinehart J, Karande V, Coulam C, Pratt D, Gleicher N:
Human Leukocyte Antigen DQA1 Genotyping in Women with Endometriosis, 17th
ASRI Meeting, Am J Reprod Immunol, 1997; 37.
126. Karande V, Korn A, Morris R, Rao R, Balin M, Rinehart J, Larner B, Dohn K, Gleicher
N: A Prospective Randomized Trial Assessing Outcome and Cost of IVF as a First
Choice Treatment versus a Traditional Infertility Treatment Algorithm, 53rd ASRM
Annual Meeting Program Supplement Fertil Steril, 1997; O-078: S35.
127. Levrant S, Wang L, Coulam C, Larner B, Miller C, Rinehart J, Karande V, Pratt D,
Gleicher N: Evidence for Human Leukocyte Antigen DQA1 Association with with
Endometriosis. Abstract from the 53rd ASRM Annual Meeting Program Supplement,
Fertil Steril 1997; P-005: S94.
Page 94
128. Karande V, Coulam C, Morris R, Gleicher N: A Prospective Comparison of Imaging
versus Endoscopic Techniques for the Evaluation of the Infertile Patient. Abstract from
the 54th ASRM Annual Meeting Program Supplement, Fertil Steril1998: O-290: S108.
129. Gleicher N, Karande V, Pratt D, Rinehart J, Miller C: What is the Real Utilization of
Infertility Services in an Average Patient Population with Generous Infertility Benefits?
Abstract from the 54th ASRM Annual Meeting Program Supplement, Fertil Steril 1998
P-140: S170.
130. Gleicher N, Miller C, Pratt D, Rinehart J: Is there Value to a Utilization Review Program
(URP) for Injectable Fertility Medications? 54th ASRM Annual Meeting Program
Supplement, Fertil Steril 1998: P-141: S170-S171.
131. Gleicher N, Miller C, Pratt D, Coulam C, Leman C: The Routine Use of hMG
Stimulation for Standard Ovulation Induction Results in Pregnancy Rates Superior to
Results Obtained from Routine Use of FSH Products. 54th ASRM Annual Meeting
Program Supplement, Fertil Steril 1998; P-1138: S477.
132. Gleicher N, Coulam C: Autoantibodies in Reproduction.VII the International Congress
of Reproductive Immunology, Ame J Reprod Immun, 1998; 34: 249.
133. Gleicher N, Kaberlein G, Pratt D, Rinehart J, Morris R, Rao R, Karande V: Definition of
High Risk Patients for High-Order Multiple Pregnancies With Ovarian Stimulation by
Gonadotripns. Conjoint Annual ASRM/CFAS Meeting Program Supplement, Fertil
Steril 1999: O-155.
134. Pratt D, Coulam C, Karande V, Gleicher N: What Are the True Cumulative Pregnancy
Rates of Patients Entering a Standard Treatment Algorithm for Infertility? Conjoint
Annual ASRM/CFAS Meeting Program Supplement, Fertil Steril 1999: O-172.
135. Karande V, Chapman C, Gleicher N: Is There Any Value in Splitting Sibling Oocytes
Between Intracytoplasmic Sperm Injections (ICSI) and Conventional In Vitro
Fertilization? Conjoint Annual ASRM/CFAS Meeting Program Supplement, Fertil Steril
1999: P-175.
136. Karande V, Chapman C, Gleicher N: A Prospective Evaluation of the Value of
Blastocyst Transfere in Low Responders Undergoing IVF-ET. Conjoint Annual
ASRM/CFAS Meeting Program Supplement, Fertil Steril 1999: P-176.
137. Gleicher N, Rinehart J, Pratt D, Morris R, Rao R, Balin M, Karande V: How Does
Female Age Affect Medication Utilization in IVF? Conjoint Annual ASRM/CFAS
Meeting Program Supplement, Fertil Steril 1999: P-177.
138. Gleicher N, Coulam C, Pratt D, Rinehart J, Morris R, Rao R, Balin M, Karande V:
Comparison of Utilization Patterns in Consecutive Years: Is There Value in a Formal
Utilization Review Program for Infertility Services? Conjoint Annual ASRM/CFAS
Meeting Program Supplement, Fertil Steril 1999: P-347.
139. Gleicher N, Kaberlein G, Rinehart J, Morris R, Pratt D, Rao R, Balin M, Karande V:
High Order Multiples, A Preventable or Unpreventable Complication of Controlled
Ovarian Stimulation with Gonadotropins? Conjoint Annual ASRM/CFAS Meeting
Program Supplement, Fertil Steril 1999: P-452.
140. Chapman C, Karande V, Rinehart J, Gleicher N: Does the Production of Blastocysts
from Supernumerary Embryos Predict Pregnancy Outcome After 3 Days ET? Conjoint
Annual ASRM/CFAS Meeting Program Supplement, Fertil Steril 1999:P-476.
141. Gleicher, N: How does the immune system affect IVF? J Assist Reprod Genetics, 1999;
16:144.
Page 95
142. Gleicher, N: Quality & Management Control. J Assist Reprod Genet, 1999; 16:144.
143. Gleicher N: What do abnormal autoantibodies in pregnancy really mean? Abstract frp,
the 2nd International Congress on Autoimmunity Supplement, Tel-Aviv, Israel, March 7-
11, 1999: 46.
144. Gleicher N: Gynecoradiology. Abstract from the 8th Annual Congress of the
International Society for Gynecological Endoscopy, Montreal, Canada, April 25-28,
1999: 75.
145. Gleicher, N: What is the Most Cost Effective Algorithm for Infertility Treatment.
Second World Conference of APART, Budapest, Hungary, September 14-17, 2000. J
Assist Reprod Genetics, 2000; 17:8
146. Gleicher, N: Criteria for the Prevention of High Order Multple Births Following
Ovulation Induction with Gonadotropins. ASRM 2000, 56th Annual Meeting San Diego,
CA October 21-26, 2000: Fert Steril: 2000; 74:S90
147. Gleicher N., I. Tur-Kaspa, C. Chapman, V. Karande, D. Hazlett, W. Skoog: Can We
Predict Patient’s Chance to Conceive at the Time of Embryo Transfer? ASRM 2000, 56th
Annual Meeting, San Diego, CA October 21-26, 2000 Fert Steril: 2000; 74:S111
148. Gleicher, N, I. Turkaspa, A. Vidali, V. Karande, The Changing Practice Pattern of
Infertility Care in the U.S.: ASRM 2000, 56th Annual Meeting, San Diego, CA: Oct 21-
26, 2000; Fertil Steril; 2000; 74:S248
149. Gleicher, N: The Reproductive Autoimmune Failure Syndrome: VIII International
Congress of Reproductive Immunology, Opatija, Croatia, July 2-6, 2001, AJRI, 2001;
46:31-32
150. Gleicher, N: Cost-Effective IVF: 4th World Conference of A Part, Vienna, Austria, June
28-30 2002, Journal of Assisted Reproduction and Genetics, May 2002; 19:253
151. Gleicher, N: Dehydroepiandrosterone (DHEA) treatment improves response to ovulation
induction: 21st Meeting of The European Society of Human Reproduction and
Embryology, Copenhagen, Denmark, June 19-22, 2005; 20:S1:i74
152. Barad D, Gleicher N: Dehydroepiandrosterone (DHEA) Pre-Treatment and Ovulation
Induction for In Vitro Fertilization among Women with a History of Decreased Ovarian
Reserve: Fertility and Sterility: ASRM/CFAS 2005, American Society for Reproductive
Medicine, Montreal, Quebec, September 2005, Vol 84, Sup 1.
153. Barad D, Gleicher N: Effect of Race in Ovulation Induction, Oocyte Recovery, and
Pregnancy Outcome in In-Vitro Fertilization: Fertility and Sterility: ASRM/CFAS 2005,
American Society for Reproductive Medicine, Montreal, Quebec, September 2005, Vol
84, Sup 1.
154. Gleicher N: Can we affect the aging ovary, after all?: 8th Annual Meeting of the Japan
Society of Assisted Reproduction, Osaka, Japan, September 2005, Issn 1880-4950, Vol 8.
155. Gleicher N, Barad D: Effect of Transdermal Testosterone Application. Hum Reprod
2006; 21: 3027-3031.
156. Gleicher N: Decision Models and their Application. Fertil Steril 2006; 85:813-814.
157. Weghofer A, Munne S, Brannath W, Chen S, Cohen J, Gleicher N: The quantative and
qualitative impact of gonadotropin stimulation on human preimplantation embryos. Fertil
Steril 2006; 86: S124-5.
158. Barad D, Weghofer A, Gleicher N: Evidence for an empiric definition of diminished
ovarian reserve (DOR), resistance to stimulation and diagnosis of premature ovarian
aging (POA), based on age-specific baseline. Fertil Steril 2006; 86:S125-6.
Page 96
159. Gleicher N, Weghofer A, Barad D: Adrenal function in women with premature again
ovaries. Fertil Steril 2006; 86:S401.
160. Weghofer A, Barad D, Gleicher N: Are women with premature ovarian aging (POA) at
risk for chromosomally abnormal embryos? The association between embryonic
aneuploidy rates and POA. Fertil Steril 2006; 86:S403-4.
161. Brill H, Barad D, Gleicher N: Dehydroepiandrosterone (DHEA) supplementation and
pregnancy outcome: Effect on pregnancy rate and speed of conception. Fertil Steril 2006;
86: S124-5.
162. Weghofer A, Barad D, Gleicher N: Premature Ovarian Aging (POA) is not characterized
by an increase in aneuploidy rates. Hum Reprod Abstract Book 2006; 21: Supplement 1:
i8.
163. Gleicher N, Barad D: The effect of dehydroepiandroserone on diminished ovarian reserve.
Hum Reprod Abstract Book 2006; 21: Supplement 1: i69.
164. Gleicher N: A difficult decision. J Asst Reprod Genet 2007; 23: 3-4.
165. Weghofer A, Munne S, Chen S, Barad D, Gleicher N: Lack of association between
polycystic ovary syndrome and embryonic aneuploidy. Fertil Steril 2007; 86:S462.
166. Singer T, Barad D, Gleicher N: A comparison of serum anti-mullerian hormone and cycle
baseline follicle stimulating hormone in prediction of ivf outcomes. American Society for
Reproductive Medicine, 63rd Annual Meeting, Washington, D.C. 2007.
167. Barad D, Weghofer A, Gleicher N: Age-specific cut-offs for FSH assessment of ovarian
function: improved diagnosis of premature ovarian aging (POA). American Society for
Reproductive Medicine, 63rd Annual Meeting, Washington, D.C. 2007.
168. Gleicher N, Weghofer A, Barad D: Increased euploid embryos after supplementation
with DHEA in women with premature ovarian aging. American Society for Reproductive
Medicine, 63rd Annual Meeting, Washington, D.C. 2007.
169. Gleicher N, Barad D: Does gender selection devalue women? American Society for
Reproductive Medicine, 63rd Annual Meeting, Washington, D.C. 2007.
170. Weghofer A, Brill H, Barad D, Gleicher N: Does autoimmunity play a causative role in
the pathophysiology of premature ovarian aging (POA)? American Society for
Reproductive Medicine, 63rd Annual Meeting, Washington, D.C. 2007.
171. Gleicher N, Weghofer A, Li J-M, Barad D: Increased risk of POA in Chinese women.
American Society for Reproductive Medicine, 63rd Annual Meeting, Washington, D.C.
2007.
172. Barad D, Gleicher N, Weghofer A, Chen S, Cohen J: Validation of age-specific cut-offs
for ovarian function assessment by FSH levels via a second patient population: inherent
differences in patient populations between IVF centers. American Society for
Reproductive Medicine, 63rd Annual Meeting, Washington, D.C. 2007.
173. Gleicher N, Barad D: The impact of DHEA supplementation on IVF pregnancy rates in
women ages 40-47 years. American Society for Reproductive Medicine, 63rd Annual
Meeting, Washington, D.C. 2007.
174. Barad D, Gleicher N: Implantation rate and pregnancy rates following all freeze
cryopreservation cycles compared to those following cryopreservation of excess embryos.
American Society for Reproductive Medicine, 63rd Annual Meeting, Washington, D.C.
2007.
Page 97
175. Oktay K, Sahin G, Ucar F, Barad D, Blanchette H, Gleicher N: Fertility preservation is an
emerging discipline extending beyond cancer patients: analysis of a large experience.”
Fertil Steril 2008; 90(Supl): S51.
176. Oktay K, Oktem O, Barad D, Gleicher N: “Longevity of autologous ovarian transplants:
extended experience in humans.” Fertil Steril 2008; 90(Supl): S53.
177. Gleicher N, Weghofer A, Oktay K, Barad D. “Relevance of low expansion CGG triple
repeat numbers on the FMR1 gene to functional ovarian reserve.” Fertil Steril 2008;
90(Supl): S58.
178. Oktay K, Barad D, Gleicher N, Smotkin-Tangorra M. “Retrieval and cryopreservation of
large number of oocytes from a 15 year old with primary amenorrhea and diagnosis of
premature ovarian failure.” Fertil Steril 2008; 90(Supl): S91.
179. Gleicher N, Weghofer A, Oktay K, Barad D: “Autoimmune function and numbef or triple
CGG expansions on the FMR1 gene as independent risk factors for premature ovarian
senescence.” Fertil Steril 2008; 90(Supl): S151.
180. Oktay K, Kim JY, Barad D, Gleicher N, Blanchett H: “Serum FSH monitoring improves
decision making in women undergoint controlled ovarian hyperstimulation with letrozole
and follicle stimulating hormone.” Fertil Steril 2008; 90(Supl): S183.
181. Klein K, Stammler-Safar M, Krampl E, Gleicher N, Barad D, Weghofer A: “The impact
of fetal sex on prematurity in dichorial-diamniotic twin pregnancies after assisted
reproduction.” Fertil Steril 2008; 90(Supl): S209.
182. Barad DH, Weghofer A, Oktay K, Gleicher N: “Triple CGG expansions on the FMR1
gene and response to ovarian stimulation.” Fertil Steril 2008; 90(Supl): S233.
183. Gleicher N, Ryan E, Weghofer A, Oktay K, Blanco-Mejia S, Barad DH:
“Dehydroepiandrosterone (DHEA) reduces miscarriage rates in women with diminished
ovarian reserve: a multicenter study.” Fertil Steril 2008; 90(Supl): S258-259.
184. Gleicher N, Weghofer A, Oktay K, Barad D: “The distribution of causative etiologies in
infertile women with a diagnosis of spontaneous premature ovarian senescence, exclusive
of end-stage premature ovarian failure (POF).” Fertil Steril 2008; 90(Supl): S259.
185. Barad D, Oktay K, Weghofer A, Gleicher N: “Anti-Mullerian hormone (AMH), but not
follicle stimulating hormone (FSH), correlates to oocyte yield in in vitro fertilization.”
Fertil Steril 2008; 90(Supl): S259-260.
186. Goyal A, Barad DH, WEghofer A, Oktay K, Gleicher N. Predicting improvements in
ovaian reserve and pregnancy rates after supplementation of dehydroepiandrosterone
(DHEA) in diinihshed ovarian reserve. Hum Reprod 2009;24 (Suppl1):i79.
187. Barad DH, Wefhtoer A, Oktay K, Gleicher N. What are the effects of race/ethnicity on
triple CGG counts on the FMR1 (fragile X) gene? Hum Reprod 2009;24(Suppl 1):i100.
188. Oktay K, Turkcuoglu I, Barad DH, Gleicher N, Kim JY. Prospective comparison of
letrozole-FSH stimulation followed by hCG vs GnRH for fertility preservation in women
with breast cancer. Hum Reprod 2009;24(Suppl 1):i119-i120.
189. Gleicher N, Weghofer A, Oktay K, Barad DH. A potential new function of the FMR1
(fragile X) gene: Regulation of functional ovarian reserve. Hum Reprod
2009;24(Suppl1):i97.
190. Gleicher N. Weghofer A, Barad DH. Triple CGG counts on the FMR1 (fragile X) gene
vary between races/ethnicities based on distribution, but not based on normal range and
median. Fertil Steril 2009;92(Suppl):S13.
Page 98
191. Gleicher N, Goyal A, Weghofer A, Barad DH. Supplementation with
dehydroepiandrosterone (DHEA) improves ovarian reserve, as reflected by anti-
Müllerian hormone levels. Fertil Steril 2009;92(Suppl):S54-5.
192. Barad DH, Weghofer A, Goyal A, Gleicher N. Age-specific anti-Müllerian hormone
(AMH) levels discriminate at each age between poorer and better oocytes yields. Fertil
Steril 2009;92(Suppl):S101.
193. Barad DH, Weghofer A, Goyal A, Gleicher N. Further refinement in defining the effect
of heterozygous-abnormal CGG counts on the FMR1 (fragile X) gene: definition of
distinct subgroup of PCOS patients, based on normal/low genotype. Fertil Steril
2009;92(Suppl):S105.
194. Gleicher N, Weghofer A, Barad DH. The FMR1 gene, a regulator of functional ovarian
reserve over reproductive life times. Fertil Steril 2009;92(S174-5).
195. Barad DH, Weghofer A, Goyal A, Gleicher N. What does discordance between follicle
stimulating hormone (FSH) and anti-Müllerian hormone (AMH) mean? Fertil Steril
2009;92(Suppl):S178.
196. Barad DH, Weghofer A, Gleicher N. How predictive of basic pregnancy potential are
extremely low levels of anti-Müllerian hormone (AMH)? Fertil Steril
2009;92(Suppl):S178-9.
197. Weghofer A, Dietrich W, Ortner I, Barad DH, Biegelmayer C, Gleicher N. Age-specific
anti-Mullerian hormone (AMH) levels in a fertile cohort: not as stable as previously
thought. Hum Reprod 2010;25(suppl1):i2-3.
198. Barad DH, Gupta A, Gleicher N. A slim PCOS-phenotype, characterized by
heterozygous-normal/low genotype on the FMR1 (fragile X) gene. Hum Reprod
2010;25(Suppl1):i82-83.
199. Gleicher N, Barad DH. A new concept of ovarian aging: oocytes remain perpetually
"young"; it is the ovarian environment in which folliculogenesis occurs that ages. Hum
Reprod 2010;25(Suppl1):i295.
200. Lee I, Barad DH, Weghofer A, Gleicher N. New evidence as an explanation for the
negative impact of autoimmunity on reproductive success in association with IVF. Hum
Reprod 2011;26 (Suppl 1):i20-21.
201. Gleicher N, Weghofer A, Barad DH. The impact of ovarian FMR1 genotypes and sub-
genotypes in young oocyte donors on ovarian reserve and recipient pregnancy rates. Hum
Reprod 2011;26 (Suppl 1):i72-73.
202. Vidali A, Barad DH, Gleicher N. Successful treatment with intrauterine perfusion of
granulocyte colony stimulating factor (G-CSF) of chronically intractable thin
endometrium. Hum Reprod 2011;26 (Suppl 1):i222-223.
203. Weghofer A, Dietrich W, Barad DH, Gleicher N. Live birth chances in women with
extremely low anti-Mullerian hormone levels. Hum Reprod 2011;26 (Suppl1):i335.
204. Gleicher N, Shohat-Tal A, Lazzaroni E, Michaeli T, Lee HJ, Barad DH. Androgen
dynamics in women with diminished functional ovarian reserve (DOR) after
dehydroepiandrosterone (DHEA) supplementation. Fertil Steril 2012;98 (Suppl 3):S201.
205. Weghofer A, Kim A, Barad DH, Gleicher N. Increased recipient pregnancy rates are
associated with CGGn on donors’ FMR1 genes. Fertil Steril 2012;98 (Suppl 3): S269-
S270.
206. Weghofer A, Himaya E, Kushnir VA, Shohat-Tal A, Barad DH, Gleicher N. Is immune
system activation/systemic inflammation a prerequesite for successful reproduction?
Page 99
Association of immune system activation with embryo quality during in vitro fertilization
(IVF) ? Fertil Steril 2013;100(3): S329.
207. Weghofer A, Himaya E, Kushnir VA, Shohat-Tal A, Barad DH, Gleicher N. Further
evidence for an association between immune system activation/systemic inflammation
and androgen levels in infertile women. Fertil Steril 2013;100(3): S329.
208. Kushnir VA, Himaya E, Barad DH, Shohat-Tal A, Gleicher N. Adrenal response to
cosyntropin (ACTH) stimulation in patients with premature ovarian senescence. Fertil
Steril 2013;100(3): S161-162.
209. Kushnir VA, Vidali A, Barad DH, Gleicher N. Transparency of public reporting fo
clinical outcomes in assisted reproductive technology. Fertil Steril 2013;100(3): S146.
210. Himaya E, Barad DH, Kushnir VA, Shohat-Tal A, Lee HJ, Gleicher N. Does the FMR1
gene affect IVF pregnancy rate via oocytes or embryo quality? Fertil Steril 2013;100(3):
S93.
211. Lazzaroni E, Gelicher N, Yu Y, Kushnir VA, Shohat-Tal A, Barad DH. A new oocyte
scoring system with better predictability for clinical pregnancy than day 3 embryo quality.
Fertil Steril 2013;100(3): S502.
212. Lee HJ, Barad DH, Kushnir VA, Shohat-Tal A, Lazzaroni E, Gleicher N. Differences
observed during in vitro maturation (IVM) of immature oocytes from women with
diminished functional ovarian reserve (DFOR) and women with normal ovarian reserve
(NOR). Fertil Steril 2013;100(3): S232.
213. Barad DH, Kushnir VA, Shohat-Tal A, Lazzaroni E, Lee HJ, Gleicher N. Synergistic
effects of androgen supplementation and follicle stimulating hormone (FSH) on 3
consecutive IVF cycles in women with diminished functional ovarian reserve (DFOR).
Fertil Steril 2013;100(3): S519-520.
214. Lee HJ, Sen A, Barad DH, Kushnir VA, Shohat-Tal A, Gleicher N. NPR2, SMAD2/3,
BMP and GDF-9 expressions in human granulosa and cumulus cells during oocyte
maturation. Fertil Steril 2013;100(3): S233.
215. Barad DH, Kushnir VA, Shohat-Tal A, Lazzaroni E, Lee HJ, Gleicher N. Prospective
randomized study of endometrial perfusion with granulocyte colony-stimulating factor
(G-CSF) in unselected IVF cycles: impact on endometrial thickness and clinical
pregnancy rates. Fertil Steril 2013;100(3): S144.
216. Shohat-Tal A, Kushnir VA, Barad DH, Gleicher N. Genetics of exogenous
dehydroepiandrosterone (DHEA) conversion to testosterone (T) in hypoandrogenic
women as tool to individualized infertility treatments. Fertil Steril 2013;100(3): S162.
217. Kushnir VA, Himaya E, Barad DH, Weghofer A, Gleicher N. Functional ovarian reserve
assessments in young oocyte donors based on FMR1 genotypes and sub-genotypes. Fertil
Steril 2013;100(3): S114.
218. Elkayam U, Gleicher N. Preventing congenital neonatal heart block in offspring of
mothers with anti-ssa/ro and anti-SSB/La antibodies: review of literature and registered
trials. Fertil Steril 2013;100(3): S375.
219. Weghofer A, Himaya E, Kushnir VA, Barad DH, Gleicher N. The impact of thyroid
function on embryo quality for in vitro fertilization (IVF). Fertil Steril 2013;100(3): S333.
220. Himaya E, Weghofer A, Kushnir VA, Shohat-Tal A, Barad DH, Gleicher N. Association
of FMR1 sub-genotypes with embryo aneuploidy and miscarriage rates following in-vitro
fertilization (IVF). Fertil Steril 2013;100(3): S190.
Page 100
221. Shohat-Tal A, Lazzaroni E, Kushnir VA, Barad DH, Gleihcer N. Correlation between
fragile-x mental retardation protein (FMRP) levels in peripheral blood lymphocytes and
in granulosa cells of preovulatory follicles in IVF cycles. Fertil Steril 2013;100(3): S230.
222. Barad DH, Lahtam GJ, Filipovic-Sadic S, Kushnir VA, Shohat-Tal A, Gleicher N.
Following previously described ovarian phenotypes of the FMR1 gene, methylation
fractions were significantly skewed between FMR1 genotypes and sub-genotypes. Fertil
Steril 2013;100(3): S345.
223. Barad DH, Khanna P, Kushnir VA, Lazzaroni-Tealdi E, Wu Y-G, Lee H-J, Gleicher N.
Differences in amh assessments between standard and new high sensitivity AMH assays
and impact on prediction of ivf outcomes. Fertil Steril 2014. 10:77.
224. Wu Y-G, Lee H-J, Barad DH, Kushnir VA, Lazzaroni-Tealdi E, Gleicher N. Effects of
advancing female age on proliferation and gene expression in cultured human granulosa
cells from post-hCG retrieved follicles. Fertil Steril 2014. 101(3): e331-e332.
225. Wu Y-G, Lee HJ, Barad DH, Kushnir VA, Lazzaroni-Tealdi E, Sen A, Gleicher N. The
effects of dehydroepiandrosterone (DHEA) on cultured human granulosa cells from
postovulatory human follicles after in vitro fertilization (IVF). Fertil Steril 2014. 102(3):
e272.
226. Khanna P, Kushnir VA, Barad DH, Gleicher N. Live births rates following oocyte
donation reflect performance of IVF centers in autologous IVF cycles. Fertil Steril 2014.
102(3): e340.
227. Kushnir VA, Khanna P, Barad DH, Gleicher N. Assesment of practice in IVF clinics in
which success in autologous and donor oocyte cyles do not correlate. Fertil Steril 2014.
102(3): e113-e114.
228. Kushnir VA, Wu Y-G, Chen I-C, Lee H-J, Barad DH, Lazzaroni-Tealdi E, Gleicher N.
Mitochondrial DNA abundance declines in human cumulus granulosa cells with age.
Fertil Steril 2014. 102(3): e331.
229. Lee H-J, Wu Y-G, Lazzaroni-Tealdi E, Barad DH, Kushnir VA, Gleicher N. Aging is
associated with differential gene expression in human granulosa and cumulus cells
leading to rapid progression of meiotic and oocyte maturation competence. Fertil Steril
2014. 102(3): e200-e201.
230. Vega M, Barad DH, Weghofer A, Kushnir VA, Gleicher N. Evidence that a degree of
mucosal inflammation is beneficial for pregnancy success in association with IVF. Fertil
Steril 2014. 102(3): e279-e280.
231. Kushnir VA, Barad DH, Albertini, DF, Darmon SK, Gleicher N, Cryopreserved Donor
Oocytes Yield Significantly Lower Birth Rates Than Fresh Oocytes. ASRM Annual
Meetings, Baltimore, USA, 10/20/2015
232. Wu Y, Albertini DF, Wang Q, Barad DH, Kushnir VA, Lazzaroni-Tealdi E, Gleicher N,
Functional Characterization Of Cultured Human Granulosa Cells In Serum Free Culture
System. ASRM Annual Meetings, Baltimore, USA, 10/21/2015
233. Vega M, Barad DH, Darmon SK, Kushnir VA, Gleicher N, Utility Of Autologous Fresh
IVF Cycles In Extremely Poor Prognosis Patients. ASRM Annual Meetings, Baltimore,
USA, 10/21/2015
234. Vega M, Barad DH, Darmon SK, Kushnir VA, Gleicher N, Live Birth Rates In Very
Poor Prognosis Patients With Non-Elective Single (neSET), 2-Embryo (2-ET) And ≥3-
Emrbyo Transfers (≥3-ET). ASRM Annual Meetings, Baltimore, USA, 10/21/2015
Page 101
235. Wu Y, Lazzaroni-Tealdi E, Wang Q, Albertini DF, Barad DH, Kushnir VA, Gleicher N,
Randomized Comparison Of Embryo Development In Closed Time-Laspse Photography
System With Traditional Standard Embryology Culture With Day-3 Embryo Transfers.
ASRM Annual Meetings, Baltimore, USA, 10/21/2015.
236. Gleicher N, Vidali A, Braverman J, Kushnir VA, Barad DH, Hudson C, Wu YG, Wang Q,
Zhang L, Albertini DF. Mosaicism in human embryos compromises accuracy of
preimplantation genetic screening (PGS). Reprod Sci Suppl. 2016;O-162.
237. Wu YG et al. What is the best lead follicle size for ovulation induction in older women
≥43 years to avoid premature luteinization of follicles? Fertil Steril 2016;106(3):e349–
e350.
238. Kushnir VA et al. Effects of newly introduced practices over 10 years (2004-2013) on
worldwide trends in assisted reproductive technology. Fertil Steril 2016;106(3):e365.
239. Kushnir VA et al. Utilization and effects of embryo banking on art outcome reporting in
the U.S. Fertil Steril 2016;106(3):e333.
240. Barad DH et al. Prevalence and effect of preimplantation genetic screening (PGS) on
oocyte donation cycles in the United States: 2005 to 2013. Fertil Steril 2016;106(3):e330.
241. Kushnir VA et al. Contribution of third party reproduction to the birth cohort following
art in the U.S.A. Fertil Steril 2016;106(3):e108.
242. Barad DH et al. Contribution of cryopreservation cycles to cumulative live birth
outcomes following oocyte donation with preimplantation genetic screening (PGS) in the
United States: 2005 to 2013. Fertil Steril 2016;106(3):e321.
243. Shapiro AJ et al. Racial and ethnic disparities in the use of third-party art in the U.S.
Fertil Steril 2016;106(3):e108-e109.
244. Shapiro AJ et al. Effect of race and ethnicity on live birth rates in third-party art cycles in
the U.S. Fertil Steril 2016;106(3):e367.
245. Kushnir VA et al. Effect of race and ethnicity on fertility rates and utilization of art in the
USA. Fertil Steril 2016;106(3):e367-e368.
246. Barad DH et al. Effect of time trends of preimplantation genetic screening (PGS)
utilization on oocyte donation cycle live birth rates in the United States: 2005 to 2013.
Fertil Steril 2016;106(3):e326.
247. Gleicher N et al. Preimplantation genetic screening (PGS) appears unable to correctly
determine ploidy of embryos from a single trophectoderm biopsy (TEB). Fertil Steril
2016;106(3):e371.
248. Barad DH et al. Effect of PGS on IVF outcomes following eSET in oocyte donation in
the United States: 2005 to 2013. Fertil Steril 2016;106(3):e209.
249. Albertini DF, et al. Ontogeny of newly described hypo-androgenic PCOS phenotype in
infertile women from younger through older ages. Hum Reprod 2017;32(Supp1):i447.
250. Barad DH, et al. Prevalence and impact of elective gender selection in oocyte donor
recipient cycles in the United States 2005-2013. Hum Reprod 2017;32(Supp1):i481.
251. Barad DH, Kushnir VA, Albertini DF, Darmon SK, Gleicher N. Does gender selection in
donor-recipient cycles affect IVF cycle outcomes? Fertil Steril 2017;108(3):e342-343.
252. Kushnir VA, Choi J, Darmon SK, Albertini DF, Barad DH, Gleicher N. CDC reported
assisted reproductive technology (art) live birth rates are misleading to the public. Fertil
Steril 2017;108(3):e333.
253. Gleicher N, Barad DH, Darmon SK, Kushnir VA. Declining birth rates from IVF over the
last decade due to commoditization and industrialization. Fertil Steril 2017;108(3):e344.
Page 102
254. Gleicher N, Barad DH, Darmon SK, Kushnir VA. Deterioration of inherent treatment
prognosis of infertility patients over the last 5 years (2012-2016). Fertil Steril
2017;108(3):e344-345.
255. Shapiro A, Darmon SK, Barad DH, Gleicher N, Kushnir VA. Do serum vitamin d and
anti-mullerian hormone levels correlate in reproductive-age women? Fertil Steril
2017;108(3):e219-220.
256. Wang Q, Kushnir VA, Darmon SK, Barad DH, Wu Y-G, Zhang L, Albertini DF,
Gleicher N. Reduced mRNA levels of the FMR1 gene and changes of gene expression of
cyp19 and FSHR in infertile women with low (CGGn < 26) repeats. Fertil Steril
2017;108(3):e143.
257. Weghofer A, Kushnir VA, Darmon SK, Hu J, Lazzaroni-Tealdi E, Zhang L, Albertini DF,
Barad DH, Gleicher N. Oocyte size and morphology predict embryo quality. Fertil Steril
2018;110(4):e309-e310.
258. Weghofer A, Kushnir VA, Darmon SK, Hu J, Lazzaroni-Tealdi E, Zhang L, Albertini DF,
Barad DH, Gleicher N. Association between characteristics of infertile patients and
oocyte measurements. Fertil Steril 2018;110(4): e310.
259. Kushnir VA, Hu J, Barad DH, Weghofer A, Gleicher N. Sexual function in older
premenopausal infertile women does not correlate with patient demographics and
endocrine parameters. Fertil Steril 2018;110(4): e157.
260. Weghofer A, Darmon SK, Kushnir VA, Albertini DF, Barad DH, Gleicher N. The
ovarian sensitivity index (OSI) predicts embryo quality in oocyte donors. Fertil Steril
2018;110(4): e317.
261. Weghofer A, Darmon SK, Kushnir VA, Gleicher N, Barad DH. Euploid miscarriage is
associated with elevated serum C-reactive protein levels in infertile women. Fertil Steril
2018;110(4): e129-e130.
262. Gleicher N, Darmon SK, Albertini DF, Molinari E, Patrizio P, Barad DH. Do insulin-like
growth factor (igf-1) levels in infertility patients affect ivf outcomes? Fertil Steril 2020;
114(3): e326-e327
263. Gleicher N, Weghofer A, Albertini DF, Molinari E, Patrizio P, Barad DH. Surprising rate
of rebound in follicle growth after cessation of ovaian stimulation in initial non-
responders. Fertil Steril 2020; 114(3): e163
264. Barad DH, Albertini DF, Molinari E, Gleicher N. Transfer of chromosomal-abnormal
embryos, previously refused such transfers. Fertil Steril 2020; 114(3): e162-e163
265. Hu J, Yang M, Zhang L, Albertini DF, Molinari E, Barad DH, Gleicher N. Unique
subcellular co-localization of fmr1 with fibrillarin and amh in granulosa cells suggests
novel roles in localized regulation of cell cycle progression. Fertil Steril 2020; 114(3):
e344-e345
266. Hu J, Zhang L, Albertini DF, Molinari E, Barad DH, Gleicher N. Systemic categorization
of oocyte granulation patterns and their predictive value for ivf outcomes. Fertil Steril
2020; 114(3): e289-e290
267. Barad DH, Albertini DF, Gleicher N. Endocrine effects of intraovarian injection of
platelet-rich plasma (prp) in women with premature ovarian aging. Fertil Steril 2020;
114(3): e89
268. Barad DH, Darmon SK, Albertini DF, Molinari E, Gleicher N. Is immunoglobulin IgE
relevant for pregnancy loss? Fertil Steril 2020; 114(3): e356
Page 103
269. Yang M, Rito T, Naftaly J, Hu J, Albertini DF, Barad DH, Brivanlou AH, Gleicher. Self-
correction of mosaicism in human self-organizing gastruloids as potential explanation for
normal births after transfer of chromosomal-abnormal embryos. Fertil Steril 2020; 114(3)
Letters
1. Gleicher N: Letter of response. JAMA, 1985; 254:3247-3249
2. Gleicher N: The fetus is a graft, both biologically and legally. Fertil Steril, 1985; 44:280
3. Gleicher N: Hypertensive diseases of pregnancy: Nulliparity, primiparity, multiparity,
and gravidy. Am J Obstet Gynecol, 1987; 157:1011
4. Gleicher N: Cesarean section rates in the United States. JAMA, 1985; 253:3248-3249
5. Gleicher N, El-Roeiy A, Confino E, Friberg J: Is endometriosis an autoimmune disease?
Obstet Gynecol, 1988; 71:280-282
6. Boler L, Zbella E, Gleicher N: Quantitation of proteinuria in pregnancy by the use of
single voided urine samples. Obstet Gynecol, 1988; 71:143
7. Myers S, Gleicher N: A program to lower cesarean section rates. N Engl J Med, 1989;
320:1694
8. El-Roeiy A, Dmowski W, Radwanska E, Harlow L, Binor Z, Tummon I, Rawlins R,
Gleicher N: Endometriosis and autoantibodies. Fertil Steril, 1989; 51:1069
9. Confino E, Gleicher N: Letter in response. Fertil Steril, 1990; 53:581
10. Gleicher N, El-Roeiy A: Letter in response. Am J Obstet Gynecol, 1990; 162:867
11. Myers S, Gleicher N: 1988 U.S. cesarean-section rate: Good news or bad? N Eng J Med,
1990; 323-200
12. Gleicher N: Mandatory trial of Labor after cesarean delivery: An alternative viewpoint.
N Eng J Med, 1991; 78:727
13. Gleicher N, Pratt D, Dudkiewicz A: The association of antiphospholipid antibodies with
pregnancies complicated by fetal growth restriction. Obstet Gynecol, 1992; 79:637-638
14. Gleicher N, Dudkiewicz A, Pratt D: Biochemical pregnancies or heterophil antibodies?
Fertil Steril, 1992; 57:1363-1366
15. Gleicher N, Pratt D, Dudkiewicz A: Autoantibodies in in vitro fertilization patients.
Fertil Steril, 1992; 58:863
16. Gleicher N, Liu H, Rosenwaks Z: Autoantibody profiles as a predictor of in vitro
fertilization-embryo success. Am J Obstet Gynecol, 1995; 172: 1637-1638
17. Gleicher N, Karande V, Rao R, Balin M, Pratt D: Multiple births in couples with
infertility problems. Hum Reprod, 1995; 10: 2748-2749
18. Karande V, Rao R, Pratt D, Balin M, Levrant S, Morris R, Dudkiewica A, Gleicher N:
The efficacy of “tubal sperm perfusion”? Fertil Steril, 1996; 66: 169-170
19. Karande V, Rao R, Pratt D, Levrant S, Balin M, Morris R, Dudkiewicz A, Gleicher N:
Reply to the reply on IUI, Fertil Steril, 1997; 67: 1178-1179
20. Gleicher N, Zbella E: Case reports- spam or ham? Fertil Steril, 1998; 70:388-389
21. Gleicher N, Coulam C: Relationship of anti-FSH antibodies to ovarian failure? Fertil
Steril, 1998; 70: 1185
22. Karande V, Gleicher N: Response to letter to the editor. Fertil Steril, 1999; 72: 566-567
23. Karande V, Gleicher N: The diameter of the proximal tube – large enough for a single
sperm or do you need more? Fertil Steril, 1999; 72(5): 950
Page 104
24. Gleicher N, Brown T, Dudkiewicz A, Karande V, Rao R, Balin M, Campbell D, Pratt D:
Estradiol/progesterone substitution in the luteal phase improves pregnancy rates in
stimulated cycles – but only in younger women. Early Pregnancy, 2000; 4:064-073
25. Gleicher N, Vidali V, Karande V: Risks of multiple pregnancy – the decision belongs to
whom? Fertil Steril, August 2001; 76(2): 423-24
26. Gleicher N: Some thoughts on the reproductive autoimmune failure syndrome (RAFS)
and Th-1 versus Th-2 immune responses. American Journal of Reproductive
Immunology, 2002; 48: 252-254
27. Gleicher N: Mixed opinions on egg sharing. The Lancet, 2003; 362: 1502
28. Gleicher, N: Sex presentation and full disclosure. Fertil Steril, 2003; 80:469-470
29. Gleicher N: Pessimism and optimism. Fertil Steril, 2004; 81: 221
30. Gleicher N: A step backward or forward to somatic cell hybrids? Fertil Steril, 2005; 83:
1585-1586
31. Gleicher N: Prediction models for high-order multiple pregnancy. Fertil Steril, 2005; 83:
1888-1889.
32. Gleicher N: Measure of diagnostic accuracy for hysterography? Fertil Steril, 2005; 84;
1059-1060.
33. Gleicher N: Decision models and their applications. Fertil Steril 2006; 85: 813-814;
(author reply 813-4).
34. Gleicher N: Appropos Political Editorials. The Lancet 2006; 368:1325-6.
35. Gleicher N, Barad D: Effects of transdermanl testosterone application on the ovarian
response to FSH in poor responders undergoing assisted reproduction technique-a
prospective, randomized double-blind study. Hum Reprod. 2006; 21; 3027-3031.
36. Gleicher N, Weghofer A, Barad D: On the benefit of assisted reproduction techniques, a
comparision of the USA and Europe. Hum Reprod, 2006; 10: 1093.
37. Gleicher N, Weghofer A, Barad D: Letters to the Editor. Hum Reprod 2006; 624-626.
38. Gleicher N, Barad D: Correspondance, To the Editor. NEJM 2007; 6: 636.
39. Gleicher N: (Postpartum) Depression, an autoimmune disease? AutoImm Reviews 2007;
6(8): 572-6.
40. Gleicher N, Barad D: Mild versus standard in-vitro fertilization techniques. Lancet 2007;
369: 1855.
41. Weghofer A, Barad D, Gleicher N: Quality of residual follicles may depend on the
etiology of ‘declining’ ovarian function? Reply of the authors. Fertil Steril 2007; 88:
1481.
42. Gleicher N: Letter to the editor. Hum Reprod 2008.
43. Gleicher N and Weghofer A. Letter to the editor: topic/ Hum Reprod. 2009.
44. Oktay K, Sonmezer M, Barad D, Gleicher N: Trying to reduce ovarian damage in
patients with Hodgkin lymphoma using GnRH agonists? Fertil Steril 2009; 91: 298-299.
45. Gleicher N and Barad D: Androgen priming before ovarian stimulation for IVF. Hum
Reprod 2008; 2868-71.
46. Gleicher N and Weghofer A: Why depression is associated with increased risk toward
premature labor. Hum Reprod 2009.
47. Barad D, Weghofer A, Gleicher N: Premature ovarian failure and
dehydroepiandrosterone. Fertil Steril 2009;91(5):e16.
48. Barad D, Gleicher N: Less may, indeed, be less: multi-collinearity in studies of ovarian
reserve. Fertil Steril 2009;91(5):e16.
Page 105
49. Gleicher N, Barad DH: Androgen priming before ovarian stimulation for IVF. Hum
Reprod 2009;23:2868-70.
50. Barad DH et al.: Premature ovarian failure and dehydroepiandrosterone. Fertil Steril
2009;91 (5):e14.
51. Weghofer et al.: Reply: Possible impact of LH-contaning gonadotrophins on diploidy
rates in preimplantataion embryos. Hum Reprod doi: 10.1093/humrep/den478.
52. Gleicher N and Weghofer A. Why depression is associated with increased risk towards
premature labor. Hum Reprod 2009, doi: 10.1093/humrep/den470.
53. Gleicher N Weghofer A and Barad DH. To the Editor, on Sunkara et al. Hum Reprod
2011
[http://humrep.oxfordjournals.org/content/early/2011/04/18/humrep.der106/reply#humre
p_el_182].
54. Gleicher N, Weghofer A, Barad DH. Letter to the editor, Intermediate and normal sized
CGG repeat on the FMR1 gene does not negatively affect donor ovarian response. Hum
Reprod 2012
[http://humrep.oxfordjournals.org/content/early/2012/05/21/humrep.des161.extract].
55. Kushnir VA, Vidali A, Barad DH, Gleicher N. Reply of the authors. Fertil Steril
2013;100(3):e18.
56. Kushnir VA, Barad DH, Gleicher N, Vidali A. Reply of the authors. Fertil Steril
2013;100(4):e26.
57. Kushnir VA, Barad DH, Gleicher N. Defining assisted reproductive technology success.
Fertil Steril 2013;100(4):e30.
58. Kushnir VA, Barad DH, Gleicher N. Association of abnormal obarian reserve parameters
with a higher incidence of aneuploid blastocysts. Obstet Gynecol 2013;121(6):1361.
59. Gleicher N, Kushnir VA, Barad DH. The danger of ignoring pregnancy and delivery rates
in ART. Hum Reprod 2014; 29(8):1828-9.
60. Gleicher N, Kushnir VA, Barad DH. What misguided campaign against SET? Hum
Reprod 2014;29(2):380-382.
61. Gleichier N, Kushnir VA, Barad DH. Fertiliy treatments and multiple births in the United
States, NEJM 2014;370:1069-1071.
62. Gleicher N, Barad DH, Kushnir VA, Sen A, Weghofer A. Poor responders and androgen
ajuvant treatment: “Still haven’t found what I’m looking for...” Reprod Biomed Online
2014;29(5):650-652.
63. Gleicher N, Kushnir VA, Barad DH. Euploid single-embryo transfer is not the new IVF
paradigm. Contemporary OBGYN 2014.
64. Barad DH, Kushnri VA, Albertini DF, Gleicher N. CDC analysis of ICSI/autism:
association is not causation. Hum Reprod 2015;30(7):1745-6.
65. Kushnir VA, Barad DH, Gleicher N. Intracytoplasmic sperm injection and reproductive
outcomes. JAMA 2015;313(16):1672.
66. Kushnir VA, Barad DH, Gleicher N. Advanced reproductive age and maternal mortality.
Obstet Gynecol 2015;125(4):984.
67. Kushnir VA, Barad DH, Gleicher N. Intracytoplasmic sperm injection and reproductive
outcomes. JAMA. 2015;313:1672.
68. Kushnir VA, Barad DH, Gleicher N. Fresh vs Cryopreserved Donor Oocytes--Reply.
JAMA 2015;314(23):2570.
Page 106
69. Gleicher N, Kushnir VA, Albertini DF, Barad DH. Letter to the Editor: Including the
Zona Reticularis in the Definition of Hypoadrenalism and Hyperadrenalism. J Clin
Endocrinol Metab 2017;102(9):3569-70.
70. Gleicher N, Kushnir VA, Albertini DA, Barad DH. First birth following spindle transfer.
Reprod Biomed Online 2017;35(5):542-543.
Invited Editorials and Book Chapters
1. Gleicher N: Editorial; Am J Reprod Immunol l980; l:l.
2. Gleicher N, Siegel I: The immunologic concept of EPH gestosis. In Reproductive
Immunology, Gleicher N, ed., Alan R. Liss, Inc; l98l:229-243.
3. Gleicher N, Siegel I: Common denominators of pregnancy and malignancy. In
Reproductive Immunology, Gleicher N, ed., Alan R. Liss, Inc; l98l:339-353.
4. Siegel I, Gleicher N: Fetal and maternal red cell immune adherence (RCIA) receptors.
In Reproductive Immunology, Gleicher N, ed., Alan R. Liss, Inc; l98l:ll5-l20.
5. Siegel I, Gleicher N: The development of the fetal immune system. In Reproductive
Immunology, Gleicher N, ed., Alan R. Liss, Inc; l98l:31-40.
6. Theofilopoulos A, Gleicher N, Pereira A, Dixon F: The biology of immune complexes
and their possible role in pregnancy. In Reproductive Immunology, Gleicher N, ed., Alan
R. Liss, Inc; l98l:93-ll4.
7. Siegel I, Gleicher N. Changes in peripheral mononuclear cells in pregnancy. Am J
Reprod Immunol l98l; l:l54-l55.
8. Gleicher N, Siegel I, Cederquist LL: Do glucocorticosteroids affect the fetal immune
system? Am J Reprod Immunol l98l; l:l85.
9. Gleicher N, Elkayam U: Intrauterine dysrhythmias. In Cardiac Problems in Pregnancy,
Gleicher N and Elkayam U, eds., Alan R. Liss, Inc; 1982:5-26.
10. Gleicher N, Elkayam U: Intrauterine congestive heart failure. In Cardiac Problems in
Pregnancy, Gleicher N and Elkayam U, eds., Alan R. Liss, Inc; 1982:61-78.
11. Gleicher N, Elkayam U: When should pregnancy be contraindicated in cardiac patients?
In Cardiac Problems in Pregnancy, Gleicher N and Elkayam U, eds., Alan R. Liss, Inc;
1982:153-160.
12. Elkayam U, Gleicher N: Primary pulmonary hypertension and pregnancy. In Cardiac
Problems in Pregnancy, Gleicher N and Elkayam U, eds., Alan R. Liss, Inc; 1982:305-
316.
13. Elkayam U, Gleicher N: Physiologic changes during normal pregnancy and the
puerpurium A. Cardiovascular. In Cardiac Problems in Pregnancy, Gleicher N and
Elkayam U, eds., Alan R. Liss, Inc; 1982:535-564.
14. Elkayam U, Gleicher N: Endocardial endocarditis and pregnancy. In Cardiac Problems in
Pregnancy, Gleicher N and Elkayam U, eds., Alan R. Liss, Inc; 1982:565-578.
15. Toder V, Blank M, Gleicher N, Voljovich I, Mashiash S, Nebel H: The suppression of
natural killer (NK) activity by pregnancy. Immunology of Reproduction, Proceedings of
the 5th Symposium on the Immunology of Reproduction Varna, Bulgaria, May 25-29,
1982; 445-448.
16. Gleicher N, Siegel I: Pregnancy and the immune state. In Autoimmune Endocrine
Disease, Davies TF, ed., John Wiley & Sons, Inc; 1983:225-245.
17. Siegel I, Liu TL, Gleicher N: Red cell immune adherence(picture & test). Yearbook of
Science and the Future. Chicago: Encyclopedia Britannica, Inc., 1982.
Page 107
18. Siegel I, Gleicher N: The red army. The Sciences: Official Organ of the New York
Academy of Sciences, 1983 (January/February) 30-34.
19. Gleicher N, Friberg J: In Vitro fertilization in Illinois. The Female Patient October 1983;
8:3811-3816.
20. Adelsberg B, Gleicher N: Immune Complexes. Am J Reprod Immunol 1983; 3:152.
21. Elkayam U, Rotmensch H, Gleicher N: Treating the arrhythmias of pregnant patients.
Contemp Ob/GYN June 1984; pp 55-70.
22. Confino E, Zbella E, Elkayam U, Gleicher N: Using cardiac drugs during pregnancy.
Drug Therapy 1985; 15:131-145.
23. Gleicher N: In Vitro Fertilization. Carl Wood and Alan Trounson, eds., Book Review,
JAMA 1984; 252:3189.
24. Elrad H, Wall D, Agrawala G, Stankeyvych G, Elkayam U, Gleicher N: Mother without
cardiac history bears second child with heart block. Hospital Practice March 15, 1985; pp
100A-100E.
25. Gleicher N, Elkayam U: Principles of internal medicine in pregnancy. In Principles Of
Medical Therapy In Pregnancy, Gleicher N and Elkayam U, eds., Plenum Publishing
Corp.; 1985:3-7.
26. Gleicher N, Elkayam U: Fertility control in female patients with medical disease. In
Principles Of Medical Therapy In Pregnancy, Gleicher N and Elkayam U, eds., Plenum
Publishing Corp.; 1985:7-19.
27. Elrad H, Gleicher N: Physiologic changes during pregnancy. In Principles Of Medical
Therapy In Pregnancy, Gleicher N, ed., Plenum Publishing Corp.; 1985:33-56.
28. Mayden K, Elrad H, Gleicher N: Obstetrical ultrasound in the management of pregnancy
complicated by maternal and fetal disease. In Principles Of Medical Therapy In
Pregnancy, Gleicher N, ed., Plenum Publishing Corp.; 1985:64-77.
29. Confino E, Gleicher N: Drug abuse during pregnancy. In Principles Of Medical Therapy
In Pregnancy, Gleicher N, ed., Plenum Publishing Corp.; 1985:90-102.
30. Boler L Jr., Gleicher N: Maternal versus fetal rights. In Principles of Medical Therapy in
Pregnancy, Gleicher N, ed., Plenum Publishing Corp.; 1985:141.
31. Zbella E, Gleicher N: The pineal gland. In Principles Of Medical Therapy In Pregnancy,
Gleicher N, ed., Plenum Publishing Corp.; 1985: 269-271.
32. Confino E, Gleicher N: Metabolism during pregnancy. In Principles of Medical Therapy
in Pregnancy, Gleicher N, ed., Plenum Publishing Corp.; 1985:281-2.
33. Vermesh M, Gleicher N: Disorders of amino acid metabolism. In Principles of Medical
Therapy in Pregnancy, Gleicher N, ed., Plenum Publishing Corp.; 1985:283-285.
34. Smith P, Gleicher N: Disorders of nucleic acid metabolism. In Principles of Medical
Therapy in Pregnancy, Gleicher N, ed., Plenum Publishing Corp; 1985:289-294.
35. Zbella E, Gleicher N: Disorders of metals and metallo proteins. In Principles of Medical
Therapy in Pregnancy, Gleicher N, ed., Plenum Publishing Corp.; 1985:295-300.
36. Boler L Jr, Gleicher N: Disorders of carbohydrate metabolism. In Principles of Medical
Therapy in Pregnancy, Gleicher N, ed., Plenum Publishing Corp.; 1985:301-303.
37. Confino E, Gleicher N: Disorders of lipid metabolism pregnancy. In Principles of
Medical Therapy in Pregnancy, Gleicher N, ed., Plenum Publishing Corp.; 1985:303-308.
38. Vermesh M, Gleicher N: Disorders of connective tissue. In Principles of Medical
Therapy in Pregnancy, Gleicher N, ed., Plenum Publishing Corp.; 1985:308-311.
Page 108
39. Elkayam U, Gleicher N: The evaluation of the cardiac patient during pregnancy. In
Principles of Medical Therapy in Pregnancy, Gleicher N, ed., Plenum Publishing Corp.;
1985:639-643.
40. Zbella E, Gleicher N: The oral cavity. In Principles of Medical Therapy in Pregnancy,
Gleicher N, ed., Plenum Publishing Corp.; 1985: 811-813.
41. Gleicher N: Principles of autoimmunity in pregnancy. In Principles Of Medical Therapy
In Pregnancy, Gleicher N, ed., Plenum Publishing Corp.; 1985:990-994.
42. Vermesh M, Gleicher N: Disorders of bone and bone mineral metabolism. In Principles
Of Medical Therapy In Pregnancy, Gleicher N, ed., Plenum Publishing Corp.;
1985:1027-1033.
43. Elkayam V, Gleicher N: Cardiac arrhythmia during pregnancy. JAMA 1985; 254:1511
(answer to question).
44. Gleicher N: In Vitro Fertilization and Embryo transfer. Alan Trounson and Carl Wood
eds., Book review; JAMA 1985; 254:2974.
45. Zaffaro N, Gleicher N: Making miracles: In Vitro Fertilization. Nan and Todd Tilton
46. Confino E, Mayden K, Gleicher N: Sonographic diagnosis of ectopic pregnancy. In
Ectopic Pregnancy, DeCherney AH, ed., Aspen Publishers, Inc; 1986: 35-51.
47. Gleicher N: The cesarean section epidemic. Mt Sinai J Med 1986; 53:563-565.
48. Elkayam U, Gleicher N: Pregnancy in the patient with heart disease. In Current Therapy
in Cardiovascular Disease - 2, Fortain NJ, ed., B.C.Decker, Inc; 1987:301-305.
49. Elkayam U, Gleicher N: Anticoagulation in pregnant women with artifical heart valves.
JAMA 1987; 316:1663.
50. El-Roeiy A, Gleicher N: The immunologic concept of pre-eclampsia (EPH Gestosis). In
Handbook of Hypertension, Rubin PC (ed), Elsevier Science Publishers B.V.; 1988:257-
266.
51. El-Roeiy A, Gleicher N: Endometriosis and Autoimmunity. In Perspectives in
Immunoreproduction: Conception and Contraception, Mathur S (ed), Hemisphere
Publishing Corp.; 1988:177-191.
52. Gleicher N: A potential animal model for autoimmune reproductive failure. Am J Reprod
Immunol Microbiol 1987; 14:122.
53. Gleicher N: Progress in infertility. Behrman ed, Book Review, JAMA 1988; Volume:
3628-3629.
54. Gleicher N: The physiological role of autoantibodies in reproduction. Proceedings of the
4th International Congress of Reproductive Immunology, Kiel, FRG, July 26-29, 1989. J
Reprod Immunol (Suppl).
55. Gleicher N: IVF and immunological infertility. In Advances in Assisted Reproductive
Technologies, Mashiach S, Ben-Rafael Z, Laufer N, Schenker J, eds., Plenum Press, New
York; 1989:459-463.
56. Elkayam U, Gleicher N: Hemodynamics and cardiac function during normal pregnancy
and the puerperium. In Cardiac Problems in Pregnancy, 2nd Edition, Elkayam U,
Gleicher N, eds., Alan R. Liss, Inc, New York; 1990:5-24.
57. Elkayam U, Gleicher N: Changes in cardiac findings during normal pregnancy. Idem
1990:31-38.
58. Elkayam U, Gleicher N: Diagnostic approaches to maternal heart disease during
pregnancy. Idem 1990:41-45.
Page 109
59. Elkayam U, Cobb T, Gleicher N: Congenital heart disease and pregnancy. Idem
1990:73-98.
60. Elkayam U, Gleicher N: Primary pulmonary hypertension and pregnancy. Idem
1990:189-197.
61. Gleicher N, Elkayam U: Fertility control in the cardiac patient. Idem 1990:453-460.
62. Gleicher N, Elkayam U: Fetal heart rate and rhythm disorders. Idem 1990:723-748.
63. Gleicher N, Elkayam U: Intrauterine therapy of rhythm and rate disorders. Idem
1990:749-763.
64. Confino E, Gleicher N: Pregnancy wastage with abnormal autoimmunity. In
Immunology and Allergy Clinics of North America 1990:103-108.
65. Tur-Kaspa I, Gleicher N: Diagnosis Eclampsia. Hospital Med 1990; 26:55-68.
66. Gleicher N: Immunology of pregnancy: The relationship to autoimmune pathology. In
Pregnancy, Autoimmunity and Connective Tissue Disorders, Scott JS and Bird HA, eds.,
Oxford University Press; 1991:1-14.
67. Gleicher N: Autoimmunity and Reproductive Failure. In Frontiers in Human
Reproduction, Vol 626, Markku Seppala, Lars Hamberger, eds., New York Academy of
Sciences; 1991: 537-544.
68. Tur-Kaspa I, Gleicher N: Immunology of the uterus. In The Uterus Altcheck A,
Deligdisch L, eds., Springer-Verlag Publishers; 1991:27-38.
69. Gleicher N: Discussion of Martin Jr JN, Blake PG, Perry Jr KG, McCaul JF, Hess LW,
Martin RW: The material history of HELPP syndrome: Patterns of disease progression
and regression. Am J Obstet Gynecol 1991; 164:1509-1510.
70. Gleicher N, Elkayam U: Fertility Control in the Female Patient with Medical Disease. In
Principles and Practice of Medical Therapy in Pregnancy, 2d Edition, Gleicher N, ed.,
Appleton & Lange, Stamford, Connecticut; 1992:1-10.
71. Gleicher N, Elkayam U: Principles of Medical Care. Idem 1992:11-14.
72. Myers S, Gleicher N: Medical Records and Statistics. Idem 1992: 14-34.
73. Myers S, Gleicher N: Physiologic Changes in Normal Pregnancy. Idem 1992: 35-52.
74. Confino E, Gleicher N: Metabolism. Idem 1992:251-253.
75. Vermesh M, Gleicher N: Disorders of Amino Acid Metabolism. Idem 1992:253-255.
76. Boler L, Gleicher N: Disorders of Carbohydrate Metabolism. Idem 1992: 270-272.
77. Confino E, Gleicher N: Disorders of Lipid Metabolism. Idem 1992:272-276.
78. Tur-Kaspa I, Gleicher N: Disorders of Connective Tissue. Idem 1992:277-280.
79. Zilberstein ME, Gleicher N: Endocrinology. Idem 1992:281-300.
80. Tur-Kaspa I, Gleicher N: Disorders of the Hypothalamus and Pituitary. Idem 1992: 314-
321.
81. Zilberstein M, Feingold M, Gleicher N: Adrenal Disorders. Idem 1992:345-356.
82. Gleicher N: Autoimmunity. Idem 1992:413-421.
83. Gleicher N: The Pneumonias. Idem 1992:746-748.
84. Elkayam U, Gleicher N: The Evaluation of the Cardiac Patient. Idem 1992:759-762.
85. Vermesh M, Gleicher N: Disorders of Bone and Cartilage. Idem 1992:1170-1191.
86. Confino E, Gleicher N: Drug Abuse. Idem 1992:1214-1224.
87. Gleicher N: What’s New in Obstetrics and Gynecology. In Bulletin American College of
Surgeons 1992, 77:32-35.
88. Gleicher N: Autoimmunity in Obstetrics and Gynecology. In Immunological Obstetrics,
Coulam C, Faulk P, McIntyre J eds., Norton Medical Books. 1992:404-411.
Page 110
89. Gleicher N. Pratt D: Transvaginal Procedures for Infertility. In Progress in Infertility (4th
edition), Behrman FJ, Patton GW, Holtz G eds., Little Brown & Co. 1994:225-248.
90. Gleicher N: Immunological Infertility and Its Diagnosis. In Infertility Male and Female,
Lunenfeld B, Insler V eds., Churchill Livinstone. 1993:353-368.
91. Gleicher N, Pratt D, Parrilli M: Diagnosis of Tubal Disease by Hysterosalpingography.
In Tubal Catheterization Procedures, N. Gleicher ed., Wiley-Liss; 1992:27-54.
92. Gleicher N, Pratt D, Parrilli M: Treatment of Tubal Disease by Hysterosalpingography
and Selective Salpingography. In Tubal Catheterization Procedures, N. Gleicher ed.,
Wiley-Liss; 1992:55-68.
93. Pratt D, Gleicher N, Parrilli M: Transvaginal Tubal Catheterization for Intratubal
Insemination. In Tubal Catheterization Procedures, N. Gleicher ed., Wiley-Liss;
1992:117-125.
94. Gleicher N: Doctors heal thyselves by making moral commitments. In Physicians
Financial News ; supplement June 1992: S9-S10.
95. Gleicher N, Tur-Kaspa I: Transcervical Balloon Tuboplasty. Female Patient 1993;18:65-
68.
96. Gleicher N: Autoantibodies and pregnancy loss: Lancet 1994; 343:747-748.
97. Gleicher N, Pratt D, Karande V, Rabin D, Dudkiewicz A: The autoimmune system in
assisted reproductive technology (ART). In Frontiers in Endocrinology, Vol 4, Mori T,
Tominaga T, Aono T, Hiroi M eds., Ares-Symposia Publications 1994:199-204.
98. Gleicher N: Autoimmunity in reproduction. In Immunology and Allergy Clinics of North
99. Gleicher N: Unexplained infertility, endometriosis, and adenomyosis. In Allergy Clinics
100. Gleicher N: Editorial; Introduction - The worldwide collaborative observational study
and MULTI-Analysis on allogeneic leukocyte immunotherapy for recurrent abortion.
Am J Reprod Immunol 1994; 32: 53-54.
101. Gleicher N, Pratt D, Dudkiewicz A: Que savons-nous vraiment des anomalies des auto-
anticorps et de la maladie reproductive? Une revue critique. Contraception, Fertilité,
Sexualité 1995; 23: 239-254.
102. Gleicher N: The credibility of the profession (Editorial). J Assist Reprod Genet 1995; 12:
661-662.
103. Karande V, Gleicher N: A comparison of abnormal findings during a GynecoRadiologic
procedure. In Diagnostic Pelvic Imaging and Endoscopy in Gynecology. Brosen I,
Wamsteker K, eds.; 1997 W.B. Saunders Co.
104. Morris R, Gleicher N: Genetic abnormalities, male infertility and ICSI (editorial). Lancet
1996; 347:1277.
105. Cusick W, Gleicher N: Multiple Conceptions, Implantation, and Prematurity, Assisted
Reproduction Reviews, Copyright 1995 by Williams & Wilkins, Volume 5, No. 4.
106. Gleicher N, Demir R, Novas J, Myers S: Methods for Safe Reduction of Cesarean
Section Rates, Cesarean Section - Guidelines for Appropriate Utilization by Bruce I.
Flamm and Edward J. Quilligan, Editors.
107. Karande V, Gleicher N: Selective salpingography, Diagnostic Pelvic Imaging and
Endoscopy in Gynecology. Brosen I, Wamsteker K, eds.; 1997 W.B. Saunders Co.
108. Gleicher N: The Subspecialty Contract. In Managed Care: Infertility and Reproductive
Medicine Clinics of North America. Gleicher N, ed; W.B. Saunders Co. 1998; 9:61-69.
109. Gleicher N: The Need to Re-engineer Medical Care. Idem 1998; 9:97-106.
Page 111
110. Gleicher N, Miller C, Pratt D: How to Evaluate Infertility Programs. Idem 1998; 9: 107-
111.
111. Gleicher N: The Concept of Physician Practice Management Companies. Idem 1998; 9:
113-121.
112. Gleicher N: Be Aware of the Second Revolution: The Need to Expand the Market for
Infertility Care and How to do it. (Editorial). J Assist Reprod Genet 1998; 4: 165.
113. Gleicher N: Forward - To Intrauterine Insemination. Allahbadia, ed; Rotunda Medical
Technologies Pvt. Ltd. 1998.
114. Dmowski W, Gleicher N: Does Endometriosis Have an Adverse Effect on the
Fertilization In Vitro and the IVF Outcome? J Assist Reprod Genet 1998; 9: 527-529.
115. Elkayam U, Gleicher N: Hemodynamics and Cardiac Function During Normal
Pregnancy and the Puerperium. In Cardiac Problems in Pregnancy, 3rd Edition, Elkayam
U, Gleicher N, eds. Wiley-Liss, New York, New York; 1998: 3-20.
116. Elkayam U, Gleicher N: Cardiac Evaluation During Pregnancy. Idem 1998: 23-32.
117. Cusick W, Buttino L Jr., Gleicher N: The Normal and Abnormal Fetal Heart Rate. Idem
1998: 553-560.
118. Buttino L Jr., Cusick W, Gleicher N: Fetal Heart Rate and Rhythm Disorders. Idem
1998: 583-602.
119. Cusick W, Buttino L Jr., Gleicher N: Intrauterine Therapy of Rhythm and Rate Disorders
and Heart Failure. Idem 1998: 603-614.
120. Buttino L Jr., Gleicher N: Environmental Causes of Congenital Heart Abnormalities.
Idem 1998: 721-724.
121. Buttino L Jr., Gleicher N: Fertility Control in the Female Patient with Medical Disease.
In Principles & Practice of Medical Therapy in Pregnancy, 3rd Edition, Gleicher N, ed.
Appleton & Lange, Stamford, Connecticut; 1998: 1-11.
122. Gleicher N, Elkayam U: Principles of Medical Care. Idem 1998: 12-15.
123. Buttino L Jr., Gleicher N: Effect of Managed Care on Obstetrics. Idem 1998: 120-122.
124. Coulam C, Gleicher N: Autoimmunity. Idem 1998: 521-528.
125. Gleicher N: History of Infectious Diseases in Pregnancy. Idem 1998: 567.
126. Elkayam U, Gleicher N: Evaluating the Cardiac Patient. Idem 1998: 908-910.
127. Gleicher N: Breast Implants. Idem 1998: 1358-1360.
128. Gleicher N: Reproductive Failure Prior to the Onset of Clinical Autoimmune Disease.
Rheumatology 1999; 38:485-487.
129. Gleicher N: Assessing Outcome. J Assist Reprod Genet 2001; 18:71-72
130. Gleicher N: High-Order Multiples. OB.GYN. NEWS September 1, 2001; 7
131. Gleicher N, Karande V: Forget About Ovulation Induction! Proceed Directly to IVF. In
2nd World Congress on Controversies in Obstetrics Gynecology & Infertility Paris,
France September 6-9, 2001: Ovulation Induction and Insemination; 211-215
132. Gleicher N: Reducing the Incidence of Multiple Births. In The Journal of the Bellevue
Obstetrical & Gynecological Society 2001; XVII: 26-28.
133. Weghofer, A. Barad, D. Gleicher, N. Premature Ovarian Aging (POA) is Not
Characterized by an Increase in Aneuploidy rates. Hum. Reprod. Abstract Book 2006;
21: i8.
134. Gleicher, N. Barad, D. The Effect of Dehydroepiandroserone on Diminished Ovarian
Reserve. Hum. Reprod. Abstract Book 2006, 21: i69.
135. Gleicher N. A difficult decision. J Assist Reprod Genet 2007; 23:3-4.
Page 112
136. Gleicher N. JARG Blog. J Assist Reprod Genet 2007; 24: 557-59.
137. Gleicher N and Barad D. Update on In Vitro Fertilization Approaches. US Obstetrics and
Gynecology. 2008; 27-31.
138. Gleicher N and Barad DH. Dehydroepiandrosterone. How to Improve Your ART Success
Rates: An Evidence-Based Review of Adjuncts to IVF. 2011;93-98.
139. Gleicher N. Autoimmunity and Pregnancy. In Immunology of Pregnancy 2013. Chaouat
G, Sandra O and Ledee N eds. 2013;800-826.
140. Shohat-Tal A, et al. Anti-Müllerian hormone. Biology, role in ovarian function and
clinical significance, Obstetrics and Gynecology Advances, Nova Biomedical, Nova
Sciences Publishes Inc., 2016. 291-308.
Book Reviews
1. Dudkiewicz A, Gleicher N: Male Infertility. Comhaire FH (ed). London: Chapman and
Hall. 1995. Pp 395. ISBN 0-4132-57250-8. Lancet 1996:347:1028.
2. Coulam C, Gleicher N: Reproductive Immunology. Olding LB (ed). Berlin & Heidelberg,
Germany: Springer-Verlag. 1997 Pp 219. ISBN: 3-540-61888-0. Orgyn 1998;3:28.
Videos
1. Gleicher N: Diagnosis and Treatment of Tubal Disease by Hysterosalpingography and
Selective Salpingography. In Tubal Catheterization Procedures, N. Gleicher ed., Wiley
Liss; 1992.
2. Gleicher N: Transcervical Balloon Tuboplasty. In Tubal Catheterization Procedures, N.
Gleicher ed., Wiley-Liss; 1992.
3. Gleicher N: The bubble test: A new tool in the diagnosis of endometriosis. The American
Fertility Society Annual Meeting, Montreal Canada, October 11, 1993.
4. Oktay K, Oktem O, Barad D, Gleicher N: “Oocyte retrieval from subcutaneous
transplanted frozen-thawed ovarian tissue.” 64th Annual Meeting of the ASRM, San
Francisco, CA, November 8-12, 2008 (V-2).